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Although adolescents have the highest force of Mycobacterium tuberculosis infection1 and rapidly increasing 
burden of tuberculosis (TB) disease through 10–19 years of age,2 there are few studies on adolescent  
Mycobacterium tuberculosis infection, transmission, and TB disease in the WHO African region. Adolescents 
in the high TB burden countries of Africa are therefore an important, but neglected risk group for global 
TB control efforts. Adolescents spend a considerable amount of their time in school classrooms, but there 
is paucity of data on classroom risk of Mycobacterium tuberculosis transmission. To the best of our knowledge, 
no published study has conducted measurement of air quality and air sampling for Mycobacterium tuberculosis 
DNA in school classrooms, a novel approach that may support targeted TB disease case–finding strategies 
which may be more efficient than symptom–based TB screening in the congregate school setting. 
The overall aims of this PhD project were: 
1) To conduct a systematic review of adolescent latent TB infection (LTBI) and TB disease 
prevalence, and to examine the relationship between adolescent Mycobacterium tuberculosis infection 
and TB disease rates, in high TB burden African countries. 
2) To describe temporal changes in prevalence of LTBI among adolescents living in a single TB 
endemic South African community, across two time periods spanning the decade 2005–2015. 
3) To describe temporal changes in adolescent TB disease notification rates in the same community 
for the decade 2005–2015. 
4) To determine classroom ventilation risk for Mycobacterium tuberculosis transmission in tandem with 
a pilot study of air sampling for Mycobacterium tuberculosis DNA; and to investigate the operational 
feasibility and yield of a pragmatic, symptom–based approach to TB disease surveillance in high 
schools. 
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Methods 
To achieve Aim 1, we performed a bibliographic database search for studies conducted and published 
between 1990 and 2018 on prevalence of adolescent (10–19 years) LTBI and TB disease in high TB burden 
African countries. We calculated the ratio between the number of Mycobacterium tuberculosis infections based 
on Annual Risk of TB Infection (ARTI) estimates and the number of microbiologically–confirmed TB 
disease cases per year, and compared the observed ratio to the expected ratio of 8–12 published by Styblo 
et al.3  
To achieve Aim 2, we collected adolescent LTBI (defined by positive QuantiFERON®–TB Gold In–Tube 
test) prevalence data from eight South African high schools, spanning the decade 2005–2015, from 
databases of an adolescent cohort study (2005–2007) and an adolescent vaccine trial (2014–2015). We 
used the two–sample test of equality of proportions to compare changes in LTBI prevalence over the two 
periods. 
To achieve Aim 3, we collected adolescent TB disease notification data from the same community (using 
an electronic tuberculosis disease register) for the decade 2005–2015 and we used the Mann–Kendall test 
to explore temporal changes in notification rates. 
To achieve Aim 4, we conducted a cross sectional study of 72 classrooms occupied by 1,836 high school 
learners, in addition to 7 comparator clinic spaces selected for high a priori risk of Mycobacterium tuberculosis 
transmission, and performed ventilation (carbon dioxide concentration) measurement to define spaces 
with high ventilation risk (>1,000 ppm) and ddPCR air sampling for Mycobacterium tuberculosis DNA, with 
active TB symptom screening among learners.  
Results  
1) There is paucity of data on adolescent LTBI and TB disease prevalence in high TB burden African 
countries (1990–2018). Based on the limited available data, both LTBI (16%–55%)4–8 and TB disease 
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prevalence rates are high (180–679 cases per 100,000),6–10 but corresponding infection–to–disease 
ratios are inconsistently low compared to that expected from Styblo’s Rule.3  
2) Overall adolescent LTBI prevalence remained high and relatively unchanged (44–49%) between 2005–
2015.11 However, although average LTBI prevalence was unchanged in lower socio–economic quintile 
schools, prevalence increased in highest socio–economic quintile schools (from 20% to 38%).11 
3) Adolescent TB disease notification rates fell 45% (662 to 361 per 100,000) in the same community 
over the same period. Despite this decrease, recent TB disease prevalence remains high and is three–
fold higher in older (15–19 years) than younger (10–14 years) adolescents (566 vs. 151 per 100,000 in 
2015).  
4) More than one–third of 72 high school classrooms were inadequately ventilated and one–fifth of 
classrooms had evidence of airborne Mycobacterium tuberculosis DNA detected by ddPCR air sampling. 
The average risk of inhaling 1 Mycobacterium tuberculosis DNA copy was similar between clinics and 
classrooms. Across all classrooms the average risk of a classroom occupant inhaling 1 Mycobacterium 
tuberculosis DNA copy over 1 lesson (35 minutes) was 0.71%; and the estimated risk over 1 academic 
year was 100%. However, yield from symptom–based TB screening was low, consistent with the 
presence of undiagnosed subclinical TB cases and risk of ongoing transmission in the school setting. 
Conclusion 
Despite the encouraging decline in adolescent TB disease notification rates observed between 2005–2015 
in the study area, adolescent LTBI prevalence remains high, consistent with ongoing medium–term 
transmission. The relatively high proportion of inadequately ventilated classrooms would place learners at 
high risk of Mycobacterium tuberculosis transmission if exposed to an infectious occupant. This risk appears 
material, given the proportion of classrooms with a positive ddPCR air filtrate sample and the estimated 
cumulative risk of inhaling of at least one copy of Mycobacterium tuberculosis DNA. The presence of 
previously undiagnosed TB cases among learners is inferred from our classroom ddPCR air sampling data, 
which further suggest that pragmatic school–based TB symptom screening is an inefficient surveillance 
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strategy that likely missed learners with subclinical TB. Improved ventilation in school classrooms is a 
low–cost intervention that may reduce the risk of TB transmission in schools. New and more efficient 
targeted TB disease case–finding strategies are needed for congregate settings, including schools, in high 
TB burden countries. Based on our preliminary data, classroom ddPCR air sampling for Mycobacterium 
tuberculosis DNA appears feasible for this purpose, but requires further research to optimise diagnostic 
accuracy and demonstrate cost–effectiveness and public health value in high TB burden countries. 
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 Overview  
This thesis examines the epidemiological burden of tuberculosis (TB) among adolescents in a high TB 
burden community in South Africa (Worcester) over the decade 2005–2015 to determine epidemiological 
trends and impact of TB control efforts, describe high school classroom ventilation risk for Mycobacterium 
tuberculosis transmission and investigate air sampling for Mycobacterium tuberculosis DNA detection as a novel 
strategy for TB disease screening in congregate spaces. 
 Rationale 
A mathematical modelling study estimated that 220,000 (30%) of the 727,000 adolescent tuberculosis (TB) 
disease cases occurring globally in 2012 were in the WHO African region, resulting in an estimated African 
regional adolescent TB prevalence of 100 per 100,000.12 Although adolescents have the highest force of 
Mycobacterium tuberculosis infection1 and increasing burden of TB disease through 10–19 years in this region,2 
there are few studies on adolescent TB burden making this an important but neglected group in TB 
control. Data on the burden and temporal trends of adolescent TB disease and LTBI is vital for re–
appraisal of TB control interventions in line with the 2030 global “End TB Strategy” targets.13 
Furthermore, few studies describe where and how adolescents acquire TB infection.4 South African studies 
show that a significant proportion of adolescents, unlike younger children, acquire TB infection from non–
household settings.4, 14–16 The lack of implementation of TB disease screening in schools,17 where 
adolescents spend a considerable amount of their time, and the attendant risk of Mycobacterium tuberculosis 
transmission if exposed to an infectious learner or staff member, makes school–based TB disease 
screening, potentially including air sampling for Mycobacterium tuberculosis DNA detection, an important 
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research priority. Studies of novel TB screening tools could inform focused screening strategies that allow 
timely and effective treatment of undiagnosed cases to ensure schools are safe places for learning.20, 21  
The objectives of this thesis were:  
1) To conduct a systematic review of adolescent latent TB infection (LTBI) and TB disease 
prevalence, and to examine the relationship between adolescent Mycobacterium tuberculosis infection 
and TB disease rates, in high TB burden African countries 
2) To describe temporal changes in LTBI prevalence among adolescents living in a single TB endemic 
South African community over the decade 2005–2015 
3) To describe temporal changes in adolescent TB disease notification rates in the same community 
over the decade 2005–2015 
4) To determine classroom ventilation risk for Mycobacterium tuberculosis transmission in tandem with 
a pilot study of air sampling for Mycobacterium tuberculosis DNA; and to investigate the operational 
feasibility and yield of a pragmatic, symptom–based approach to TB disease surveillance in high 
schools. 
 Thesis structure  
The systematic review (Chapter 2) provides a background perspective against which to view subsequent 
chapters that describe temporal trends in the burden of LTBI (Chapter 3) and TB disease (Chapter 4) 
among adolescents in the study region. Chapter 5 focuses on risk for TB transmission in classrooms, where 
adolescents spend a considerable part of the school year, and evaluates classroom ventilation as a risk 
factor for exposure to airborne Mycobacterium tuberculosis and investigates the operational feasibility and yield 
of TB disease surveillance in high schools. The individual chapters are further described below: 
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Chapter 2: Systematic review of prevalence of latent Mycobacterium tuberculosis infection and 
tuberculosis disease among adolescents in high TB burden countries in Africa 
This chapter presents a systematic literature review of the prevalence and relationships between adolescent 
LTBI and TB disease in high TB burden African countries, benchmarked against expected infection–to–
disease ratios (8–12) reported by Styblo et al., and against national TB disease data reported for the year of 
study.  
Chapter 3: Temporal trends in prevalence of Mycobacterium tuberculosis infection in South 
African adolescents 
This chapter presents an analysis of temporal trends in adolescent prevalence of LTBI in the study region 
(2005–2015) to monitor the impact of TB control interventions on medium–term TB transmission. These 
data informed school selection for the field work (classroom air quality testing, symptom–based TB case–
finding, and air sampling for Mycobacterium tuberculosis DNA) that is presented in Chapter 5. 
Chapter 4: Regional changes in tuberculosis disease burden among South African adolescents 
(2005–2015) 
This chapter describes temporal changes in prevalence of TB disease in the study region over the decade 
2005–2015, in the context of the LTBI prevalence data presented in Chapter 2. 
Chapter 5: Indoor air quality and tuberculosis risk in South African schools 
This chapter examines classroom ventilation as a risk factor for Mycobacterium tuberculosis transmission; 
presents proof of concept for classroom air sampling of Mycobacterium tuberculosis DNA as a novel TB 
screening tool in congregate settings; and examines the feasibility and yield of a pragmatic school–based 
TB disease screening strategy. 
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Chapter 6: Discussion 
This chapter critically reviews overarching themes, conclusions, outstanding research questions and public 
health implications of the findings presented in the preceding chapters.  
Page | 5 
 
 References   
1. Andrews JR, Hatherill M, Mahomed H, et al. The Dynamics of QuantiFERON–TB Gold In–Tube conversion 
and reversion in a cohort of South African adolescents. Am J Respir Crit Care Med 2015; 19: 5; 584–591.  
2. Wood R, Lawn SD, Johnstone–Robertson S, et al. Tuberculosis control has failed in South Africa: time to 
reappraise strategy. S Afr Med J 2011; 101: 111–114.  
3. Styblo K. The relationship between the risk of tuberculous infection and the risk of developing infectious 
tuberculosis. Int Union Tuberc Lung Dis 1985; 60: 117–119.  
4. Middelkoop K, Bekker L, Morrow C, et al. Decreasing household contribution to tuberculosis transmission with 
age: a retrospective geographic analysis of young people in a South African township. BMC Infect Dis 2014; 14: 221.  
5. Mahomed H, Hawkridge T, Verver S, et al. The tuberculin skin test versus QuantiFERON TB Gold® in predicting 
tuberculosis disease in an adolescent cohort study in South Africa. PLoS One 2011; 6.  
6. Marais BJ, Obihara CC, Gie RP, et al. The prevalence of symptoms associated with pulmonary tuberculosis in 
randomly selected children from a high burden community. Arch Dis Child 2005; 90: 1166–1170.  
7. Mumpe–Mwanja D, Verver S, Yeka A, et al. Prevalence and risk factors of latent tuberculosis among adolescents 
in rural Eastern Uganda. Afr Health Sci 2015; 15: 851–860.  
8. Nduba V, Van’t Hoog AH, Mitchell E, et al. Prevalence of tuberculosis in adolescents, Western Kenya: 
implications for control programs. Int J Infect Dis 2015; 35: 11–17.  
9. Snow K, Hesseling A, Naidoo P, et al. Tuberculosis in adolescents and young adults: epidemiology and treatment 
outcomes in the Western Cape. Int J Tuberc Lung Dis 2017; 21: 651–657.  
10. Mahomed H, Ehrlich R, Hawkridge T, et al. Screening for TB in high school adolescents in a high burden setting 
in South Africa. Tuberculosis 2013; 93: 357–362.  
11. Bunyasi EW, Geldenhuys H, Mulenga H, et al. Temporal trends in the prevalence of Mycobacterium tuberculosis 
infection in South African adolescents. Int J Tuberc Lung Dis 2019; 23: 571–578.  
12. Snow KJ, Sismanidis C, Denholm J, et al. The incidence of tuberculosis among adolescents and young adults: a 
global estimate. Eur Respir J 2018; 51.  
13. WHO. The End tuberculosis strategy, http://www.who.int/tb/post2015_TBstrategy.pdf (Accessed 2nd July 
2018).  
Page | 6 
 
14. Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. 
PLoS Med 2008; 5.  
15. Wood R, Racow K, Bekker L, et al. Indoor social networks in a South African township: potential contribution 
of location to tuberculosis transmission. PLoS One 2012; 7.  
16. Middelkoop K, Mathema B, Myer L, et al. Transmission of tuberculosis in a South African community with a 
high prevalence of HIV infection. J Infect Dis 2015; 211: 53–61.  
17. Shung–King M. From 'stepchild of primary healthcare' to priority programme: lessons for the implementation 
of the National Integrated School Health Policy in South Africa. S Afr Med J 2013; 103: 895–898.  
18. Wood R, Morrow C, Ginsberg S, et al. Quantification of shared air: a social and environmental determinant of 
airborne disease transmission 2014. PLoS One 2014 9 (9). 
19. Sreeramareddy CT, Panduru KV, Menten J, et al. Time delays in diagnosis of pulmonary tuberculosis: a systematic 
review of literature. BMC Infect Dis 2009; 9: 91–2334–9–91.  
20. Department of Health, SA. National School Health Policy and implementation guidelines, 
http://www.ci.org.za/depts/ci/pubs/pdf/health/poldraft/schealthpol.pdf (Accessed 10th November 2014).  
21. Department of Health, SA. The South African Integrated School Health Policy 2012, 
http://www.education.gov.za/LinkClick.aspx?fileticket=x7XUJxMcfvs%3D&tabid=870&mid=2453 (Accessed 









Page | 7 
 
Chapter 2 
2. Systematic literature review of prevalence of latent Mycobacterium 
tuberculosis infection and tuberculosis disease among adolescents in 
high TB burden countries in Africa 
 Overview 
Summary 
This chapter provides a systematic literature review of published adolescent latent Mycobacterium tuberculosis 
infection (LTBI) and tuberculosis (TB) disease prevalence from high TB burden countries in Africa for 
the period 1990–2018. The chapter is organised into four main sections: (1) Chapter abstract; (2) 
Systematic review protocol, provided as published (Bunyasi E.W., Schmidt B–M, Abdullahi L.H., et al. 
Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: 
a systematic review protocol. BMJ Open 2017;7: e014609. doi:10.1136/BMJopen–2016–014609); (3) 
Systematic review findings; (4) Discussion.  
Contribution to thesis and novelty 
This systematic review provides a background perspective against which to view subsequent chapters that 
deal with the burden of latent Mycobacterium tuberculosis infection and tuberculosis disease in adolescents in 
the study region; and may inform TB control policies in high TB burden countries in Africa, including 
new preventive therapy and vaccination strategies, by providing a reference for monitoring of trends in 
adolescent TB transmission and TB disease prevalence. 
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Contributions of candidate 
The candidate conceived and wrote the protocol, reviewed the literature and wrote the findings with 
editorial input and guidance from supervisors. Co–authors contributed to research group discussions and 
commented on the final draft manuscript. 
Publication status 
The systematic review protocol is presented in the form of a peer–reviewed paper published by an 
international journal (Citation: Bunyasi E.W., Schmidt B–M, Abdullahi L.H., et al. Prevalence of latent 
TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review 
protocol. BMJ Open 2017;7). Approval was obtained from co–authors, journal editors and the Doctoral 
Degrees Board for inclusion of the published protocol. Minor protocol amendments are provided as 
Appendix 2.5. 
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 Chapter abstract 
Introduction 
Adolescents in TB endemic countries have a high force of Mycobacterium tuberculosis infection, but a lower 
TB disease incidence, compared to adults. We performed a systematic review to examine the relationships 
between adolescent LTBI and TB disease, benchmarked against expected infection–to–disease ratios (8–
12) reported by Styblo et al., and against national TB disease data for the year of study.  
Methods  
We performed a bibliographic database search for studies conducted and published in English between 1st 
January 1990 and 11th August 2018 on prevalence of adolescent (aged 10 to 19 years) latent Mycobacterium 
tuberculosis infection (LTBI) and TB disease in high TB burden countries in Africa in the following 
databases; PubMed, Scopus, Cochrane library, Web of Science, Africa Wide, CINAHL and the Africa Index Medicus; 
supplemented by a search of references of obtained articles. We calculated the ratio between the number 
of Mycobacterium tuberculosis infections based on Annual Risk of TB Infection (ARTI) estimates and the 
number of smear– and culture–positive TB disease cases per year for the same study population; and 
compared the observed ratio to the expected ratio of 8–12 published by Styblo et al.1  
Results  
Our search retrieved 14,724 articles, 9,120 of which were duplicates and thus excluded. 5,505 were 
excluded based on review of the title and abstract due to not being LTBI or TB prevalence studies. From 
full text review of 105 articles, 5 adolescent LTBI and 5 adolescent TB disease prevalence studies qualified 
for inclusion. Reported adolescent LTBI prevalence was between 42–55% in the three studies conducted 
in South Africa (2002–2009); 32% in one study conducted in Kenya (2010); and 16% in one study 
conducted in Uganda (2009–2011). Reported adolescent TB disease (i.e. all cases started on TB treatment) 
prevalence was between 210–341 cases per 100,000 in the three South African studies (2002–2013); 180 
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cases per 100,000 in one Ugandan study (2009–2011); and 679 cases per 100,000 in one Kenyan study 
(2010). However, when limited to culture–confirmed TB disease, TB rates were 320 per 100,000 in Kenya, 
308 per 100,000 in South Africa, 160 per 100,000 in Uganda. ARTI data were available for one South 
African study (Mahomed et al.)2 with a low infection–to–disease ratio  (6.3) and one Kenyan study (Nduba 
et al.)3 with a very high infection–to–disease ratio (40.1) on sputum smear, compared to the 8–12 ratio 
expected from the Styblo Rule. However, when restricted to culture–confirmed TB, infection–to–disease 
ratio was 5.7 and 2.5 for the Kenyan and South African studies respectively, which corrects for 
unconfirmed clinical cases in the Kenyan study.  
Conclusion 
This systematic review highlights the paucity of data on adolescent LTBI and TB disease prevalence in 
high TB burden countries in Africa and the high prevalence of both LTBI and TB disease in adolescents. 
Calculated infection–to–disease ratios in adolescents using sputum smear or culture confirmation were 
inconsistent (lower or higher) than expected from the Styblo Rule. The variability of prevalence estimates 
for the period 1990–2018 illustrates the need to benchmark comparisons across countries against 
microbiologically–confirmed TB disease. Improved age disaggregation of adolescent data in research 
studies and WHO reporting would facilitate evaluation and future monitoring of trends in adolescent TB 
transmission in response to TB control interventions.  
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Almost a third of the world population has latent TB infection (LTBI), approximately 10 million of whom 
develop TB disease annually, despite existence of effective, but lengthy, preventive and curative drug 
regimens. Although adolescents appear to have a very high force of Mycobacterium tuberculosis infection, their 
reported incidence of TB disease is less than that of their corresponding general population. The few 
available studies on adolescent TB infection and disease prevalence are not sufficient to address the 
apparent discordance between rates of infection and disease in high TB burden countries in Africa. 
Therefore, we aim to perform a systematic review to examine the relationship between adolescent LTBI 
and TB disease, benchmarked against national TB disease burden data. 
Methods and analysis 
A comprehensive literature search will be performed for cross–sectional studies and screening data in 
cohort studies to determine prevalence of LTBI and TB disease among adolescents in high TB burden 
countries in Africa in the following databases; Pubmed, Scopus, Cochrane library, Web of Science, Africa Wide, 
CINAHL and the Africa Index Medicus. This will be supplemented by a search of reference lists of selected 
articles for potentially relevant articles. We will restrict our search to articles published in English language 
between 1990 and 2016 among adolescents in order to obtain estimates reflective of the mature HIV 
epidemic in most high TB burden countries in Africa that occurred over this critical period. Primary 
endpoints are; prevalence of LTBI and TB disease. We will use the random–effects or fixed effects 
modelling for our meta–analysis based on heterogeneity estimates.  
Ethics and dissemination 
No ethics approval is required given this is a systematic review. Findings will be disseminated in a peer–
reviewed journal in line with the Preferred Reporting Items for Systematic reviews and Meta–Analyses (PRISMA). 
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Registration details 
This protocol is registered with the International Prospective Register of Ongoing Systematic Reviews (PROSPERO), 
registration number CRD42015023495. 
Key words 
Prevalence; latent TB infection; TB disease; adolescents; protocol; systematic review. 
Strengths and limitations of this study 
▪ To the best of our knowledge, this is the first systematic review to conduct and compare adolescent 
LTBI and TB disease prevalence in high TB burden countries in Africa. 
▪ By examining the relationship between adolescent LTBI and TB disease benchmarked against 
national TB disease burden data, our study will provide key insights into this relationship.  
▪ Data reporting adheres to the Preferred Reporting Items for Systematic reviews and Meta–
Analyses (PRISMA) guidelines for reviews (PRISMA) and protocols (PRISMA–P). 
▪ Our choice of period for review is primarily driven by the need to provide findings reflective of 
the mature HIV epidemic in high TB burden countries in Africa both before and after the advent 
of wide ART availability, thus we appreciate that our estimates will not provide old or historical 
trends in TB burden.  
▪ Our restriction of analysis to articles published in English language may introduce publication and 
language bias, respectively. 
 Introduction 
TB remains a key public health problem especially in Africa which reported almost a third of the 10.4 
million incident Tuberculosis (TB) disease cases globally in 2015. 4  The estimated incidence rate of TB 
disease in Africa in 2015, of roughly 237 cases per 100,000 people, was almost double the global average 
of 133 cases per 100,000 people.4  In 2015, TB caused 1.4 million deaths worldwide and was the leading 
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cause of death by an infectious agent. A relatively small proportion (5–15%) of an estimated 2–3 billion 
people worldwide who are latently infected with Mycobacterium tuberculosis will develop TB disease in their 
lifetime. The probability of developing TB disease is much higher among people living with HIV.4  
The force of Mycobacterium tuberculosis infection, defined as the proportion of susceptible individuals (i.e. 
individuals without latent TB infection (LTBI)) who become latently infected with Mycobacterium tuberculosis 
per annum, is a key measure of TB transmission in a defined population. Unfortunately, very few 
longitudinal cohort studies of child or adolescent LTBI exist across high TB burden countries in Africa. 
A South African longitudinal study reported a high annual force of Mycobacterium tuberculosis infection  
among adolescents of 14.0%.5 Similarly, there is paucity of data on prevalence of LTBI among adolescents 
in high TB burden countries in Africa, with most of the few available studies having been conducted in 
South Africa. A cross–sectional South African study reported an increase in prevalence of LTBI from 26% 
at 5–8 years to 53% at 14–17 years to 75% at 25 years.6-10 A nationally representative Kenyan survey of 
children aged 6–14 years reported prevalence of LTBI of 10.2%, a figure that did not significantly change 
over 2 decades, between 1986 and 2006.11 Although adolescents in Cape Town, South Africa, appear to 
have a very high force of Mycobacterium tuberculosis infection(14%)5, their reported incidence of TB disease 
(approximately 710/100,000) is less than the incidence in young adults (1,400/100,000) and less than the 
incidence in the general population (834/100,000).4, 5, 10, 12  
A new TB infection in an infant or young child is a sentinel signal of active transmission from a person, 
usually an adult within their household, with active pulmonary TB disease. Thus, we would expect high 
rates of childhood LTBI to be associated with high prevalence of adult TB disease in the same community. 
There is little research that describes settings from which adolescents acquire TB infection 13 which makes 
it difficult to explain the apparent discordance between very high rates of adolescent force of Mycobacterium 
tuberculosis infection and low rates of notified adolescent TB disease in the same community. In a South 
African township, prevalent TB infection among children aged 5 to 14 years was directly and significantly 
associated with residential (i.e. within their residential plot) exposure to an adult case of TB disease. 
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However, a non–significant association was observed for individuals aged 15–22 years despite their high 
force of Mycobacterium tuberculosis infection.13 This finding suggests increasing significance of settings other 
than residential plot as a determinant of TB infection and subsequent disease from mid–adolescence 
onwards.14, 15 Glynn et al. recently (2015) demonstrated via whole genome sequencing that, overall, known 
smear positive prior contacts accounted for less than 10% of tuberculosis cases in a Malawian community, 
and that even for those with a prior contact with smear positive tuberculosis in their family, there was a  
higher than 50% chance that they acquired their tuberculosis elsewhere, similar to our own previous 
finding in Cape Town, South Africa.13, 16, 17 Andrews et al. used statistical modelling techniques to estimate 
that up to a half of TB transmission among individuals aged 15–19 years occurs in the school setting, with 
this figure being 25% in individuals aged 0–14 years.9 If this hypothesis were true, we would expect to 
observe high prevalence of TB disease in parallel with high force of Mycobacterium tuberculosis infection 
among high school–aged adolescents in the same high burden communities. The fact that this apparently 
reasonable observation does not appear to hold true deserves further investigation. Our study will quantify 
prevalence of LTBI and TB disease among adolescents in high TB burden countries in Africa and highlight 
this pattern across these countries. However, we appreciate that the design of this systematic review may 
not provide definitive reasons for this paradoxical yet persistent observation across many countries and 
settings. Due to lack of a systematic review on prevalence of LTBI and TB disease among adolescents, 
this systematic review will provide useful data for policy by consolidating and synthesising available data 
regarding a key sub–population with the highest force of Mycobacterium tuberculosis infection5 but a relatively 
low reported notification rate of TB disease as compared to their corresponding general population. Our 
findings will not only contribute to our better understanding of TB transmission among adolescents, but 
will also inform TB policies in high TB burden countries in Africa by providing a reference for monitoring 
future TB transmission trends in the wake of global efforts to end the TB epidemic whose targets are 
defined in sustainable development goals for 2035. 4 Our findings will also be useful in planning of novel 
TB vaccine research studies among adolescents who are increasingly becoming a key focus subpopulation 
for global TB vaccine research efforts.  
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 Methods 
This protocol was developed in line with the Preferred Reporting Items for Systematic reviews and Meta–Analyses 
guidelines for protocols (PRISMA–P),18, 19 see Appendix 1 for a PRISMA–P checklist of the recommended 
bare minimum items to be included. 
2.5.1. Objectives 
Primary objectives  
▪ To determine prevalence of latent TB infection in adolescents in the 25 high TB burden countries 
in Africa as defined by the WHO in the 2016 Global TB report. 
▪ To determine prevalence of TB disease among adolescents in the 25 high TB burden countries in 
Africa, as defined by the WHO in the 2016 Global TB report. 
Secondary objective 
▪ To explore the relationship between age–specific risk of LTBI and age–specific prevalence of TB 
disease, benchmarked against published estimates of national TB disease incidence and notification 
rates. 
2.5.2. Definitions  
Prevalence of LTBI is defined as the number of individuals with LTBI divided by total number of 
individuals in a cross–sectional, population–based study or screening database in cohort studies with a 
positive or negative result from a diagnostic test for LTBI. We will consider LTBI diagnosed by the 
Tuberculin Skin Test (TST) and/or the Interferon Gamma Release Assay. 
Prevalence of TB disease is defined as the number of individuals with TB disease divided by total number 
of individuals in a cross–sectional, population–based study, or screening database in cohort studies. We 
will consider the following diagnostic modalities for TB disease: solid and liquid mycobacterial culture, 
Xpert MTB/RIF assay, sputum smear for acid fast bacilli and clinical diagnosis. Studies restricted to one 
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or more forms of non–pulmonary TB disease only e.g. Koch’s disease, TB lymphadenitis or disseminated 
TB, will not be included. Studies reporting on respiratory diseases in general and not clearly defining the 
prevalence of LTBI or TB disease will not be eligible.  
Adolescents will be defined as individuals aged between 10 to 19 years, as defined by the WHO.20 In 2016, 
the WHO defined ‘high TB burden countries’ along three broad categories that included: (1) countries 
with the highest burden of TB/HIV coinfection, (2) countries with the highest burden of multi–drug 
resistant TB and (3) countries with the highest burden of TB. This classification takes consideration of 
both the absolute number of cases of TB disease and the relative burden of TB disease after factoring the 
population size or denominator.  In this study, we will restrict our review to the 25 countries from across 
these three WHO high TB disease burden categories that are found on the African continent.4   These 
include:  (a) The Democratic Republic of Congo, (b) Ethiopia, (c) Kenya, (d) Uganda, (e) United Republic 
of Tanzania, (f) Zimbabwe, (g) South Africa, (h) Mozambique, (i) Angola, (j) Sierra Leone, (k) Central 
African Republic, (l) Congo, (m) Lesotho, (n) Liberia, (o) Namibia, (p) Zambia, (q) Botswana, (r) 
Cameroon, (s) Chad, (t) Ghana, (u) Guinea–Bissau, (v) Malawi, (w) Swaziland, (x) Somalia and (y) Nigeria. 
2.5.3. Eligibility criteria  
This is the criteria for consideration of studies for this review. 
(i) Study designs 
We will consider cross–sectional or prevalence study designs and screening data in cohort studies that 
report primary data on prevalence of LTBI or TB disease. Statistical or mathematical modelling articles, 
cost–effectiveness studies, opinion pieces, narrative reviews, case studies, case series and letters to editors 
will not be considered. Grey/unpublished literature will also be excluded. 
(ii) Participants 
Adolescent participants should be representative of the general adolescent population in the setting in 
which the study was conducted. Studies conducted among the general school–going population will also 
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be considered provided that age is reported. For studies that report on age ranges that extend beyond the 
10–to–19–year age bracket, data on individuals aged 10 to 19 years will be extracted, if possible. Otherwise, 
these data will be sought from corresponding authors. If extraction is not possible and these data are not 
obtainable from corresponding authors, at least 75% of participants should fall between the ages of 10 to 
19 years. Studies reporting prevalence of TB infection or TB disease in subpopulations that are not 
representative of the general adolescent or school–going population in a specific study setting will be 
excluded e.g. studies reporting prevalence of TB restricted to HIV positive adolescents only.  
(iii) Outcome measures  
Outcome measures of interest will include; prevalence of LTBI and TB disease. Studies which do not 
measure any of our primary outcomes; do not clearly state the case definition of LTBI or TB disease; do 
not report primary data; or lack explicit description of methodology, will be excluded.  
(iv) Time frame 
We will consider studies reported between 1st January 1990 and 1st July 2016 because this period will also 
reflect the TB burden in mature or generalised Human Immunodeficiency Virus (HIV) epidemics across 
the high TB burden countries in Africa.  
(v) Study setting 
Studies should have been performed in at least one of the 25 high TB burden countries in Africa as defined 
above. 4   Studies not conducted in one of these countries or, for multi–country studies, if data pertaining 
to the listed high TB burden countries in Africa is not obtainable, they will be excluded. 
(vi) Language 
We will only consider articles published in English language because of limited time and financial resources 
available to this study. 
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2.5.4. Search strategy 
We will systematically search for articles published between 1990 and 2016 using a combination of 
database specific medical subject headings (MeSH terms) and a range of free text or key words that will 
include the following, among others: adolescents, persons, latent, tuberculosis, LTBI, epidemiology, 
prevalence, morbidity and burden. Our draft PubMed search–term is provided in Appendix 2. The specific 
search strategies will be finalised with guidance from a health sciences librarian with expertise in systematic 
review searching with input from the project team. After the PubMed strategy is finalized, it will be adapted 
to the syntax and subject headings of the other targeted databases. We will review reference lists of selected 
articles to identify potentially relevant articles to our research questions that would have been missed by 
our search term in specified bibliographic databases. Our search will be limited to the following electronic 
databases due to limited time and financial resources; PubMed, Scopus, Web of Science, Cochrane library, Africa 
Wide, Africa Index Medicus and CINAHL. This review will not include grey/unpublished reports due to the 
low likelihood of peer–review and potential practical difficulties of obtaining supplementary or missing 
data. We appreciate that this may lead to publication bias and acknowledge this as a limitation of our 
planned review. 
2.5.5. Selection of studies 
The first author (EB) will perform a systematic search for articles by employing the search strategy. For 
duplicate articles or publications reporting the same data in multiple articles, only the more recent and/or 
complete version of the publication will be considered. EB will review references of selected articles to 
identify articles relevant to our review which would have been missed by the search strategy.  EB and BS 
will independently classify articles as either: (i) ‘included’, (ii) ‘excluded’ or (iii) ‘pending’. A ‘pending’ status 
shall imply the reviewer is unsure on whether to include or exclude an article. This classification will be 
done by applying the inclusion and exclusion criteria, and will initially be based on the title and abstract, 
and then a quick scan, assessment or reading of the full text of the articles. Articles that both reviewers 
classify as ‘excluded’ will be excluded from further consideration whereas those that both reviewers classify 
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as ‘included’ will be included in the review. We will obtain full reports for all ‘included’ titles and those 
with contradictories in classification between the two reviewers. We will seek additional information from 
study authors where necessary to resolve questions about eligibility. A discussion will be held between EB 
and BS to resolve differences or contradictories in classification of articles by reviewing full text. A third 
reviewer (LA) will be consulted to resolve persistent disagreements following discussion. We will present 
a flow chart, in keeping with PRISMA guidelines as much as practicable, to summarise the search process 
and selection of studies for the review and document reasons for exclusion of studies (see Appendix 3). 
We will include a table of all selected studies in the final review and document reasons for exclusion of 
articles.  
2.5.6. Data management 
Data management will be done by the first author (EB) in liaison with the second author (BS). A google 
drive electronic folder will be maintained for the review and will contain; the protocol, a record of obtained 
articles and documentation of steps in data synthesis and analysis (including records included and 
excluded), risk of bias and quality scoring, among others. A back–up of the electronic records will be 
stored on a laptop and on a memory flash drive. ‘Refworks’ bibliographic management software21 will be 
used to manage references. 
2.5.7. Data extraction  
EB will read, extract and collate data from selected articles on to a standardised Data Extraction Form 
(see Appendix 4). This form will be piloted on at least 4 randomly selected studies meeting the criteria for 
consideration. BS will verify abstracted data in order to reduce bias and reduce errors in data extraction. 
Data to be abstracted will include: study characteristics– title, year of publication, authors, study design; 
study setting and population– country, socio–demographics (age and gender); study conduct– number of 
study participants (total in the study and those participants with TB, by diagnostic approach and number 
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with LTBI). Reviewers will resolve disagreements by discussion, with arbitration by LA for unresolved 
disagreements. We will contact study authors for data that may resolve any uncertainties. 
2.5.8. Approach to missing data 
In the event of missing data that are key, we will attempt to contact the corresponding authors of the 
studies to obtain the relevant missing data via email. A second email will be sent after one week of the first 
email in the event of no response to the first email. A two–week wait period from the date of submission 
of the second email will be allowed for responses, failing which these studies will be excluded, if no 
communication or response is established. 
2.5.9. Assessment of risk of bias of included studies 
Risk of bias and assessment of quality will be evaluated using an assessment tool adapted from Hoy et al.22 
by Werfalli et al. who included a scoring system for evaluation of prevalence studies.23 The tool helps 
evaluate internal and external validity (see table 2.1). This tool was preferred over others because it was 
designed via an expert consensus exercise then tested, retested, validated and thus optimised for evaluation 
of quality of prevalence studies via a rigorous published process that included a review of limitations of 
existing tools.22, 24 The tool was shown to have a high inter–rater agreement.22 Two authors (EB and BS) 
will independently score the risk of bias using this tool and the mean score calculated. Agreement between 
the two raters will be assessed for each item in the tool and overall using proportion of agreement (P0) and 
the Kappa (κ) statistic. For the Kappa statistic, its values range from –1 to +1. Values of 0 or less will be 
regarded as poor agreement, 0.01 to 0.20 slight, 0.21 to 0.40 fair, 0.41 to 0.60 moderate, 0.61 to 0.80 
substantial, and 0.81 to 0.99 almost perfect agreement.25 Raw agreement and Kappa values (including their 
95% confidence intervals) will be calculated using STATA version 14.0 for windows.26 Neither of the 
review authors will be blinded to the journal titles or to the study authors or institutions. 
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Table 2.1: Risk of bias and quality assessment criteria for prevalence studies 
Item under review Quality score 
(Points) 
External Validity  
Was the study’s target population a close representation of the national population in relation to relevant 
variables? 
1 
Was the sampling frame a true or close representation of the target population? 1 
Was some form of random selection used to select the sample, OR was a census undertaken? 1 
Was the likelihood of non–response bias minimal? 1 
Total  4 points 
Internal validity  
Were data collected directly from the participants (as opposed to a proxy)? 1 
Was an acceptable case definition used in the study? 1 
Was the study instrument that measured the parameter of interest shown to have validity and reliability? 1 
Was the same mode of data collection used for all subjects?  1 
Was the length of the shortest prevalence period for the parameter of interest appropriate? 1 
Were the numerator(s) and denominator(s) for the parameter of interest appropriate? 1 
Total 6 points 
Summary item on the overall risk of study bias (low, moderate or high)  
Legend: As described by Hoy et al., the summary assessment evaluates the overall risk of study bias and is based 
on the rater’s subjective judgment given responses to the preceding 10 items. This approach is consistent with the 
Cochrane and GRADE (GRADE=Grading of Recommendation, Assessment, Development and Evaluation) 
working group27 recommendation or approaches. Furthermore, as summarized in the PRISMA (PRISMA= The 
Preferred Reporting Items for Systematic reviews and Meta–Analyses) elaboration document, summative scales that 
numerically summarize multiple components into a single number are misleading and unhelpful,28 hence our choice 
of an overall ordinal scale for risk of bias. Response options for individual items are either low (1) or high risk of 
bias (0). If there is insufficient information in the article to permit judgment of a particular item, then the article is 
deemed to be at high risk of bias with respect to that item.22, 29, 30  
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2.5.10. Data analysis 
We hypothesise that there will be substantial statistical heterogeneity in study results because prevalence 
of LTBI and TB disease varies by distribution of socioeconomic determinants of health and HIV 
prevalence within and across settings, among other factors. A priori, random effects meta–analysis will be 
preferred due to the anticipated heterogeneity. However, choice of random–effects or fixed effects 
modelling will be based on observed statistical heterogeneity. For the latter, we will not pool the results 
but summarise findings in a narrative format. Additionally, we will derive Annual Risk of LTBI using the 
formulae: 1–(1–Prevalence) 1/(mean age) for every year of adolescence. We will then describe the relationship 
between the annual risk of TB infection and observed TB prevalence from our review. Alternatively, for 
countries with insufficient data, we will describe the relationship between the Annual Risk of TB Infection 
and reported TB notification (or incidence rates estimates) by National TB Programs or estimates from 
the WHO. 
In random effects modelling, effect measures are assumed to vary between studies and the summary effect 
is the weighted average of the effects reported in different studies.31 This model directly adjusts for inverse 
of the standard error, and thus indirectly for the sample size reported in studies. Thus, studies with smaller 
standard error and larger sample sizes will be given more weight in the calculation of the pooled prevalence 
and 95% confidence intervals.  
2.5.11. Data synthesis  
Our outcome will be combined and calculated using the Cochrane Review Manager (RevMan) statistical 
software,32 according to the statistical guidelines in the Cochrane Handbook for Systematic Reviews of 
Interventions.29 If statistical heterogeneity is observed, the random effects model will be chosen over the 
fixed effects model. If there is substantial statistical heterogeneity, we will not perform a meta–analysis; a 
narrative, qualitative summary will be done supported by a table (Appendix 2.5) and figures, where 
appropriate. This will be done by the first reviewer and checked by the second reviewer for accuracy.  
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2.5.12. Assessment of reporting biases 
The potential for publication or reporting bias will be explored by funnel plots if we obtain at least 10 
articles. This will be done by visually assessing asymmetry of funnel plots. As suggested by Egger et al., 
asymmetry of funnel plots will indicate presence of publication bias.33 We appreciate that our choice of 
considering articles reported in English only (language bias) and the fact that we are only searching in a 
sample of bibliographic databases may be a source of reporting bias. 
2.5.13. Assessment and management of heterogeneity  
We anticipate clinical and statistical heterogeneity in prevalence estimates within and across settings and 
countries. Statistical heterogeneity will be quantified using the I2 test statistic to determine the extent of 
variation in effect estimates that is due to heterogeneity rather than chance. Statistical heterogeneity will 
be explored graphically by inspection of forest plots (i.e. the ‘eyeball test’). Non–overlap of 95% 
confidence intervals will suggest remarkable heterogeneity. A formal test for statistical homogeneity, the 
Cochran’s χ2 Q test statistic, will be performed using an alpha cut–off level of 10% as suggested by Higgin’s 
et al.34 and Cochrane35, due to the test statistic’s low power in detecting heterogeneity, particularly when 
the number of studies is low. The I2 test statistic will be used to quantify statistical heterogeneity between 
studies i.e. provide percentage of observed total variation across studies that is due to real heterogeneity 
rather than chance. This will provide a quantitative measure of heterogeneity. Cochrane provides the 
following rough guide to interpretation of heterogeneity: 0% to 40%: might not be important; 30% to 
60%: may represent moderate heterogeneity; 50% to 90%: may represent substantial heterogeneity; 75% 
to 100%: considerable heterogeneity.36 If substantial heterogeneity is observed, we will try to explain the 
source of heterogeneity by subgroup analysis and/or sensitivity analysis.  
2.5.14. Subgroup analysis  
Subgroup analysis will be done in order to obtain estimates that are reflective, and thus potentially more 
useful and applicable, for specific sub–population groups or settings, and will be conducted along the 
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following strata, subject to availability of sufficient data: (1) schooling status– adolescents in school vs 
those not in school; (2) country of study participants; (3) age (4) gender; (5) years of data collection, i.e. 
1990–1999, 2000–2016 and 1990–2016; and (6) diagnostic modality of LTBI and TB disease. The analysis 
along the strata of years of data collection i.e. 1990–1999 and 2000–2016 will be done in order to account 
for differences attributable to the advent of wide and free availability of anti–retroviral therapy, although 
we appreciate that HIV prevalence is generally very low among adolescents as compared to adults. 
2.5.15. Sensitivity analyses  
Sensitivity analyses will be conducted to explore the source of heterogeneity i.e. determine impact of 
specific studies on pooled prevalence estimate, by exclusion of studies with low quality scores and thus 
higher risk of bias. We will also explore exclusion of studies with deficiency in specific items on the 10–
point modified Hoy et al. quality assessment tool, in order to evaluate impact of this exclusion on pooled 
prevalence estimates. 
2.5.16. Ethics  
Given that we will utilise published anonymised data, which is publicly available and peer–reviewed, ethical 
approval is not required for this study.  
2.5.17. Dissemination (Reporting of this review) 
Our review will be reported, as much as possible, in keeping with the Preferred Reporting Items for 
Systematic reviews and Meta–Analyses (PRISMA) Statement,37 and will include the PRISMA check–list 
(or adapted as practicable). Our findings will be published in a peer–reviewed journal and as part of a 
doctoral thesis at the University of Cape Town. 
2.5.18. Synthesis of evidence 
The Preferred Reporting Items for Systematic reviews and Meta–Analyses guidelines for protocols (PRISMA–P)18, 19 
recommends gauging of overall judgement of quality of evidence from obtained articles and indicates 
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increasing support and use of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
working group27 methodology. We will consider methodological quality of included studies and strength 
of evidence and adapt the basic principles of the GRADE approach. 
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 Results 
2.6.1. Bibliographic database search and screening  
The bibliographic database search for prevalence studies on adolescent LTBI and TB disease in high TB 
burden countries in Africa conducted and published between 1st January 1990 and 11th August 2018 
retrieved 14,724 articles, 9,120 of which were excluded because of duplication. Of 5,604 articles obtained 
after exclusion of duplicates, 5,505 were excluded based on review of the title and abstract because they 
were not LTBI or TB disease prevalence studies, or they contained an exclusion criterion within the title 
or abstract that made them ineligible. 
2.6.2. Main reason for exclusion of eligible articles 
105 articles were advanced to full text screening against the full inclusion criteria. The main reason (22/105 
(21%))  for exclusion of articles during full text screening (Figure 2.1) was the inability to extract adolescent 
data due to lack of adolescent age disaggregation in childhood TB studies (with age cut–offs of 12 or 15 
years) or adult TB studies (with age cut–offs of 15 or 18 years); and the inability to obtain these data from 
authors on multiple written attempts. For example, two authors (2/22 (9%)) who replied to supplementary 
data enquiries were not able to provide disaggregated adolescent data for 10–15–year olds, or 18–19–year 
olds, respectively. Most of the excluded adult TB prevalence studies presented data for the subpopulation 
aged 15–24 years old without disaggregation of adolescent from adult data.  
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Figure 2.1: PRISMA flowchart of study selection process 
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Legend: PRISMA=Preferred Reporting Items for Systematic Reviews and Meta–analyses guidelines for reviews; 
TB=Tuberculosis; LTBI=Latent Tuberculosis Infection. Reasons for exclusion of full text articles were: Age range 
ineligible (n=1); HIV or other patient groups only (n=1); Case definition or methods unclear (n=2); Study design 
ineligible (n=2); TB contacts only (n=2); Country ineligible (n=3); Duplicate study (n=3); Language ineligible (n=3); 
Patients only (n=3); TB symptomatic individuals only (n=4); Unpublished/not a peer–reviewed article (n=4); 
Adolescent population less than 75% of study population and adolescent data unobtainable (n=6); Year ineligible 
(n=10); TB suspects only (n=11); Not a TB/LTBI prevalence study (n=20); Adolescent data (cases or denominator) 
not obtainable (n=22). 
2.6.3. Description of included studies 
A total of 8 articles qualified for inclusion in this review. These studies were conducted in only three of 
the 25 countries eligible for review (South Africa, Kenya and Uganda). Three studies exclusively reported 
LTBI prevalence; three studies exclusively reported TB disease prevalence; and two studies reported both 
LTBI and TB prevalence (see Table 2.2 and Table 2.3). All studies were conducted between 2002–2013. 
None of the included TB prevalence studies utilised the Xpert MTB/RIF® assay to diagnose TB disease. 
All but one LTBI prevalence study used the Tuberculin Skin Test (TST) to diagnose LTBI. Criteria for 
TST positivity varied across and within included studies with TST induration cut–offs of 5mm (for HIV 
positive adolescents), 10 mm and 15 mm. 
2.6.4. Adolescent LTBI and TB prevalence 
Reported adolescent LTBI prevalence ranged between 16%–55% (2002–2011) across the three countries; 
and was between 42–55% in the three studies conducted in South Africa (2002–2009);13, 38, 39 32% in the 
one study conducted in Kenya (2010);3 and 16% in the one study conducted in Uganda (2009–2011)2 
(Table 2.2).  
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Table 2.2: Adolescent LTBI prevalence in high TB burden countries in Africa 


















TST 5 mm 2894 5244 55% 
TST 10 mm 2213 5244 42% 










10–22 TST 10 mm 406 842 48% 
Mumpe–Mwanja, 
20152 
Uganda 2009 –2011 12–18 TST 
5 mm & 10 
mm 
803 4981 16% 
Nduba, 20153 Kenya 2010 12–18 TST 
5 mm & 10 
mm 
1544 4808 32% 
Legend: ref=Reference; mm=millimetres; NR=Not reported; TST= Tuberculin Skin Test; QFT=QuantiFERON 
TB Gold In–Tube; * Induration diameter ≥5 mm for HIV positive, ≥10 mm for HIV negative or unknown HIV 
status; LTBI=Latent Tuberculosis Infection 
Reported adolescent all–TB disease rates (both microbiologically–confirmed and clinically diagnosed) 
ranged between 180–679 per 100,000 across included studies (Table 2.3). Culture–confirmed adolescent 
TB disease rates in Kenya and South Africa were comparable (320 vs. 308 cases per 100,000), but almost 
double the estimate from the Ugandan study (160 cases per 100,000). Prevalence of microbiologically–
confirmed TB among adolescents was lower than the estimated country–level general population TB 
prevalence in South Africa (734 vs. 308 cases per 100,000) and Uganda (240 vs. 160 cases per 100,000) but 
comparable for Kenya (283 vs. 320 cases per 100,000).
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Denominator Adolescent TB 
prevalence 
TB incidence in 
general country 
population40 
TB prevalence in 
general country 
population40 
HIV prevalence in 
incident TB disease 









All TB 21 6,163 341 829 734 58 
Culture 
confirmed 
19 6,163 308 NR NR NR 








All TB NR NR NR 558 NR NR 
Sputum smear  1 476 210 227 NR NR 
Nduba, 
20153 
Kenya 2010 12–18 
All TB 34 5,004 679 298 283 41 
Culture 
confirmed 
16 5,004 320 NR NR NR 






All TB 2,616 955,851 274* 860 715 61 
Sputum smear NR NR NR NR NR NR 
Uganda  12–18 All TB 9 5,000 180 238 240 53 








8 5,000 160 NR NR NR 
Sputum smear 8 5,000 160 NR NR NR 
Legend: ref=reference; TB=Tuberculosis; NR=Not reported. Adolescent TB incidence and prevalence rates are not routinely reported by the World Health 
Organization. Incidence and prevalence are for the year of study conduct, or the average for the period of study conduct. Prevalence and incidence rates are per 
100,000 population. 40 The population prevalence estimates by the World Health Organization are only provided for context. It should be noted that WHO prevalence 
estimates are indirectly derived from country notification data following extrapolations.  41 This study used routine health system TB notification data and thus presents 
TB notification rate and not prevalence 
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2.6.5. Benchmarking against 2010 TB prevalence 
We compared estimates of time–adjusted adolescent TB disease prevalence rates for 2010 for the South 
African studies to the published adolescent TB prevalence rates for the Kenyan and Ugandan studies 
conducted in the same year. Time–adjusted adolescent all–TB prevalence was highest in Kenya, followed 
by South Africa and Uganda (679 vs. 269–442 vs 180 per 100,000), a pattern also observed for culture–
positive TB (320 vs. 236 vs. 160 per 100,000), but not for sputum smear–positive TB for which the rates 
in Kenya were very low (20 vs. 204 vs. 160), respectively (Figure 2.2).  
Figure 2.2: Estimated TB disease prevalence for 2010  
 
Legend: Estimated time–adjusted TB disease prevalence for 2010 for South African studies compared with 
published adolescent TB prevalence for Kenya and Uganda in that year. SA (1) = Mahomed et al.8 SA (2) = Snow et 
al.41 SA (3) = Marais et al.39 TB=Tuberculosis. Missing bars are due to non-reporting of TB prevalence in primary 
studies so that the 2010 estimate could not be generated. General population all–TB rates were obtained from the 
2011 WHO tuberculosis report for 2010.42  
2.6.6. Infection–to–disease ratios 
Styblo et al.1 did seminal work on infection–to–disease ratios by calculating the ratio between the number 
of tuberculous infections (based on ARTI estimates) and the number of smear–positive TB disease cases 
per year and obtained a ratio of 8–12 (Appendix 5). In the present study, the annual risk of TB infection 
Page | 36 
 
(ARTI) was only available for one South African study2 and one Kenyan study3, due to lack of data 
presented in the other studies2, 39, 41 (see Appendix 5). For Kenya and South Africa, the infection–to–disease 
ratio was 6.3 for Mahomed et al.  (South Africa; ARTI 3.7%);8 and 40.1 for Nduba et al.3(Kenya; 
ARTI=2.6%)43 based on sputum smear results. However, using mycobacterial culture results TB 
infection–to–disease ratio was 5.7 and 2.5 for the Kenyan and South African studies, respectively. Both 
ratios are lower than the 8–12 range expected from the Styblo rule. 
2.6.7. Assessment of quality of included studies 
All included studies scored poorly on external validity, primarily because the tool used for assessment 
depended on national surveys, with samples randomly selected from national subpopulation or censuses. 
Such studies are costly and resource–intense and are rarely conducted. The summary of quality assessment 
is attached as Appendix 6.  
 Discussion  
We identified five adolescent LTBI and five adolescent TB disease prevalence studies from three of the 
25 high TB burden countries in Africa for the period 1990–2018. Adolescent LTBI prevalence varied 
widely (16%–55%), as did TB disease prevalence (180–679 per 100,000). If adjusted for the high rate of 
clinically diagnosed, but unconfirmed TB disease in the Kenyan study, the  infection–to–disease ratio 
based only on microbiologically–confirmed TB disease was 5.7 for the Nduba et al.3 Kenyan study and 2.5 
for the Mahomed et al.8 South African study respectively. These calculated adolescent TB infection–to–
disease ratios were lower than expected from the Styblo Rule (8–12). The remaining studies reported 
insufficient data for the infection–to–disease ratio to be estimated. Therefore, although it appears that 
adolescents in South Africa, Uganda and Kenya bear a high burden of both LTBI and TB disease, there 
are insufficient data to draw any conclusions about adolescent LTBI and TB disease prevalence in the 
majority of high TB burden countries in Africa. The disparity in infection–to–disease ratios between the 
South African and Kenyan studies also suggests that additional adolescent TB research is needed to 
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understand the epidemic in this age group in these countries. However, the apparent disparity in infection–
to–disease ratios is mitigated when only culture–confirmed TB disease cases are evaluated, suggesting that 
microbiological confirmation should be a requirement for comparison of study data across different 
research settings and populations. 
We report adolescent LTBI prevalence of 42–55% in three South African studies (2002–2009),13, 38, 39 32% 
in one Kenyan study (2010)3 and 16% in one Ugandan study (2009–2011).2 These data are consistent with 
an earlier Kenyan LTBI survey conducted between 1986–1990, which reported adolescent LTBI 
prevalence of 27%.44 By contrast, reported adolescent LTBI prevalence was low in Europe, USA and 
Australia, i.e. 0.4% in Italy (2002),45 0.8% in USA (2011)46, and 2.5% in Australia (1995).47  
We report adolescent culture–confirmed TB disease prevalence of 308 per 100,000 in South Africa, 160 
cases per 100,000 in Uganda and 320 cases per 100,000 in Kenya. These findings are consistent with other 
African studies that reported aggregate data for young adults aged 15–24, which includes adolescents.  TB 
disease prevalence (smear– or culture–positive, per 100,000) in these studies was reported as 129 
(Zimbabwe, 2014), 184 (Ghana, 2013), 274 (Nigeria, 2012), 285 (Zambia, 2003–2014) and 360 (Kenya, 
2015).48 Reported TB prevalence (smear– or culture–positive, per 100,000) was also highly variable among 
young people aged 15–24 years in Asia, i.e. 45 in China (2010),48 92 in Myanmar (2010),48 103 in Bangladesh 
(2015),48 130 in Cambodia (2010),48 142 in Laos (2010),48 155 in Thailand (2012),48 241 in Pakistan (2011),48 
799 in Philippines (2016)48 and 63 in Russia (1995).49 
The relatively lower adolescent TB disease prevalence of 210 cases per 100,000 in the Marais et al. South 
African study could be explained in part by the younger study population (10–14 years) as compared to 
the other two South African studies (10–19 years), given that TB disease prevalence is three–fold higher 
in older (15–19 years) than younger adolescents (10–14 years).41  The relatively lower adolescent TB disease 
notification rate of 274 cases per 100,000 in the Snow et al. South African study could be explained in part 
by use of routine health system TB notification data, which may underestimate TB prevalence by 
approximately one–third due to under–reporting and under–diagnosis.50 Full text screening,48, 51, 52 showed 
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that few studies disaggregate TB disease data in adolescents from young adults, which limits evaluation 
and future monitoring of adolescent TB disease burden. A mathematical modelling study estimated that 
220,000 (30%) of the 727,000 adolescent TB disease cases occurring globally were in the WHO African 
region, resulting in an estimated regional adolescent TB prevalence of 100 per 100,000 (2012).52  
We also report a relatively low infection–to–disease ratio in the Mahomed et al.8 study (South Africa), 
although this estimate was consistent with 10 studies (1975–2008) for individuals of all ages conducted in 
the TB chemotherapy era that reported ratios ranging from 2.5–8.0:53  Similarly, a literature review of 13 
studies by Trunz et al.54 for individuals of all ages reported infection–to–disease ratios of 5.7–7.2  in China, 
3.8–7.4 in the Philippines, 4.8–7.9 in South Korea, and 7.8 in Cambodia.54 The very high infection–to–
disease ratio using all treated TB disease cases reported by Nduba et al.3 in Kenya is biased by  the large 
number of clinically diagnosed cases of unconfirmed TB disease, which likely over–estimates true TB 
disease prevalence in this study population. Using culture–confirmed TB only, infection–to–disease ratio 
was 5.7 and 2.5 for the Kenyan and South African studies, respectively. We also acknowledge that, as 
reviewed by Leth et al.53, Styblo’s1 proposed ratio of 8–12 may no longer be accurate, since it was derived 
for populations without access to TB chemotherapy. In summary, although our infection–to–disease ratios 
were below Styblo’s ratio of 8 to 12, they are comparable to more recent similar studies among adults (Van 
Leth et al.). Recent literature indicates Styblo’s Rule does not apply under conditions of adequate (albeit 
imperfect) TB control (Van Leth et al.). 
Methodological strengths of this study include the published, peer–reviewed systematic search strategy55  
and data reporting that adhered to the Preferred Reporting Items for Systematic Reviews and Meta–
Analyses (PRISMA–R). Potential limitations to generalisability include the few studies meeting eligibility 
criteria for inclusion, which precluded a meta–analysis; the fact that included studies were from single 
communities, which might not be representative of country–level prevalence; restriction of analysis to 
articles published in English; and differences in TST cut–off for positivity across studies which could 
impact LTBI prevalence and thus ARTI estimates. We acknowledge limitations of Styblo Rule including 
Page | 39 
 
that the ratio is highly dependent on prevalence of disease in the general community, duration of exposure 
to source cases and on the probability of exposure. 
In conclusion, we report high prevalence of both LTBI and TB disease among adolescents in high TB 
burden African countries for the period 1990–2018. Our review also highlights the variability of prevalence 
estimates across countries, the overall paucity of data on adolescent LTBI and TB disease prevalence in 
other high TB burden countries in Africa, and the need to benchmark cross–country comparisons against 
microbiologically–confirmed disease. Improved age disaggregation of adolescent data in research studies 
and WHO reporting would facilitate evaluation and future monitoring of trends in adolescent TB 
transmission in response to TB control interventions. 
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Chapter 3 
3. Temporal trends in prevalence of Mycobacterium tuberculosis 
infection in South African adolescents 
 Overview 
Summary 
This chapter compares prevalence of latent tuberculosis (TB) infection (LTBI) among adolescents living 
in a single endemic South African community, across two time periods spanning the decade 2005–2015.  
Contribution to the thesis and novelty 
Comparison of prevalence of LTBI among adolescents across two time periods in the same high TB 
burden community is important to evaluate medium–term impact of local and regional TB control 
measures. 
Contributions of candidate 
The candidate conceived and designed the study, managed the data, performed all analyses and wrote the 
manuscript with editorial input and guidance from supervisors. Co–authors contributed to research group 
discussions and commented on the final draft manuscript. The present analysis of change in LTBI 
prevalence over the decade 2005–2015 used existing baseline and comparative datasets published in part 
by Mahomed et al. (2005) and Nemes et al. (2015). 
Publication status 
This chapter is presented in the form of a peer–reviewed paper published by an international journal 
(Citation: Bunyasi, E.W., Geldenhuys H., Mulenga H., Shenje J., Luabeya A. K. K., Tameris M., Nemes 
E., Mahomed H., Rozot V., Wood R., Scriba T.J., Andrews J.R., and Hatherill M. Int J Tuberc Lung Dis 
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23(5):571–578; http://dx.doi.org/10.5588/ijtld.18.0283). Approval was obtained from co–authors, 
journal editors and the Doctoral Degrees Board for inclusion of the published paper. 
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To measure changes in adolescent prevalence of latent tuberculosis (TB) infection (LTBI) between 2005–
2015, to evaluate medium–term impact of TB control measures on LTBI. 
Design 
We compared baseline data from a cohort study (2005–2007) and a vaccine trial (2014–2015), which 
enrolled adolescents from the same 8 South African high schools. LTBI was defined by positive 
QuantiFERON®–TB Gold In–Tube test.  
Results  
We analysed data from 4,880 adolescents between 2005–2007 and 1,968 adolescents between 2014–2015, 
when average LTBI prevalence was 43.8% (95% confidence interval (CI) 28.4–59.1) vs 48.5% (CI: 41.1–
55.8), respectively. Age–specific LTBI prevalence increased between the ages of 12–18 years by 13% only 
in lower socio–economic quintile schools, in which average LTBI prevalence was unchanged between the 
two periods (54% vs 53%). In highest socio–economic quintile schools, LTBI prevalence did not increase 
with age, but average LTBI prevalence increased from 20% to 38% between the two periods. 
Conclusion 
Adolescent LTBI prevalence remained high and constant over a decade, suggesting Mycobacterium 
tuberculosis transmission to children was not impacted in the medium term by effective TB control efforts. 
Trends in adolescent LTBI prevalence should be interpreted in the context of socio–demographic factors 
that affect risk of transmission before and during adolescence. 
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 Introduction 
Childhood tuberculosis (TB) is considered a sentinel event that identifies an infectious adult contact, since 
children with pauci–bacillary disease rarely transmit to others. Similarly, prevalence of latent TB infection 
(LTBI) in children is an epidemiological indicator of recent Mycobacterium tuberculosis transmission from 
infectious adults.1 Improved adult TB control measures, including early diagnosis and effective treatment 
to decrease infectivity, would be expected to reduce childhood LTBI prevalence over time; and short–
term impact of improved TB control is likely to be noticed first in very young children. Adolescents have 
the highest force of Mycobacterium tuberculosis infection  and adolescent LTBI rates are  a barometer of 
medium–term TB transmission over a 5–10 year period.1 Therefore, temporal changes in adolescent 
prevalence of LTBI are proxy measures for medium–term impact of local, regional and national TB 
programs on childhood TB control.2 
Other measures of TB transmission include annual risk of tuberculosis infection (ARTI)3 which is an 
average measure of risk of infection over the lifetime of study participants that measures recent 
transmission only if calculated in young children.4, 5, 6, 7 In South Africa, 2005 was a key time–point in HIV 
and TB control due to scale–up of highly active antiretroviral therapy (HAART) in public health facilities.5 
Using estimated number of HIV+ individuals as the denominator for standardization, HAART coverage 
in the study community was <1% in 2004, 12% in 2007, 40% in 2013 and 55% in 20156. Sputum smear 
microscopy was replaced by Xpert MTB/RIF as the primary test for TB diagnosis in 20137. TB treatment 
supported by direct observation (directly observed treatment, short–course; DOTS) and passive TB case–
finding were in place and remained unchanged between 2005–2015.We compared prevalence of LTBI and 
ARTI among school–going South African adolescents living in a single endemic community near Cape 
Town, across two time periods spanning the decade 2005–2015, during which regional TB disease 
notification rate in the general population fell by 34% from 1,038 (2005) to 682 (2015) per 100,000 per 
annum.9   
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 Methods  
The study population includes adolescents attending state–funded high schools near Cape Town, South 
Africa. We analysed baseline data from an adolescent cohort study for the period 2005–2007;10–14 and 
screening data from an adolescent vaccine trial for the period 2014–2015 (ClinicalTrials.gov reference 
NCT02075203). LTBI status was defined by positive or negative QuantiFERON®–TB Gold In–Tube 
(QFT, Cellestis, Carnegie, VIC, Australia) test result15, excluding individuals diagnosed and treated for TB 
disease. QFT testing was performed as previously reported,10–15 and interpreted according to 
manufacturer's threshold.16 QFT testing was performed by the same research laboratory for both studies, 
which were conducted in the same eight high schools.  
State schools are classified by socio–economic status, in order to access government school subsidies, into 
five quintiles from lowest (quintile 1) to highest (quintile 5) socio–economic status.17 We studied eight 
schools (A to H), including one school in quintile 1 (D), one in quintile 2 (B), two in quintile 4 (A and C) 
and four in quintile 5 (E, F, G and H) (see Table 3.1). The quintile category of each school did not change 
and the annual student population remained similar across the two study periods. We analysed schools in 
two categories (quintiles 1, 2 and 4 vs. quintile 5), since half of the schools were quintile 5 schools for 
which parents paid higher fees. Choice of school is largely determined by affordability; we and others have 
previously demonstrated the relationship between socio–economic status and tuberculosis risk.1,2  
Prevalence of LTBI was calculated by dividing the number of individuals with a positive QFT test by the 
total number of individuals. Statistics were adjusted for complex survey design that included simple 
random sampling with adjustment for clustering at school–level using the svy suite of complex survey 
analysis commands in STATA. ARTI was calculated from LTBI prevalence using the formula ARTI = 1 
– (1 – Prevalence) 1/(mean age+0.5).4 We used the Wilcoxon rank–sum test to compare medians, the two–sample 
test of proportions to compare prevalence and socio–demographic characteristics, and logistic regression 
for regression modelling. With a sample size of 4880 and 1968 per cohort, assuming LTBI prevalence of 
55.2% in this community11, the study had 80% power to detect a difference in LTBI rate of 3.8% at α=0.05 
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Ethical approval was obtained from the Human Research Ethics Committee, University of Cape Town 
for the original studies, in which written informed consent was obtained from parents or guardians and 
assent from minor adolescents (HREC REF 045/2005 and HREC REF 471/2013), and for this analysis 
(HREC REF 163/2016).  
 Results  
3.5.1. Socio–demographic characteristics  
We analysed data for 6,848 participants with either a positive or a negative QFT result:  4,880 (71%) from 
the period 2005–2007 and 1,968 (29%) from the period 2014–2015 (See Appendix 1). The median age of 
study participants was 15.5 years (interquartile range (IQR) 14.4–16.7 years) overall and 15.3 (IQR: 14.3–
16.4) years in 2014–2015 vs. 15.6 (IQR: 14.5–16.8) years in 2005–2007; p–value<0.001). The number of 
students enrolled per school varied from a maximum of 1,865 (27%) in school A to a minimum of 116 
(2%) in school H (see Table 3.1), due to differences in size of the total available student population; 87% 
of all study participants were from four schools (schools A, B, C and D); and almost half of all students, 
3159 (46%), were from two socio–economic quintile 4 schools (schools A and C); there were no students 
from a quintile 3 school.  
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Table 3.1: Socio–demographic characteristics of study population 
Variable  2005–2007 2014–2015 P–value Combined  




NA 6848  
(100%) 






<0.001 15.5  
(14.4–16.7) 
Gender n/N  
(%) 
    




0.055 3047/6848  
(44.5%) 




0.055 3801/6848  
(55.5%) 
Ethnicity n/N  
(%) 
    




<0.001 1347/6848  
(19.6%) 




<0.001 5094/6848  
(74.4%) 




<0.001 396/6848  
(5.8%) 




0.576 11/6848  
(0.2%) 
Age     




0.007 86  
(1.3%) 
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<0.001 1003  
(14.6%) 




0.017 1500  
(21.9%) 




0.086 1559  
(22.8%) 




0.917 1370  
(20.0%) 




0.042 973  
(14.2%) 




<0.001 356  
(5.2%) 




0.525 1  
(0.0%) 
School     




<0.001 1865  
(27.2%) 




<0.001 1580  
(23.1%) 




<0.001 1294  
(18.9%) 




<0.001 1190  
(17.4%) 




0.334 355  
(5.2%) 
F 215  20  <0.001 235  
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(4.4%) (1.0%) (3.4%) 




<0.001 213  
(3.1%) 




0.046 116  
(1.7%) 
Quintile     




<0.001 1190/6848  
(17.4%) 




<0.001 1580/6848  
(23.1%) 
3 … … … … 




0.122 3159/6848  
(46.1%) 




<0.001 919/6848  
(13.4%) 
Legend: n=Number of study participants with specified attribute. N=Total number of participants forming the 
denominator; %=Percentage; IQR=Interquartile range; …=no data; NA=Not Applicable. 
3.5.2. Prevalence and risk factors for LTBI  
Overall, across both time periods, 3,459 (46.1%) of 6,848 study participants had LTBI. In multivariate 
analysis there was no significant association between risk of LTBI and sex, or time period, but a significant 
association was observed between LTBI and age, race and socio–economic quintile (Figure 3.1A and 
Table 3.2). There was an inverse association between LTBI prevalence and socio–economic quintile 
classification of schools. On average, students in quintile 5 schools had 51% lower odds of LTBI at any 
age; were less likely to be infected at school entry; and less likely to become infected between the ages of 
12–18 years, than those in lower socio–economic quintile schools (Figure 3.1B and Table 3.2). LTBI 
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prevalence was significantly lower at school entry in socio–economic quintile 5 schools (34.0% (CI: 24.2–
45.5)) than in lower socio–economic quintile schools (60.3% (CI: 51.5–68.6)), p–value=0.003. 
Figure 3.1: Prevalence of LTBI by age and socioeconomic quintiles 
 
Legend: LTBI=Latent Tuberculosis Infection. Panel A shows prevalence of LTBI by age among all students 
(grey). LTBI prevalence increased from 38.7% at 12 years to 50.3% at 18 years. Panel B shows prevalence of LTBI 
by age among students in quintile 5 schools (blue) and among students in quintiles 1, 2 and 4 schools combined 
(purple). LTBI prevalence increased from 48.2% at 12 years to 61.3% at 18 years among quintile 1, 2 and 4 schools. 
In quintile 5 schools, none of the 5 students aged 12 years had LTBI; LTBI prevalence was 26.6% at 13 years and 
20.7% at 18 years. Shaded areas represent 95% confidence interval of prevalence estimates.  
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Table 3.2: Factors associated with risk of latent tuberculosis infection 
Variable n/N  
(Prevalence of LTBI; CI) 
Crude OR  
(CI) 
P–value Adjusted OR*  
(CI) 
P–value* 
All  3459/6848  
(46.1%; 39.2 – 58.4) 
1.21  
(0.84–1.73) † 
0.255 NA NA 
Age (in years) NA 1.14  
(1.08–1.19) 
<0.001 1.16  
(1.10–1.22) 
<0.001 
Sex      
Female 1911/3801  
(47.1%; 37.0 – 57.2) 
1.00  
(Ref) 
NA 1.00  
(Ref) 
NA  
Male 1548/3047  
(45.0%; 30.4 – 59.6) 
0.92  
(0.58–1.47) 
0.682 1.06  
(0.91– 1.25) 
0.391 
Race      
Black African 669/1347  
(49.4%; 45.8 – 53.1) 
1.00  
(Ref) 
NA 1.00  
(Ref) 
NA 
Mixed race 2741/5094  
(49.7%; 40.6 – 58.8) 
1.01  
(0.73–1.40) 
0.944 1.11  
(0.84–1.48) 
0.410 
Asian 2/11  
(12.2%; 2.8 – 21.5) 
0.24  
(0.06–1.02) 
0.053 0.30  
(0.05–1.82) 
0.157 




0.001 0.29  
(0.11–0.56) 
0.005 
Socioeconomic category of school      
Quintile 1, 2 and 4 3236/5929  
(53.8%; 49.3, 58.4) 
1.00  
(Ref) 
NA 1.00  
(Ref) 
NA 
Quintile 5 223/919  0.35  0.002 0.49  0.002 
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(29.2%; 19.4, 39.0) (0.21–0.59) (0.34–0.69) 
Legend: * =Results from multivariate logistic regression adjusted for survey design with the following variables; 
age, race, school. †=the period 2014–2015 was the reference. There were no students from quintile 3 schools. 
Ref=Reference variable in analysis. CI=95% Confidence interval. LTBI=Latent tuberculosis infection. 
n/N=Number of participants with latent tuberculosis infection/total number of participants. Age of adolescents 
is between 12 and 19 years. 
3.5.3. Prevalence of LTBI across time periods 
Analysed by school and time period, prevalence of LTBI was highest in school B (quintile 2) in 2005–2007 
(64.6%) and lowest in school G (quintile 5) in 2005–2007 (12.0%) (see Figure 3.2 and Appendix 2). 
Prevalence of LTBI changed significantly over time only in three schools, increasing from 19.2% (CI: 
14.4–23.9) to 40.4% (CI: 30.5–50.3) and from 12.0% (CI: 7.4–16.6) to 28.6% (CI: 9.2–47.9) in quintile 5 
schools E and G respectively, but decreasing from 64.6% (CI: 61.9–67.3) to 55.1% (CI: 50.3–60.0) in 
quintile 2 school B (Figure 3.2). 
Figure 3.2: Prevalence of LTBI by school and time period  
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Legend: Letters A to H represent the 8 schools in the study area. Whiskers on bar charts represent 95% confidence 
intervals of the prevalence of LTBI at each school. Prevalence of LTBI significantly changed over time in 3 schools, 
increasing in quintile 5 schools E (p=<0.001) and G (p=<0.035), but falling in quintile 2 school B (p=0.001).  
There was no significant difference in overall prevalence of LTBI by sex, age or race between the two time 
periods (Table 3.3 and Figure 3.3). Students in socio–economic quintile 5 schools had the largest increase 
in prevalence of LTBI across the two time periods (from 20.4% to 38.0%), compared to all other quintile 
categories (from 54.4% to 53.2%) (Figure 3.3 and Appendix 3), increasing at all ages, although a 
statistically significant difference was only observed among students aged 16 years (Figure 3.3). Each 
quintile 5 school recorded >10% increase in prevalence of LTBI, with a collective 17.6% increase in 
prevalence (p < 0.001) between the periods 2005–2007 and 2014–2015. 
Figure 3.3: Prevalence of LTBI across two time periods, 2005–2007 and 2014–2015 
 
Legend: Panel A shows prevalence of LTBI by socioeconomic quintile category of school and time period, 2005–
2007 vs 2014–2015. Panel A shows prevalence of LTBI significantly increased among students in quintile 5 schools 
(p<0.001), but did not significantly change among students in quintile 1, 2 and 4 schools (p=0.658) across the two 
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time periods. Panels B–D show prevalence difference of LTBI by age across the two time periods, 2005–2007 vs 
2014–2015: for all students (Panel B); for students in quintile 5 schools (Panel C); and for students in quintile 1, 
2 and 4 schools (Panel D). LTBI=Latent Tuberculosis Infection. Stars represent the difference in prevalence of 
LTBI between 2005–2007 and 2014–2015 (i.e. prevalence difference). Error bars represent 95% confidence interval 
of the prevalence difference. Stars above the X–axis denote an increase in prevalence of LTBI whereas those below 
the X–axis represent a reduction in prevalence of LTBI in 2014–2015 as compared to 2005–2007. Error bars 
completely above or below the X–axis represent a statistically significant increase or decrease in prevalence. 
Table 3.3: Prevalence of latent tuberculosis infection by socio–demographic variables 
Variable  Prevalence 2005 – 2007  
{n/N (%; CI)} 
Prevalence 2014 – 2015  
{n/N (%; CI)} 
Prevalence difference  
(%; CI) 
P–value  
All  2434/4880  
(43.8%; 28.4 – 59.1) 
1025/1968  




Sex     
Male 1111/2207  
(42.5%; 22.5 – 62.4) 
437/840  




Female 1323/2673  
(45.0%; 31.1 – 58.8) 
588/1128  




Race     
Black African 386/787  
(48.0.%; 41.4 – 54.7) 
283/560  




Mixed Race 2002/3697  
(51.1%; 39.8 – 62.5) 
739/1397  




White 45/389  
(10.5%; 6.4 – 14.6) 
2/7  




Asian 1/7  
(15.8%; 0 – 41.9) 
1/4  




Age     
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13 283/658  
(36.8%; 20.7 – 52.9) 
145/345  




14 479/1032  
(40.8%; 25.8 – 55.8) 
230/468  




15 557/1084  
(44.4%; 27.4 – 61.3) 
253/475  




16 507/979  
(46.8%; 33.4 – 60.1) 
226/391 




17 379/720  
(45.7%; 29.0 – 62.3) 
156/253  




18 204/356  
(50.3%; 31.1 – 69.5) 
…* …* …* 
19 1/1 (…) * …* …* …* 
Socioeconomic quintile of school     














Legend: …*=insufficient data for generation of estimates. n/N=Number of participants with latent tuberculosis 
infection/total number of participants. CI=95% confidence interval. 
The demographic composition of study participants in quintile 5 schools changed significantly between 
the periods 2005–2007 and 2014–2015. In 2005–2007, 387/741 (52%) and 301/741 (41%) of participants 
were of White and Cape Mixed Race ancestry, respectively, whereas in 2014–2015, 136/178 (76%) and 
36/178 (20%) of participants were of Cape Mixed Race and Black African ancestry. Among quintile 5 
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schools, prevalence of LTBI significantly increased only among students of Black African ancestry, in 
whom it increased by 24.0% (CI: 9.0, 39.0). Participants were significantly older in 2005–2007 as compared 
to 2014–2015 in quintile 5 schools, although the magnitude of the difference was small: 15.5 (CI: 14.5–
16.8) vs 15.2 (CI: 14.1–16.4) respectively. Prevalence of LTBI in quintile 5 schools significantly increased 
in both sexes, by 14.3% (CI: 4.7, 23.9) and 20.0% (CI: 14.4–25.6) among female and male students, 
respectively.  
Participants in quintile 1, 2 and 4 schools were also significantly older in 2005–2007 as compared to 2014–
2015: 15.7 vs 15.3 respectively, although the magnitude of the difference was small. Prevalence of LTBI 
in these schools did not significantly increase in any racial group, or by sex, across the two time periods.  
3.5.4. Annual risk of tuberculosis infection (ARTI) 
Median age of study participants in each year of the two periods was between 14.7 and 16.0 years. Overall 
ARTI was 3.9% (CI: 2.7–5.3) per annum for the two time periods combined; and 3.6% (CI: 2.1–5.5) per 
annum in 2005–2007, compared to 4.2% (CI: 3.4–5.2) per annum in 2014–2015. ARTI varied by calendar 
year (see Table 3.4 and Appendices 4 & 5). ARTI in lower socio–economic quintile schools was 4.9% 
for school A, 5.6% for school B, 4.5% for school C, and 4.4% for school D. In highest socio–economic 
quintile schools, ARTI was 2.3% for school E, 2.3% for school F, 1.4% for school G and 3.8% for school 
H.  
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Table 3.4: Annual risk of tuberculosis infection  
Year of study Notification rate  
of TB disease in year  
Number  
(%) 
Median age  
(IQR) 












































Legend: IQR=Interquartile range; CI =95% confidence interval; TB=Tuberculosis; LTBI=Latent Tuberculosis 
Infection; ARTI=Annual risk of TB infection. Rates of TB disease are presented per 100,000 population. * / † 
Estimates were derived from the Health Systems Trust. 
 Discussion 
We showed no overall change in LTBI prevalence or ARTI among South African adolescents over the 
decade 2005–2015. Notably, school–level prevalence of LTBI varied between 12% and 65%; and school–
level ARTI varied between 1.4% and 5.6%. Students in socio–economic quintile 5 schools were less likely 
to be infected at school entry and less likely to become infected between the ages of 12–18 years, than 
those in lower socio–economic quintile schools, yet this was the only category in which overall prevalence 
of LTBI increased over the decade 2005–2015. Our finding of differential risk of LTBI by school and 
socioeconomic category, coupled with our previous finding that schools are a significant source of 
adolescent TB transmission,19 emphasises the need to understand school–level factors that put some 
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adolescents at higher risk for LTBI. We observed no difference in overall prevalence of LTBI by sex, age 
or race between the two time periods.  
Reduced TB transmission depends upon early TB case–finding and treatment. Thus LTBI prevalence and 
ARTI estimates reflect effectiveness of TB control and declining trends would reflect increasing impact 
of control programmes.20 Short–term risk of LTBI, which is best measured by force of Mycobacterium 
tuberculosis infection  in prospective cohort studies, changes quickly in response to improved diagnosis and 
treatment of active TB disease, whereas prevalence and ARTI rates change more slowly.21 Nonetheless, 
prevalence and ARTI are useful to evaluate medium–term geographical and temporal trends in TB 
transmission and effectiveness of TB control.22 Periodic LTBI surveys also have the advantage of being 
cheaper and logistically easier to conduct than cohort studies in resource–limited, high TB burden 
settings.21 Our observation that adolescent prevalence of LTBI remained high and relatively unchanged, 
while notification rates of TB disease fell in the same calendar years, may be explained by the fact that the 
adolescent ARTI and LTBI prevalence represent cumulative lifetime measures3 and the majority of latently 
infected individuals do not exhibit reversion of their positive IGRA result to negative.4 Few studies 
compare prevalence of LTBI or ARTI across two time periods among African or Asian children or 
adolescents in the same source population. In Kenya, there was an increase in prevalence of LTBI from 
5.7% to 8.7% in school children aged 6–14 years between 1986–1996.24  In South Africa, among 6–9 year–
old children, there was  no significant change in prevalence of LTBI  between 1998 and 2005 (26.2% vs 
28.9%).25 These prevalence are also representative of a period when TB notification rates were on an 
upward trend in the Western Cape Province 9 and South Africa.26 By contrast, an Egyptian study reported 
a decline in prevalence of LTBI among children aged 6–7 years over a much longer period between 1949–
1952 and 1995–1997;27 and in India there was a significant decline in prevalence of LTBI, defined by 
positive TST, among children younger than 10 years of age (from 7.8% to 6.9% to 6.0% for the periods 
1999–2001, 2001–2003 and 2004–2005, respectively), following implementation of DOTS.28 
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The key strengths of our study include the large sample size, the same community, and laboratory testing 
under rigorous conditions in the same research laboratory.31 Interpretation of our data is subject to certain 
limitations. We acknowledge that the demographic composition of study participants may not be exactly 
representative of the local community, especially in respect of racial ancestry, which is critical when 
evaluating temporal changes in prevalence of LTBI. Changing racial ancestry in quintile 5 schools over 
time may partly explain differential risks for LTBI, given the long–standing racial disparities in 
socioeconomic status of South Africans, which is in turn associated with differential risk of TB. There is 
also a high drop–out rate (30%–55%) among South Africa high school students, primarily affecting poor 
underperforming students.29 Differential drop–out by socioeconomic status might therefore lead to 
underestimation of true LTBI prevalence among older adolescents. HIV infection may also result in 
underestimation of LTBI prevalence defined by IGRA.24 However, HIV prevalence is historically low 
among adolescents in this region, for example, only 1.6% of participants diagnosed with TB disease in 
2005–2007 were confirmed HIV positive;11 and all participants in the period 2014–2015 were confirmed 
HIV ELISA negative at the time of IGRA testing. Finally, our finding that adolescent prevalence of LTBI 
did not change over the decade 2005 – 2015 may not be generalizable to settings with different social 
determinants of health, regardless of the success of regional TB disease control efforts. 
LTBI surveys for estimation of ARTI are often carried out among children younger than 10 years of age.20 
The cross–sectional adolescent LTBI prevalence and ARTI estimates reported here depict medium–term, 
not short–term changes in TB transmission. Compared to longitudinal cohorts, cross–sectional IGRA 
studies may underestimate the true rate of infection, owing to IGRA reversion after conversion.23 For 
example in the same source population, force of Mycobacterium tuberculosis infection  among adolescents 
almost doubled when QFT reversions were included.23 Thus, changes in LTBI prevalence and ARTI 
reported in our cross–sectional analyses likely underestimate the true scale of TB transmission in this 
community. Mathematical modeling studies are planned to investigate the inter–relationships between 
these different measures of TB transmission in this adolescent population.  
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Conclusion 
In conclusion, adolescent prevalence of LTBI and ARTI remained high and constant over the decade 
2005–2015 in this South African community, suggesting that TB transmission to school–age children was 
not yet impacted significantly by successful programmatic TB control efforts. We also show that 
differential risk of LTBI before and during adolescence is closely associated with socio–economic factors 
that must be taken into account when conducting LTBI surveys in this population. The World Health 
Organisation recommends repeated LTBI surveys at 5–7 year intervals to monitor short–term impact of 
TB control programmes.20 We additionally recommend that periodic IGRA surveys should be carried out 
among adolescents from a wide range of socio–economic backgrounds, to demonstrate if and when falling 
TB disease notification rates have a lasting impact on TB transmission to children.  
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Chapter 4 
4. Regional changes in tuberculosis disease burden among South 
African adolescents (2005–2015) 
 Overview 
Summary 
This chapter describes temporal changes in adolescent TB notification rates in a South African community 
over the decade 2005–2015. 
Contribution to the thesis and novelty 
Demonstration of temporal changes in the TB epidemic is important for re–appraisal of local and regional 
TB control efforts in line with global “End TB Strategy” targets. 
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Adolescents in the Western Cape Province of South Africa had high force of Mycobacterium tuberculosis 
infection (14% per annum) and high TB incidence (710 per 100,000 person–years) in 2005. We describe 
temporal changes in adolescent TB notification rates for the decade 2005–2015. 
Method 
We conducted an analysis of regional patient–level adolescent TB disease data, obtained from an electronic 
TB register, for 2005–2015. Numerators were annual TB notifications (HIV–related and HIV–unrelated); 
denominators were mid–year population estimates. Period averages of TB rates were obtained using time 
series modeling. The Agresti Coull method was used to derive confidence intervals for TB rates. Temporal 
trends in TB rates were explored using the Mann–Kendall test.  
Findings 
The average adolescent TB notification rate was 477 (95% Confidence Interval (CI): 313–641) per 100,000 
for all cases (all–TB) and 361 (CI: 280–441) per 100,000 for microbiologically–confirmed cases. The 
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adolescent all–TB rate fell by 45% from 662 to 361 per 100,000 and the microbiologically–confirmed TB 
rate by 38% from 492 to 305 per 100,000 between 2005–2015, driven mainly by rapid decreases for the 
period 2005–2009. There was a significant negative temporal trend in adolescent TB rates between 2005–
2015 (p=0·005), but that trend differed markedly pre– and post–2009. There was a statistically significant 
negative temporal trend in both all–TB (p=0·028) and microbiologically confirmed TB (p=0·027) for 
2005–2009, which was not observed for the period 2009–2015 (p=0·764 and p=1·000, respectively).  
Interpretation 
We observed an encouraging fall in adolescent TB rates between 2005–2009 with a subsequent plateau 
during 2010–2015, suggesting that additional interventions are needed to sustain advances in TB control. 
 Background 
Historical tuberculosis (TB) case notification rates in the greater Cape Town region of South Africa have 
changed significantly over the last century. The annual TB disease rate was approximately 450 per 100,000 
general population between 1910–1950, but decreased in parallel with introduction of TB chemotherapy 
to the 20th century nadir of 250 per 100,000 in 1970,1 followed by a sustained increase to 850 per 100,000 
in 2005, driven primarily by the HIV epidemic.1 The year 2005 was key for national HIV and TB control, 
due to scale–up of antiretroviral therapy (ART) in public health facilities, with increasing ART coverage 
over subsequent years.2 It was hoped that introduction of the sputum Xpert MTB/RIF assay as the 
primary test for TB diagnosis in 20133 would improve diagnostic yield, laboratory efficiency, and ability to 
detect rifampicin–resistant Mycobacterium tuberculosis faster than liquid culture.4 Introduction of these 
measures against the background of sustained programmatic TB control, including direct observation of 
treatment (directly observed treatment, short–course; DOTS),5 raises the question of whether these 
interventions had measurable impact on TB rates in South African communities. Demonstration of 
temporal changes in the epidemic is important for re–appraisal of regional TB control in line with global 
“End TB Strategy” targets.6  
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Whereas early childhood TB disease by definition reflects only recent Mycobacterium tuberculosis transmission 
and adult TB disease is a function of cumulative lifetime risk of infection and progression to disease, 
adolescent TB  rates represents an ideal proxy for medium–term Mycobacterium tuberculosis transmission over 
a 10–15 year period by which impact of TB control programs may be extrapolated.7 
We aimed to describe temporal changes in adolescent TB notification rates over the decade 2005–2015, 
based on analysis of electronic health service data for the Breede Valley subdistrict, a high TB incidence 
setting near Cape Town, South Africa. Background TB rates among adults and children are provided for 
context. 
 Methods 
4.4.1. Study design, population and setting 
This is an analysis of electronic TB disease patient notification data from health authorities in the Breede 
Valley subdistrict, Western Cape Province, South Africa, between 1st January 2005 – 31st December 2015. 
Estimated population in 2005 was 154,565, of whom 28,643 (18·5%) were adolescents. Average annual 
population growth between 2005–2015 was 1·31%.8 The general population composition in this 
subdistrict in 2010 was 63·3% Mixed Race, 24·3% Black African, 10·7% Caucasian, and 1·7% other 
classifications8; estimated general population HIV prevalence was 3·7% in 2005 and 4·6% in 2010.9 In the 
local general population, the proportion of persons living with HIV and receiving antiretroviral therapy 
(ART) increased from <1% in 2005 to 55% in 2015. TB diagnostic, prevention and treatment guidelines 
did not change significantly between 2005–2015 with the exception of introduction of sputum Xpert 
MTB/RIF in place of sputum smear microscopy as the primary TB diagnostic test from 2013 onwards.10  
4.4.2. Definitions 
A TB disease case was defined as an episode of TB disease that was electronically notified by public health 
authorities. All treatment for TB disease is undertaken in public health facilities and is free of charge. The 
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regional TB control program maintains both a paper record and from 2001 onwards an electronic register 
of TB disease cases treated in health facilities. TB disease cases include all TB disease patients, regardless 
of clinical site or diagnostic approach (microbiologically confirmed or clinically diagnosed), that were 
treated and notified by public health authorities, with the exclusion of patients started on treatment outside 
the study area and referred to facilities within the study area; and (ii) patients re–treated after default or 
treatment failure and re–registered, in line with WHO recommendations11, 12. Due to high rates of re–
infection after cure, relapse or re–infection TB disease cases were treated in statistical analysis as new TB 
disease events. Persons who received only isoniazid chemoprophylaxis were excluded.  
Adolescents were defined as persons aged 10–19 years13, adults as persons aged ≥ 20 years and children 
as persons aged <10 years. TB disease case notification rate was determined by dividing the annual number 
of notified TB disease cases by the estimated mid–year population, multiplied by 100,000. Annual 
percentage change in TB rate was obtained by dividing the difference between TB rate for a given year 
and TB rate for the previous year by the TB rate for the previous year multiplied by 100%. 
Microbiologically–confirmed TB was defined as sputum smear microscopy positive for acid–fast bacilli 
and/or positive liquid Mycobacterium Tuberculosis culture and/or positive Xpert MTB/RIF assay on one or 
more occasions. TB disease cases were defined as living with HIV if a positive HIV serology result was 
recorded, or if the patient was recorded to be receiving ART or co–trimoxazole prophylaxis. HIV–negative 
status was defined by a recorded HIV–negative serology result. All other cases were considered to be of 
unknown HIV status.  
4.4.3. Statistical analysis 
The annual mid–year population estimate was derived from the 2001 and 2011 national census14 and 
adjusted for annual population growth assuming linear growth between census estimates.8 Trend analysis 
for demographic and clinical characteristics was assessed using the Chi–squared test for trend (X2 trend), 
except for age and TB rates for which the Mann–Kendall15 test was used, allowing for quantification of 
the magnitude of trend using the Theil–Sen median slope estimator.16 The Durbin–Watson statistic was 
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used to test and quantify autocorrelation in TB rates.  The average TB rates for each period was estimated 
using a first order Box–Jenkins autoregressive integrated moving–average (ARIMA).  The Agresti Coull 
method was used to obtain confidence intervals for TB rates. All statistical tests were 2–sided at alpha 
0·05. This being a population level study, sample size considerations do not apply.  
4.4.4. Ethical approval 
Ethical approval was obtained from the University of Cape Town Human Research Ethics Committee 
(HREC REF 163/2016).  
4.4.5. Role of the funding source 
Funding sources had no role in study design, data collection, data analysis, data interpretation, or writing 
of the report. The corresponding author had full access to all the data in the study and had final 
responsibility for the decision to submit for publication.  
 Results 
4.5.1. Demographic and clinical characteristics  
A total of 21,250 TB disease cases were notified in Breede Valley subdistrict between 2005–2015, of whom 
1,461 (6·9%) were among adolescents. The annual number of adolescent TB disease cases ranged between 
102 (6·3%) – 187 (7·9%), with a statistically significant negative trend in proportion of all cases, falling 
from 8% to 6% between 2005–2015. The median age of adolescent TB disease cases also increased by an 
average of 1·0 (0·6–1·5) month annually over that period (p<0·001) (Table 4.1). 50% of adolescent TB 
disease cases occurred between the age of 17–19 years. 77% of adolescent TB disease cases were 
microbiologically–confirmed and this proportion did not change significantly after Xpert MTB/RIF scale–
up in 2013. HIV testing of adolescent TB disease patients significantly increased from 1% to 88% between 
2005–2015, when 45% of adolescent TB disease patients were known to be HIV–infected (2015).  
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Table 4.1: Demographic and clinical characteristics of adolescent TB disease cases  
Variable 2005  2006  2007 2008  2009  2010  2011  2012  2013  2014  2015  P–
value 
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adolescent TB 
disease patients (%) 
Legend: TB=Tuberculosis; %=percent; PTB=Pulmonary TB; EPTB=Extra–Pulmonary TB; new=new cases of TB disease; relapse=cases of TB disease that relapsed. P–
value is for temporal trend between 2005 and 2015 obtained using the Mann–Kendall test statistic for age but chi–squared test for trend for other variables. Proportion of all 
TB disease cases occurring among children < 10 years of age significantly increased (from 34% to 39%; p<0·001), those among adolescents significantly reduced (from 8% 
to 6%; p=0·008) whereas those among adults (≥20 years) significantly reduced between 2005–2015 (from 58% to 55%; p=0·043). However, this pattern is heavily influenced 
by the sudden upward increase in TB disease cases in children aged under five years in 2014 and 2015. 
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4.5.2. General population TB rates by age and year  
TB rates followed a bimodal age pattern with the highest risk in children aged below five years old, with a 
second peak among individuals aged 30–45 years. Adolescents aged 10–14 years had the lowest risk of TB 
disease, with TB rates increasing in adolescence from 15–19 years of age. TB rates fell consistently from 
age 45–49 years onwards (Figure 4.1). 
Figure 4.1: General population TB rates by age in 2005, 2010 and 2015. 
 
Legend: TB=Tuberculosis disease (all cases). TB rates reduced from 379 to 188 to 151 cases per 100,000 among 
adolescents aged 10–14 years old and from 938 to 663 to 566 cases per 100,000 among adolescents aged 15–19 
years old in 2005, 2010 and 2015 respectively. 
4.5.3. Trends in childhood, adolescent and adult TB disease 
Average adolescent TB rates for the decade 2005–2015 were 477 (CI: 313–641) cases per 100,000 and 361 
(CI: 280–441) cases per 100,000 for all–TB and microbiologically–confirmed TB, respectively. There was 
a significant negative temporal trend in adolescent TB rates between 2005–2015 (see Figure 4.2, Table 4.2 
and Appendix 1 and Appendix 2), but that trend differed markedly pre– and post–2009. Among 
adolescents there was a statistically significant negative temporal trend in both all–TB (p=0·028) and 
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microbiologically confirmed TB (p=0·027) for 2005–2009, which was not observed for the period 2009–
2015 (p=0·764 and p=1·000, respectively). Between 2005–2015, adult all–TB rates fell by 30% from 1,423 
to 994 per 100,000. Childhood all–TB rates dropped 15% from 2750 to 2331 per 100,000 during the same 
period, but rebounded thereafter and consistently increased between 2009–2015, consistent with a period 
of sustained Mycobacterium tuberculosis transmission (see Figure 4.2 and Appendices 3–5). 
Table 4.2: TB rate by year, age and diagnostic approach 
Year  Adolescent 





















confirmed TB rates  
(CI) 
2005 662  
(570–763) 




NA 890  
(844–939) 
2006 562  
(479–656) 




–10·4 817  
(773–863) 
2007 503  
(425–592) 




–10·1 785  
(742–830) 
2008 459  
(385–544) 




–10·0 714  
(673–756) 






–10·0 659  
(620–699) 
2010 428  
(357–509) 




10·3 657  
(619–698) 
2011 397  
(329–474) 




4·5 694  
(655–735) 
2012 382  –3·8 320  1042  –9·8 577  
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(316–457) (260–390) (994–1092) (542–615) 
2013 422  
(353–500) 




0·8 588  
(552–625) 
2014 359  
(296–432) 




12·4 551  
(517–587) 
2015 361  
(298–433) 














NA 720  
(504–936) 
Legend: CI=95% confidence interval; TB=Tuberculosis; TB rates=TB disease case notification rate per 100,000; 
NA=Not applicable. Period refers to 2005 to 2015. Overall refers to TB rates in the general population. Percentage 
annual change in TB rates varied between –25.3% and 24.8% and –10.4% and 12.4% among adolescents, and 
overall. 
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Figure 4.2: Comparison of adult and adolescent TB trends 2005–2015 
 
Legend: ART coverage= The proportion of persons living with HIV and receiving antiretroviral therapy; 
TB=Tuberculosis disease (all TB). Between 2005–2015 all–TB rates fell by 15% from 2750 to 2331 per 100,000 
among children, by 45% from 662 to 361 per 100,000 among adolescents and by 30% from 1,423 to 994 per 100,000 
among adults. The proportion of all persons living with HIV on ART in the general population was <1% in 2005, 
12% in 2007, 40% in 2013 and 55% in 2015.9 P–value is for temporal trend between 2005–2015.  
4.5.4. Adolescent TB trends by age  
Older adolescents contributed primarily to the overall reduction in adolescent TB rates (Figure 4.3A and 
Figure 4.3B). However, TB rates fell significantly in the period 2005–2009 among adolescents aged 10–14 
years (p–value 0·028) and those aged 15–19 years (p–value 0·027).  
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Figure 4.3: Adolescent TB temporal trends by age and year 
 
Legend: TB=Tuberculosis disease (all–TB). Panel 3A. Adolescent TB rates by age and year.  Between 2005–2015, 
TB rates fell by 63% (from 429 to 157 per 100,000; p–value for temporal trend (p–value) =0·350) among adolescents 
aged 10 years old; by 29% (from 560 to 400 per 100,000; p–value =0·640 among adolescents aged 15 years old and 
by 40% (from 1120 to 677 per 100,000; p–value =0·020) among adolescents aged 19 years old.  Panel 3B. Adolescent 
TB rates by five–year age groups. TB rates fell by 60% (from 379 to 151 per 100,000) among adolescents aged 10–
14 years old and by 40% (from 938 to 566 per 100,000) among adolescents aged 15–19 years old. P–value is for 
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4.5.5. Adolescent TB trends by sex  
Average TB rates for the decade 2005–2015 were 425 cases per 100,000 among male adolescents and 496 
cases per 100,000 among female adolescents. The temporal pattern of TB rates was similar by sex. Overall, 
a statistically significant temporal trend was only observed among female adolescents (see Figure 4.4 and 
Appendix 6) who had a higher baseline (2005) but a lower TB rate in 2015. 
Figure 4.4: Adolescent TB temporal trends by sex  
 
Legend: TB=Tuberculosis disease. Respectively among female and male adolescents, TB rates fell by 49% (from 
696 to 353 cases per 100,000) and by 41% (from 627 to 369 cases per 100,000) from 2005 to 2015. P–value is for 
temporal trend between 2005 and 2015. 
 Discussion  
A significant drop in adolescent TB rates was observed over the decade 2005–2015, although disease rates 
remained high compared to some high TB burden countries. The percentage fall in adolescent TB rates 
was greater than the fall in adult TB disease rates; was more marked among older than younger adolescents; 
and occurred primarily during 2005–2009, but appeared to plateau thereafter in parallel with increased TB 
rates in younger children compatible with a period of sustained Mycobacterium tuberculosis transmission. 
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The proportion of all TB disease cases occurring among adolescents also significantly reduced over this 
period, as it did that among adults, whereas childhood TB proportionally increased. The median age of 
TB in the general population dropped slightly from 25 to 24 years of age. We postulate that the 
demographic shift in the age of incidence of tuberculosis is due in part to a drop in HIV–associated TB 
that mainly affected young adults as supported by Hermans et al.,1, but further studies would be required 
to model the relationship between HIV and TB for actual attributable fraction in this setting. This shift in 
median age of TB disease is therefore unlike the shift towards older age of incident tuberculosis reported 
in Brazil17, which was due in part to population growth and aging, or that in Hong Kong due to 
immigration from higher TB burden regions of China.18 While an epidemiologic shift towards the elderly 
due to endogenous reactivation of remote TB infection is generally regarded as a sign of successful TB 
control in developed countries with low HIV burden,19 the significant fall in TB disease rates among South 
African adolescents who experience the highest force of Mycobacterium tuberculosis infection in this setting, 
is regarded as an initial sign of progress in TB control efforts. 
Low HIV testing rates between 2005–2010 likely underestimated the scale of HIV burden in adolescent 
TB disease patients, which was 45% in 2015. HIV co–infection impacts TB rates among older adolescents 
as HIV incidence increases with age,20 for example between 30–50% of TB was attributable to HIV in 
older adolescents and adults in Kenya. Since HIV increases TB risk up to 12–fold compared to that of 
HIV negative persons21, the rapidly increasing population ART coverage from less than 1% in 2005 to 
55% in 20159, and the increasing threshold for ART initiation from a cut–off CD4 cell count of 200 
cells/ml in 200422 to 350 cells/ml in 2012; and to 500 cells/ml in 201523 might be expected to contribute 
to a decline in both adult and adolescent HIV–associated TB rates, as observed in these regional data24, 
elsewhere in South Africa1, and in mathematical modelling studies.25 However the impact of improved 
ART access could not be determined for the adolescent population due to lack of HIV incidence or 
prevalence data for this age group during the period under study, and will require modelling or further 
epidemiologic studies. We note that TB rates substantially fell between 2005–2009 during nascent ART 
roll–out when HIV testing was less frequent: 21% (156/732) of adolescent TB notifications were HIV–
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tested, 12% (19/156) of whom were living with HIV. We further observe that adolescent all–TB rates 
were 582 cases per 100,000 and 682 cases per 100,000 in 2003 and 2004 respectively (unpublished data 
from regional health authorities), suggesting the onset of the fall in adolescent TB rates either occurred at 
the same time or preceded ART roll–out. We acknowledge the temporal disconnect between ART roll–
out and decrease in TB rates may not be sufficient to exclude an ART–related effect definitively. Our data 
show that the biggest increase in population ART coverage occurred between 2010–2015, when adolescent 
and adult TB disease rates appeared to plateau and childhood TB rates increased, a pattern compatible 
with a period of sustained Mycobacterium tuberculosis transmission that we are unable to explain. Whether 
this observation was due to improved diagnostic yield or clinical case detection in young children; or 
increased TB transmission to young children that did not affect adults or adolescents, requires further 
study. Similarly, additional research is required to estimate regional adolescent incidence or prevalence of 
HIV to study the impact of HIV control on TB transmission in this setting. 
Socioeconomic factors affecting regional TB rates may also be at play.  Unemployment decreased slightly 
between 2005–2009 (from 10.1% to 9.6%), but then increased slightly (from 9.6% to 11.4%) between 
2009–2015. The proportion of informal dwellings also increased from approximately 13% in 2005 to 
>22% in 2015.14 It is conceivable that the worsening housing situation could have contributed to 
stagnation in adolescent TB rates between 2009–2015, but we have no evidence for substantial impact. 
There were also no notable changes in year–on–year migration patterns for seasonal agricultural work that 
would likely have impacted adolescent TB trends in this region.26 
We have no evidence to believe that other changes in TB program activity or reporting materially impacted 
these observations. Adolescent TB treatment success rates remained stable and relatively high throughout 
the study period at an average of 84%; and the TB health management information system was 
strengthened between 2000–2005, when electronic notification of TB disease cases was introduced. 
Passive TB disease case–finding and treatment supported by DOTS was in place and remained virtually 
unchanged between 2005–2015.   
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We previously analysed temporal trends in prevalence of latent TB infection (LTBI) and annual risk of 
tuberculosis infection (ARTI) for the same adolescent source population, in order to determine whether 
trends in LTBI and ARTI are in line with observed adolescent TB disease trends. By contrast, we showed 
that ARTI and LTBI remained high and relatively unchanged over the decade 2005–2015.27 However, 
adolescent ARTI and LTBI prevalence represent cumulative lifetime measures7 and the majority of latently 
infected individuals do not exhibit reversion of their positive interferon gamma release assay result to 
negative.28 Force of Mycobacterium tuberculosis infection is a more accurate measure of short–term change or 
instantaneous adolescent TB risk. Therefore, prevalence of LTBI may not accurately correlate with 
declining TB rates in the short term. 
Studies describing temporal trends in adolescent TB between 1990–2018 in high TB burden countries in 
Africa are scarce. Increasing temporal TB trends in the general population have previously been noted in 
Botswana, Zimbabwe, Lesotho, South Africa and Swaziland29 due to the worsening HIV epidemic.  
A key strength of this analysis is the large dataset, high quality public laboratory support and robust time 
series analysis. TB notification underestimates TB prevalence by at least 34% due to under–reporting and 
under–diagnosis30. Therefore, our estimates likely underestimate the true burden of adolescent TB. HIV 
testing among adolescents was limited between 2005–2008 and no reliable data on ART uptake among 
HIV–infected TB disease patients during TB treatment was available. Regional ART uptake data are 
maintained in a different health management information system that is unlinked to the TB information 
system. Lack of adolescent HIV incidence or prevalence data and reliable ART usage data limits our ability 
to accurately determine whether the decrease in TB rates was driven by a decrease in HIV–associated TB, 
HIV–negative TB, or both. Lastly, lack of racial ancestry data precludes analyses stratified by race which 
has been shown to be a useful proxy for socioeconomic status in this context due to historical factors. In 
high TB and HIV co–burdened countries, trends in TB incidence have been shaped substantially by 
management of the HIV epidemic and thus we appreciate that the finding of declining adolescent TB rates 
may not be generalisable to other settings. 
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In conclusion, the overall rate of reduction in adolescent TB over the decade 2005–2015 was almost two–
fold that among adults and three–fold that among younger children. The substantial fall in adolescent TB 
disease case notification rates between 2005–2009 plateaued thereafter, coupled with an increase in the 
TB rate among younger children that is consistent with a period of sustained Mycobacterium tuberculosis 
transmission. It follows that additional TB and/or HIV control interventions are needed to sustain the 
encouraging early decline in adolescent TB rates. Given the apparent stagnation in adolescent TB and the 
marked increase in childhood TB rates between 2010–2015, close monitoring will be needed to guard 
against a rebound in adolescent TB and to ensure that these early gains are consolidated. 
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Chapter 5 
5. Indoor Air Quality and tuberculosis risk in South African schools 
 Overview 
Summary  
In this chapter we describe school classrooms as high–risk spaces for Mycobacterium tuberculosis transmission 
due to poor ventilation; pilot a strategy to test for RD9 Mycobacterium tuberculosis DNA by classroom air 
sampling; and examine the yield and feasibility of a pragmatic school–based tuberculosis screening strategy. 
The chapter is organised as follows: (1) Chapter Abstract; (2) Background and rationale; (3) Objectives; 
(4) Methods; (5) Results; (6) Discussion. 
Contribution to the thesis and novelty  
Investigation of classroom ventilation risk status is important to inform education authorities on whether 
classrooms contribute to Mycobacterium tuberculosis transmission among adolescent students; and to inform 
guidelines on engineering and environmental control measures for prevention of Mycobacterium tuberculosis 
transmission in the school setting. We further describe a proof of concept pilot study of classroom air 
sampling of RD9 Mycobacterium tuberculosis DNA to test whether this approach can distinguish classrooms 
at high risk for Mycobacterium tuberculosis transmission, based on ventilation status and/or presence of a 
known tuberculosis disease case.  
Contributions of candidate 
The candidate conceived and designed the study, conducted the fieldwork, collected the samples, managed 
the data, performed all data analysis and wrote the chapter with editorial input and guidance from 
supervisors. Trained field workers assisted in home language consenting and questionnaire administration, 
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and sample collection. The Mycobacterium tuberculosis ddPCR assay was performed by Desmond Tutu HIV 
Centre laboratory staff with support from the Warner laboratory. 
Publication status 
Unpublished as on 28th November 2019.  
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 Chapter abstract 
Introduction 
A South African study previously showed that high school students spend 60% of their time in school in 
inadequately ventilated spaces, defined as above the recommended threshold median ambient carbon 
dioxide concentration of 1000 parts per million (ppm), which is often used as a proxy for adequate 
ventilation. However, there is a lack of data on classroom risk of Mycobacterium tuberculosis transmission, 
and to the best of our knowledge there is no published study of air sampling for RD9 Mycobacterium 
tuberculosis DNA in schools. We aimed to: (1) determine the high school classroom ventilation risk for 
Mycobacterium tuberculosis transmission; (2) conduct a pilot study of classroom air sampling for RD9 
Mycobacterium tuberculosis DNA; and (3) investigate the operational feasibility and yield of tuberculosis 
disease surveillance in high schools. 
Methods  
Between 1st September 2017 and 30th September 2018, we conducted a cross–sectional study of 72 high 
school classrooms (occupied by 1,836 students); and 7 clinic spaces that were selected based on high risk 
of Mycobacterium tuberculosis transmission, in Worcester, South Africa. We measured ambient carbon dioxide 
concentration for the first classroom session of the day, using portable carbon dioxide monitors to define 
high risk ventilation spaces for Mycobacterium tuberculosis transmission (threshold median carbon dioxide 
≥1,000 ppm). We simultaneously sampled filtered air, using a Dry Filtration Unit, through a removable 
polyester felt filter of 47mm diameter and 1.0 μm pore size (American Felt and Filter Company, New 
Windsor, New York; Lockheed Martin, Alexandria, VA, USA), extracted DNA from each filter, and 
performed a droplet digital PCR (ddPCR) assay to detect and quantify RD9 Mycobacterium tuberculosis DNA 
copies in air samples.  RD9 Mycobacterium tuberculosis DNA concentration was calculated for 180,000 litres 
of air (=180 cubic metres), based on the average estimated volume of classrooms. We performed active 
symptom screening and collected voluntary spontaneously expectorated sputum samples from participants 
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reporting at least one symptom (cough of ≥2 weeks, haemoptysis, weight loss for ≥2 months, fever for 
≥2 weeks or nights sweats for ≥2 weeks) for Xpert MTB/RIF Ultra testing. The Wilcoxon rank–sum test 
was used to compare median carbon dioxide values by type of space. The two–sample test for equality of 
proportions was used to assess statistically significant differences between groups for categorical variables. 
Results  
Median duration of sampling for 44 clinic air sampling episodes was 82 minutes (interquartile range (IQR): 
40–120) and median number of occupants was 6 (IQR: 3–22). Median duration of sampling for 72 
classrooms was 40 minutes (35–54) and median number of occupants was 34 (29–39). No clinics, but 40% 
of classrooms were high risk ventilation spaces for Mycobacterium tuberculosis transmission, based on 
threshold median ambient carbon dioxide concentration ≥1,000 ppm. A positive Mycobacterium tuberculosis 
ddPCR assay was obtained in 4/39 (10.3%) clinics and 13/72 (18.1%) classrooms (p=0.276). Overall, the 
estimated average concentration of RD9 Mycobacterium tuberculosis DNA was 1.74 copies per 180,000 litres 
of air for all clinic spaces; and 17 copies (range 2–27) per 180,000 litres of air when limited to those clinics 
with a positive ddPCR assay. Similarly, the estimated average concentration of RD9 Mycobacterium 
tuberculosis DNA in classrooms was 3.61 copies per 180,000 litres overall; and 20 copies (range 8–82 copies) 
per 180,000 litres in those classrooms with a positive ddPCR assay. Across all classrooms, the average risk 
of an occupant inhaling 1 RD9 Mycobacterium tuberculosis DNA copy during one lesson of 35 minutes was 
0.71%. The estimated risk for one academic day was 2.7%, for one academic week was 12.6%; for one 
academic month was 41.7%; and for one academic year was 100%. Therefore, we estimate each student 
will have inhaled on average 11 RD9 Mycobacterium tuberculosis DNA copies over the 1,155 hours South 
African high school students spend congregated in classrooms during approximately 199 school days each 
calendar year. We enrolled 1,836/2,262 (81.2%) of students in classrooms where air sampling was 
conducted. Median age was 16.2 years and 779 (45.8%) were male. The number of students reporting 
cough ≥2 weeks was 90/1820 (4.9%); 58/90 students with cough (64.4%) offered to provide a 
spontaneously expectorated sputum sample, but only 21 (36.2%) submitted a sputum sample for analysis. 
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One student (4.8%) was Xpert MTB/RIF Ultra positive (prevalence 55 (CI: 0–341) per 100,000). Air 
sampling from the classroom occupied by the student with confirmed tuberculosis disease yielded a 
positive ddPCR assay; was categorised as high ventilation risk based on ambient carbon dioxide 
concentration; and was occupied by three students with self–reported cough, only one of whom was 
sputum productive and Xpert MTB/RIF Ultra positive. 
Conclusion 
We showed that more than one–third of high school classrooms were a high ventilation risk for 
Mycobacterium tuberculosis transmission if they were occupied by a student with undiagnosed tuberculosis 
disease, whereas clinic spaces, where known tuberculosis patients were expected, were adequately 
ventilated. However, air sampling filters from classrooms were as likely to be Mycobacterium tuberculosis 
ddPCR assay positive as those from clinics, which reflects the combined contribution of bacillary droplet 
inoculation and ventilation to risk of Mycobacterium tuberculosis transmission. Estimated risk of inhalation of 
potentially infectious RD9 Mycobacterium tuberculosis DNA copies in classrooms was similar to that of clinics. 
However, one RD9 Mycobacterium tuberculosis DNA copy does not necessarily translate to one infectious 
quantum of Mycobacterium tuberculosis and more research is required to estimate the number of inhaled RD9 
Mycobacterium tuberculosis DNA copies leading to established Mycobacterium tuberculosis infection in humans. 
Nonetheless, these findings highlight the importance of ventilation management for Mycobacterium 
tuberculosis infection control in congregate school settings. Education authorities should sensitize students 
and staff to open windows and allow adequate classroom ventilation, which is a low–cost structural 
intervention for tuberculosis control. Our tuberculosis screening strategy was pragmatic and designed to 
mimic real–life field conditions for a classroom–based tuberculosis symptom screening programme. Yield 
of screening for tuberculosis disease cases was low, but the Mycobacterium tuberculosis ddPCR data from all 
classrooms suggest additional cases of undiagnosed tuberculosis disease may have been missed by 
symptom screening and voluntary spontaneous expectorated sputum sampling of symptomatic students. 
Addition of chest radiography and/or IGRA testing might increase yield, but also increases cost and 
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logistic complexity of tuberculosis screening. Therefore, although we have shown that classroom air 
sampling for RD9 Mycobacterium tuberculosis DNA is feasible and potentially useful as a mass screening tool, 
further research is needed to determine the significance of Mycobacterium tuberculosis ddPCR air sampling 
for risk of Mycobacterium tuberculosis transmission, and the association between a positive Mycobacterium 
tuberculosis ddPCR assay and detection of an undiagnosed tuberculosis disease case in congregate spaces 
such as school classrooms. 
 Background and Rationale 
The South African Integrated School Health Policy of 20121, 2 plans for tuberculosis disease screening of 
students in high schools, in combination with environmental assessment to prevent airborne infections as 
part of the package of healthcare to schools, but little is known about implementation of this policy.3 There 
are 12 million students in the South African basic education sector, which comprises the first 12 years of 
formal schooling.4 These 12 million students include a large pool of susceptible children, as yet uninfected 
with Mycobacterium tuberculosis, in addition to previously–infected children at risk of progression to 
tuberculosis disease.5 Since adolescence is characterised by a rapid increase in tuberculosis disease 
incidence,6 school–based infection control and tuberculosis disease surveillance measures may represent 
an opportunity to reduce the risk of Mycobacterium tuberculosis transmission and to detect previously 
undiagnosed tuberculosis disease cases for early therapeutic intervention.  
There are limited published data that describe the yield of tuberculosis disease surveillance in schools in 
Africa. Three tuberculosis disease prevalence studies in Africa among school–age adolescents, which 
conducted tuberculosis disease case–finding by both symptom screening and Tuberculin Skin Test or 
Interferon Gamma Release Assay (TST/IGRA), detected one case of tuberculosis disease for every 303 
(South Africa), 625 (Uganda) and 313 (Kenya) adolescents screened.7–9  However, none of these studies 
reported on feasibility considerations or cost–effectiveness of school–based tuberculosis disease screening. 
A 2014–2015 study in Swaziland, where tuberculosis disease prevalence was 733 cases per 100,000 in 
2015,10 investigated utility of school–based symptom screening of tuberculosis disease contacts and 
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identified no secondary tuberculosis disease cases among 2,015 school contacts of 7 index GeneXpert–
positive tuberculosis disease patients attending 6 different schools.11 The cost/benefit ratio of school–
based infection control and tuberculosis disease surveillance measures is yet to be determined in Africa. A 
South African community–based study that conducted sputum induction on all individuals with 
tuberculosis disease symptoms and symptomatic HIV–positive individuals reported a cost of US$1,117 
per tuberculosis disease case detected and US$2,458 per tuberculosis disease case cured.12 However, 
approaches to tuberculosis disease case–finding among adolescents in high schools may be more efficient 
if targeted at school classrooms with a priori evidence of increased risk for Mycobacterium tuberculosis 
transmission.  
We conducted a study of classroom ventilation, in conjunction with a proof of concept study of classroom 
air sampling for RD9 Mycobacterium tuberculosis DNA, and evaluated the yield of symptom–based 
tuberculosis disease surveillance, to inform stakeholders in the education and health sectors of the 
feasibility and potential impact of these approaches to improve tuberculosis control among school–going 
adolescents. 
5.3.1. Burden of adolescent tuberculosis 
The estimated incidence of tuberculosis disease in the general South African population for 2018 was 520 
cases per 100,000 people.13 Annualized force of Mycobacterium tuberculosis infection  in the study region 
during adolescence is approximately 14%,14 with a latent tuberculosis infection prevalence of 49%  (2014–
2015)5 that increases to approximately 90% in adulthood.15 Snow et al. showed that regional (Western Cape 
Province, South Africa) tuberculosis disease notification rate is three–fold higher in older adolescents aged 
15–19 years than in younger adolescents aged 10–14 years (418 tuberculosis disease cases/100 000 person–
years vs. 141/100 000 person–years).16   
Although South Africa has 12 million students in the basic education sector,4 there is a paucity of data 
evaluating the fraction of Mycobacterium tuberculosis transmission that might be attributable to school 
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attendance.17 A previous study in Cape Town, South Africa, showed that adolescents aged 10–19 years 
had an average of 12–14 close social contacts indoors with a mean duration of 86–96 minutes.19 Although 
Mycobacterium tuberculosis infection among children aged 5–14 years was associated with residential exposure 
to an adult case of tuberculosis disease, there was no association among older adolescents aged 15–22 
years.17 This finding suggests increased significance of other congregate settings, such as school 
classrooms, as determinants of Mycobacterium tuberculosis infection and disease among adolescents.20, 21 A 
statistical modeling study estimated that 25% and 50% of new Mycobacterium tuberculosis infections among 
South African individuals aged  0–14 and 15–19 years, respectively, occurs in the school setting.18 
Therefore, since schools may be important locations for Mycobacterium tuberculosis transmission from 
adolescents with tuberculosis disease to susceptible, uninfected adolescents, the classroom setting should 
be targeted for surveillance and prevention efforts.  
5.3.2. Measurement of ventilation in classrooms 
Students attending a South African high school will spend approximately 1,155 hours congregated in 
classrooms during the 199 school days of the academic year.22 The indoor school environment and 
classroom ventilation are likely key determinants of transmission for airborne infections such as 
tuberculosis, as demonstrated by Wells and Riley.23, 24 Given that Mycobacterium tuberculosis transmission 
occurs via aerosol droplet spread, classroom air quality may affect the risk of Mycobacterium tuberculosis 
transmission in the congregate school setting. Indoor air quality refers to the air quality within and around 
buildings, as it relates to the health and comfort of occupants.25 Source control (e.g. isolation of infectious 
disease cases), particulate air filtration, and ventilation to dilute and remove airborne contaminants, are the 
primary methods for improving classroom ventilation.25  
Ventilation in this study is defined as the provision of fresh air to a room to reduce the risk of transmission 
of tuberculosis disease,25 and is measured using: (1) volume of the space (i.e. air changes per hour (ACH)); 
and (2) an occupancy–based approach that accounts for the number of people in a space (i.e. the amount 
of available fresh air per person per second).26 The World Health Organization (WHO) defines adequacy 
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of ventilation using air changes per hour.26 One air change has occurred when the volume of air entering 
or exiting a room is equal to the volume of the room.26 Under ideal conditions, in which expired droplet 
nuclei are evenly distributed and room air is uniformly mixed, the proportion of infectious particles 
eliminated with one air change is 63%. At a ventilation rate of 10 air changes per hour, it would take 14 
minutes to remove 90% of airborne contaminants in a room; and 28 minutes to remove 99%.27  
The recommended ventilation for high risk clinic areas, such as sputum collection rooms that are known 
to be occupied by tuberculosis patients,  is 12 ACH or 80–160 litres per person per second (l/p/s); and 
that for low risk  clinic areas, such as outpatient consultation rooms, is 6 ACH or 40 l/p/s.28 Ambient 
indoor carbon dioxide concentration is often used as a proxy for indoor ventilation due to ease of 
measurement. The WHO recommendation for classroom ventilation (12 air changes per hour or 8.6 litres 
per person per second), is equivalent to maintaining the median ambient carbon dioxide concentration at 
<1000 parts per million (ppm) for a standard classroom of approximately 180 cubic metres (180,000 litres), 
which is occupied by the average class size of 31 students, in South African high schools.28 This 1,000 ppm 
carbon dioxide concentration threshold is also in line with classroom air quality regulations in Sweden, the 
United States and Portugal.28  
The concentration of carbon dioxide in exhaled breath (~38,000 ppm) is roughly 100 times higher than 
that of open environmental air (~400 ppm);29 and carbon dioxide decay curves have also been used for 
estimation of ventilation.30 An unoccupied room has an ambient carbon dioxide concentration of about 
400 ppm. Since exhaled breath is the primary source of excess carbon dioxide in indoor settings, ambient 
room carbon dioxide measurement allows estimation of the relative proportion of exhaled air from other 
occupants, and thus risk for Mycobacterium tuberculosis transmission from an infectious person to uninfected, 
susceptible occupants.29 Indoor ambient carbon dioxide measurement can be used to estimate probability 
of Mycobacterium tuberculosis transmission using the equation developed by Issarow et al.31 that builds on the 
historic work of Rudnick and Milton29, and Wells and Riley.28 The equation derived by Rudnick and Milton 
expanded upon the work of Wells and Riley and used rebreathed fraction to substitute for the more 
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difficult analysis of room ventilation and size.29 The Rudnick–Milton equation does not require the 
assumption of steady–state conditions and assumes the loss of infectious particles to settling, filtration, 
and loss of viability is negligible compared to that removed by ventilation.29 
Measurement of ambient room carbon dioxide using portable carbon dioxide monitors32 (see Appendix 
5.1) might therefore be used to identify poorly ventilated school classrooms that might pose increased risk 
for Mycobacterium tuberculosis transmission, but there is limited research into classroom ambient carbon 
dioxide measurement that would inform Mycobacterium tuberculosis transmission research. A previous South 
African study showed that high school students spend 60% of their time in school occupying spaces with 
median ambient carbon dioxide concentration above the recommended threshold of 1000 ppm.28  
It is therefore important to study not only adequacy of classroom air quality in South African high schools, 
but also to determine whether inadequate ventilation in the classroom setting puts susceptible students at 
risk of Mycobacterium tuberculosis exposure and tuberculosis disease. These data may inform South African 
School Health Policy and help plan engineering and environmental controls for prevention of 
Mycobacterium tuberculosis transmission in the classroom setting.  
5.3.3. Classroom air sampling for RD9 Mycobacterium tuberculosis DNA 
The risk of Mycobacterium tuberculosis transmission in classrooms is determined not only by inadequate 
ventilation, but by the presence of exhaled Mycobacterium tuberculosis bacilli in suspended droplet nuclei. We 
have shown in previous chapters that half or more of adolescents in this study community are Mycobacterium 
tuberculosis–uninfected and would be susceptible to classroom Mycobacterium tuberculosis transmission from 
undiagnosed infectious tuberculosis cases. We have also shown that the incidence of tuberculosis disease 
in the adolescent age group is sufficiently high to constitute material risk of Mycobacterium tuberculosis 
transmission to susceptible students and staff in the school environment. Therefore, given the variable 
implementation of tuberculosis disease screening in South African schools,3 and the attendant risk of 
Mycobacterium tuberculosis transmission to susceptible students due to delays in tuberculosis disease 
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diagnosis,32, 33 it is important to investigate alternative tuberculosis surveillance and control strategies in 
the school setting.  
Air sampling was informed by the landmark studies of Riley and colleagues in the 1960s as a tool to 
investigate aerosol Mycobacterium tuberculosis transmission;34, 35 and subsequent studies in healthcare settings 
that used molecular detection methods (PCR) to test filtrate samples obtained from room air.36–39 Air 
sampling has potential as a mass tuberculosis disease surveillance tool for students and occupants of high 
risk spaces. Targeted tuberculosis disease symptom screening in classrooms with high risk for tuberculosis 
transmission has potential for more efficient and faster identification of undiagnosed tuberculosis disease 
cases than indiscriminate screening of all 12 million South African students, as currently prescribed in the 
South African School Health Policy.4  
Indoor air sampling can be used to obtain RD9 Mycobacterium tuberculosis DNA using air filtration devices 
such as the Dry Filtration Unit (see Appendix 5.2). The Dry Filtration Unit40 is a portable biological sample 
collection device that samples room air via fine filters (polyester felt filter of 47mm diameter and 1.0μm 
pore size (American Felt and Filter Company, New Windsor, New York; Lockheed Martin, Alexandria, 
VA, USA) that allow collection and quantification of the DNA of bacteria and viruses 37, 40, 41 by Polymerase 
Chain Reaction (PCR), but there is limited data on use of the Dry Filtration Unit in tuberculosis research.37, 
40, 41 The Dry Filtration Unit samples approximately 1,000 litres of room air per minute.42 Air sampling in 
tandem with a multiplex real–time PCR assay that targets Mycobacterium tuberculosis genes can provide 
quantitative data on amount of inoculum43, which has potential as a tool for targeted mass screening of 
undiagnosed tuberculosis disease in schools and other congregate settings. 
Therefore, our second objective was to conduct a school–based pilot study to show proof of concept that 
air sampling for RD9 Mycobacterium tuberculosis DNA could identify classrooms with and without RD9 
Mycobacterium tuberculosis DNA detected by ddPCR assay. We hypothesized that positive ddPCR assays 
would correlate with high ventilation risk for transmission, identified by simultaneous ambient room 
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carbon dioxide measurement, and/or occupation of the sampled classroom by a student with undiagnosed 
tuberculosis disease. 
5.3.4. Droplet digital polymerase chain reaction (ddPCR) 
Droplet digital polymerase chain reaction (ddPCR) offers greater accuracy compared to traditional PCR 
methods, which is crucial if DNA copy numbers are low, as in the case of air sampling for Mycobacterium 
tuberculosis.44 ddPCR is a form of PCR in which a sample is diluted and partitioned into multiple separate 
reaction chambers, each containing ≥1 or no copies of the DNA sequence of interest. The number of 
copies of DNA from the original sample may be determined by counting the number of positive versus 
negative partitions and applying Poisson distribution statistics.44 This approach allows increased accuracy 
over real time PCR and accurate quantification of DNA copies,44 although positive assay thresholds are 
not yet standardised.44 An important potential limitation to the use of DNA–based technologies for 
tuberculosis disease surveillance is that the PCR assay does not distinguish between living or dead 
inoculum, and thus between infectious and non–infectious quanta.43 
5.3.5. Classroom–based Symptom Screening for tuberculosis disease 
The WHO defines occupants of congregate settings as a tuberculosis risk group45 and recommends that 
close contacts of individuals with tuberculosis disease are systematically screened for tuberculosis disease.45 
However, there are few studies that report the yield of active symptom–based tuberculosis disease 
surveillance among adolescents in the high school setting, despite the fact that an estimated 50% of new 
adolescent Mycobacterium tuberculosis infections occur in schools.18 Systematic analysis of the number of 
adolescents needed to screen in order to detect one undiagnosed tuberculosis disease case has not been 
estimated for school–based screening programmes.46 A systematic review of community–based 
tuberculosis screening reported a weighted number–needed–to–screen of 100 (range: 16 – 6,355)46; and 
sensitivity of 71% and specificity 99% for any tuberculosis disease symptom and Xpert MTB/RIF testing 
in high tuberculosis burden countries.47 Ugandan and Kenyan tuberculosis disease prevalence studies 
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detected one case of tuberculosis disease for every 625 and 313 adolescents screened, respectively.7, 8  A 
South African study among school–going adolescents diagnosed one tuberculosis disease case for every 
303 students screened by both symptoms and TST/IGRA,9 but symptom screening alone performed 
poorly, with a sensitivity of 12% and specificity of 97%. However, testing all school students for 
tuberculosis using IGRA or TST, and then testing for tuberculosis disease using sputum Xpert MTB/RIF, 
is logistically challenging and expensive for resource–limited countries. A modelling study in South Korea 
reported that screening for tuberculosis among 1000 high–school adolescents using an IGRA–based 
strategy diagnosed  2 tuberculosis disease cases at a total cost of US$ 108,435 i.e. US$ 54,218 per 
tuberculosis case detected.48 Our demonstration in prior chapters of the changing regional tuberculosis 
epidemic, in which adolescent tuberculosis disease case notification rates fell 45% from 662 to 361 per 
100,000 between 2005–2015, is a strong motivation for feasibility studies to demonstrate the yield of 
school–based tuberculosis disease surveillance before adopting untested strategies as policy. 
Therefore, our third objective was to investigate the yield of a pragmatic tuberculosis disease case–finding 
strategy among adolescents in the high school setting. A school–based tuberculosis disease surveillance 
strategy for endemic countries should be logistically simple, efficient, and require few resources. We 
conducted symptom–based screening for undiagnosed tuberculosis disease among students in the same 
classrooms that had undergone ambient carbon dioxide monitoring and Mycobacterium tuberculosis ddPCR 
air sampling; and followed symptom questionnaires with further investigation of symptomatic students 
who were willing and able to spontaneously expectorate a sputum sample for laboratory Xpert MTB/RIF 
Ultra testing.   
 Objectives 
Our objectives were to: (1) determine the ventilation risk for Mycobacterium tuberculosis transmission based 
on classroom air quality in high schools in Worcester, South Africa; (2) conduct a pilot study of classroom 
ddPCR air sampling for RD9 Mycobacterium tuberculosis DNA; and (3) investigate the operational feasibility 
and yield of tuberculosis disease surveillance among adolescents in the high school setting. 
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 Methods 
5.5.1. Study setting 
This study was conducted in Breede Valley local municipality (Worcester), Western Cape Province, South 
Africa, between 1st September 2017 and 30th September 2018. Breede Valley local municipality had an 
estimated population of 180,375 in 2017, a figure obtained using the 2011 census estimate of 166,825 and 
applying the population growth rate of 1.31% per annum.49 In 2017, the general population composition 
was 63·3% Mixed Race Ancestry, 24·3% African, 10·7% White, and 1·7% other classifications.49 There 
were approximately 33,370 (18·5%) adolescents in Worcester in 2017.49 In previous chapters, we reported 
a tuberculosis disease case notification rate among adolescents and adults in this region of 361 and 994 
cases per 100,000 respectively50, and adolescent latent tuberculosis infection prevalence of 48.5% (CI: 
41.1–55.8), for 2015.5 A summary of other key socioeconomic and health indicators for Worcester is 
provided in Appendix 5.3.  
5.5.2. Study design  
We conducted a cross–sectional study of 1,836 students in conjunction with classroom ambient carbon 
dioxide concentration measurements and ddPCR air sampling in 72 classrooms in two high schools; and 
from 7 different clinic spaces in primary public health care facilities (Figure 5.1). Ambient carbon dioxide 
concentration measurements and ddPCR air sampling were performed in both classrooms and clinic 
spaces, which were selected due to high a priori risk for presence of aerosolized RD9 Mycobacterium 
tuberculosis DNA. Classroom ambient carbon dioxide concentration measurements, ddPCR air sampling, 
and tuberculosis disease symptom screening were performed in classrooms once daily during the first 
classroom session of the day. 
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Figure 5.1: Sampling schema of spaces included in the study 
 
Legend: ddPCR air sampling was conducted in all clinics (A, B and C) and both schools (B and D). Air quality was 
measured in clinics (A, B and C) and both schools (B and D) and one open air space. All classrooms in the two 
schools and all clinic spaces in the three primary public health care facilities were naturally ventilated. 
Classrooms 
In chapter 2,5  we described prevalence of Mycobacterium tuberculosis infection among students in 8 high 
schools. We selected two of the 8 schools (school B and school D) for air sampling and tuberculosis 
disease surveillance, based on their high school–level prevalence of latent Mycobacterium tuberculosis infection 
among students. In 2015, school B students had latent tuberculosis infection prevalence of 60% (CI: 53%–
67%) and school D students had latent tuberculosis infection prevalence of 51% (CI: 50%–52%).5 
Classrooms were approximately 7–10 metres in length, by 7–10 metres in width, for both schools. 
An open–air space was included to provide a benchmark for outdoor vs classroom ambient carbon dioxide 
concentration and a negative control space for ddPCR air sampling. The open–air space was an 
unoccupied outdoor area with grass lawns, located 20 metres from the administrative office of the field 
research site. 
Clinics 
Three clinics (clinic A, clinic B and clinic C) were selected based on their high tuberculosis disease caseload. 
The absolute tuberculosis disease caseloads per annum differed between clinics due to differences in 
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population size of each clinic catchment area (Annual Notified tuberculosis disease cases in 2015 were 
5,749 for clinic A; 6,098 for clinic B, and 12,240 for clinic C). However, the 2015 general population 
tuberculosis disease case notification rate was comparable for catchment areas of the three primary health 
care facilities (1,015 cases per 100,000 for clinic A catchment area, 1,029 cases per 100,000 for clinic B 
catchment area, and 1,055 cases per 100,000 for clinic C catchment area). All the three public primary 
health care facilities offer free outpatient care for tuberculosis disease patients, rely on passive tuberculosis 
disease case finding to identify notified tuberculosis disease cases, and did not offer in–patient services.  
For all three clinics, the general patient waiting area was approximately 10–13 metres in length by 5–7 
metres in width, with benches where clients waited for administrative processing and triage before being 
directed to the tuberculosis clinic consultation room. For all three clinics, the tuberculosis clinic 
consultation room where individuals suspected of having tuberculosis disease were clinically reviewed, and 
where individuals with tuberculosis disease were followed up and received medication, measured 
approximately 5 square metres. For all three clinics, the tuberculosis clinic patient waiting area was a 
corridor of variable length (approximately 8–12 metres for Clinic A and Clinic B and approximately 25–
30 metres for clinic C) by approximately 2 metres in width. 
5.5.3. Regulatory and administrative process and approval 
Ethical approval of the project proposal was obtained from the University of Cape Town Human Research 
Ethics Committee (HREC REF 163/2016). Students were approached for written informed 
assent/consent for individual tuberculosis disease symptom screening. The HREC waived the need for 
parental consent for tuberculosis disease symptom screening of students due to the minimal risk and 
potential health benefit; and waived the need for individual assent/consent by all occupants of congregate 
spaces for ambient carbon dioxide concentration measurement and ddPCR air sampling due to the 
minimal risk of the procedure.  
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Approval was obtained from the regional Departments of Education and Health for conduct of this study. 
Clinic staff, teachers and students were sensitised about the study (i.e. education on Mycobacterium tuberculosis 
transmission, objectives of the study, how the study would be conducted, any potential benefits and 
risks/costs of the study for those involved, benefits of the study to society and when the study was 
estimated to start and conclude).  
5.5.4. Training  
Training of fieldworkers and laboratory staff covered Mycobacterium tuberculosis transmission, rationale and 
objectives of this study, study methods, anticipated impact of findings; and for field workers: the consent 
process, handling of samples, infection control, use of the carbon dioxide loggers and the ddPCR air 
sampling device; and for laboratory staff: the handling, processing and analysis of samples. 
5.5.5. Study procedures 
a) Ambient carbon dioxide concentration measurement 
In both clinics and classrooms, we measured ambient carbon dioxide concentration as a proxy for 
ventilation and used the median ambient carbon dioxide concentration (threshold of 1,000 parts per 
million (ppm)) to define high (above 1,000 ppm) and low (below 1,000 ppm) ventilation risk for 
Mycobacterium tuberculosis transmission, in line with WHO recommendations and previous studies of 
congregate settings.26–28 The median indoor carbon dioxide  concentration of 1000 parts per million (ppm) 
in naturally ventilated classrooms is equivalent to the WHO recommendation of 12 air changes per hour, 
or a ventilation rate of 8.6 litres per person per second.28  Carbon dioxide concentration was measured 
using a portable carbon dioxide monitor (Ethernet Multilogger thermo–hygro– carbon dioxide meter with 
2 MiniDIN and 2 Terminals)51 (see Appendix 5.1).  The monitors were new, factory–calibrated and 
provided with calibration certificates. Simultaneous carbon dioxide measurement with multiple devices 
showed the measurements to be within the acceptable 10% range (as per factory manual). The carbon 
dioxide monitors recorded carbon dioxide concentration in parts per million (ppm) and were set to record 
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carbon dioxide concentration every 60 seconds for the entire duration of classroom ambient carbon 
dioxide concentration measurement. The maximum carbon dioxide concentration that the monitors could 
record was 2,100 ppm. The carbon dioxide monitors were placed 50 cm from the floor at the back of the 
clinic or classroom during ambient carbon dioxide concentration measurement.  
For both clinics and classrooms, we recorded duration of ambient carbon dioxide concentration 
measurement and ddPCR air sampling, total number of windows and doors, and at the start and end of 
each ambient carbon dioxide concentration measurement and ddPCR air sampling episode, whether 
windows and doors were open or closed, and number of individuals in the space. The duration of ddPCR 
air sampling was the same as that of ambient carbon dioxide concentration measurement. We did not 
record the size of windows and doors, exact floor size or room volume, individuals entering or leaving 
these spaces, duration each individual spent in each space, or contact behavior during the sampling period. 
We did not measure temperature, humidity or wind speed. 
Clinic ambient carbon dioxide concentration measurements and ddPCR air sampling was conducted in 
November and February of 2018. The start and end time for clinic ambient carbon dioxide concentration 
measurement and ddPCR air sampling was variable and between 8:00 am and 2:00 pm, except for 3 
occasions when sampling was conducted for 5 hours and ended between 3.00 pm – 4:00 pm. Regional 
average temperature during the day for summer is 28 degrees Celsius, for autumn is 21 degrees Celsius, 
for Winter is 18 degrees Celsius and for spring is 23 degrees Celsius.52  
Classroom ambient carbon dioxide concentration measurement was done during the first classroom 
session of the day to avoid overestimation due to carbon dioxide accumulation arising from previous 
occupants. Measurement was done once for each group of students who occupied that classroom for a 
single lesson, lasting approximately 35–45 minutes. Testing was stopped before a new group of students 
entered the classroom for the next lesson. Classroom ambient carbon dioxide concentration measurement 
and ddPCR air sampling for school B was conducted in August and September; and for school D in April 
and May, except for 7 instances (3 in March, 2 in July and 2 in August) 2018. The start and end time for 
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classroom ambient carbon dioxide concentration measurement and ddPCR air sampling was usually 
between 8:00 am and 10:00 am. 
Calculation of rebreathed fraction  
Rebreathed fraction (Appendix 5.15), as defined by Rudnick and Milton, is the fraction of inhaled air that 
has been exhaled previously by another person in the same space.29  Rebreathed air volume is the absolute 
volume of rebreathed air expressed in litres.29 Rebreathed fraction of air was calculated using Rudnick and 
Milton’s equation that uses carbon dioxide  concentration, i.e.:29 
 F=(C–Co)/(Ca)         (1) 
Where F is equivalent to the rebreathed fraction, C is the observed concentration of carbon dioxide  in 
indoor air, Co is the concentration of carbon dioxide in outdoor air and Ca is the concentration of carbon 
dioxide  in exhaled air which was estimated as 38,000 ppm.53 For low levels of physical activity, Ca was 
estimated to be 38,000 ppm based on a carbon dioxide production rate of 0.31 litres/minute and 
respiratory minute volume of 8.0 litres/minute.53 Outdoor carbon dioxide concentration was defined as 
the minimum recorded value from outdoor carbon dioxide measurement.  
b) ddPCR air sampling  
We conducted ddPCR air sampling to detect and quantify RD9 Mycobacterium tuberculosis DNA in room air 
using the Dry Filtration Unit40 (see Appendix 5.2). Briefly, the Dry Filtration Unit is a portable biological 
sample collection device that samples room air via filters. We used polyester felt filter of 47mm diameter 
and 1.0μm pore size (American Felt and Filter Company, New Windsor, New York; Lockheed Martin, 
Alexandria, VA, USA) filters that neither trap carbon dioxide nor impact simultaneous classroom ambient 
carbon dioxide concentration measurement. The Dry Filtration Unit samples approximately 1,000 litres 
of room air per minute42 and has two separate holders for one filter in each holder. The filters are 
positioned side by side within the same air vent. We assumed the 1,000 litres was evenly distributed to 
each filter (i.e. 500 litres via each filter per minute). All ddPCR air sampling was accomplished using two 
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filters per Dry Filtration Unit for laboratory testing which were packaged separately, transported to the 
Desmond Tutu HIV Centre54 laboratory at UCT, and stored at 1–4 degrees Celsius for 3–6 months prior 
to processing. 
c) Droplet digital PCR (ddPCR) assay 
The ddPCR assay was performed by the Desmond Tutu HIV Centre54 (University of Cape Town) in 
collaboration with the laboratory of Professor Digby Warner (University of Cape Town). The ddPCR 
assay was conducted using a previously published protocol,55 described in Appendix 5.5. Briefly, filters 
were processed by vortexing in 10 ml sterile phosphate buffered saline (PBS) + 0.5% Tween 80 and 
centrifuged at 4,500 rpm for 15 minutes. The pellet obtained from centrifugation was lysed for DNA 
extraction and purification using a mastermix reagent from BioRad Laboratories, Inc (Denver, Colorado, 
USA).56 Positive controls were Mycobacterium tuberculosis (H37RV) and No Template Controls (NTC) 
comprised of the mastermix, with no added template. Thermal cycler parameters used for DNA 
amplification were as follows: 50 °C for 2 min (incubation for Amperase); 95 °C for 10 minutes; 94 °C for 
30 seconds; 60 °C for 1 minute; repeat 94 °C for 30 seconds (40 cycles); 98 °C for 10 minutes; holding at  
4°C for between 5 hours to 24 hours before plate reading in the FAM and HEX channels using the QX100 
BioRad Droplet Reader (BioRad Laboratories, Inc (Denver, Colorado, USA).56 Genomic DNA extraction 
for PCR confirmation used primers RD9F (5’–gtgtaggtcagccccatcc–3’), RD9R (5’–gctaccctcgaccaagtgtt–
3’) and RD9Int (5’gctaccctcgaccaagtgtt–3’) using a published protocol.57 The QuantaSoftTM software58 
from BioRad Laboratories56 which applies Poisson distribution statistics was used for RD9 Mycobacterium 
tuberculosis DNA copy quantification.58 
d) Selection of fluorescence amplitude intensity positivity threshold for ddPCR 
assay 
The range of fluorescence amplitude intensity that provided 100% discrimination between Negative (No 
Template Controls) and Positive Controls was 4,500–5,500 (Figure 5.2). The mid–point of the optimal 
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discriminatory range for fluorescence amplitude intensity, i.e. 5,000, was therefore selected as the positive 
threshold for all subsequent analyses.  Using the 5,000 threshold, the proportion of ddPCR positive assays 
for control samples was Positive Controls 24/24 (100%), Negative (No Template) Controls 0/24 (0%), 
and open air spaces 0/5 (0%). 
Figure 5.2: Proportion of positive ddPCR assay by fluorescence amplitude intensity threshold 
 
Legend: The shaded region is the fluorescence amplitude intensity cut–off that provided 100% discrimination 
between No Template Controls and Positive Controls (i.e. 4,500–5500). Line A represents the optimal fluorescence 
amplitude intensity cut–off (5,000) selected for all subsequent ddPCR analyses. 
e) Calculation of risk of inhaling RD9 Mycobacterium tuberculosis DNA 
We adjusted concentration of RD9 Mycobacterium tuberculosis DNA to 180,000 litres of air (=180 cubic 
metres) for standardisation, based on the average volume of classrooms as per the education authorities. 
This was calculated as follows; 
i.e. RD9 Mycobacterium tuberculosis DNA copies per 180,000=         (2) 
180,000
𝐴𝑖𝑟 𝑣𝑖𝑎 𝐷𝐹𝑈(𝑖. 𝑒. 1,000 𝑙/𝑚𝑖𝑛 ∗  𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛 𝑖𝑛 𝑚𝑖𝑛𝑢𝑡𝑒𝑠)
 𝑥 𝐷𝑁𝐴 𝑐𝑜𝑝𝑖𝑒𝑠 𝑓𝑟𝑜𝑚 𝑎𝑖𝑟 𝑠𝑎𝑚𝑝𝑙𝑖𝑛𝑔 𝑒𝑝𝑖𝑠𝑜𝑑𝑒 
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Where: DFU=Dry Filtration Unit. The Dry Filtration Unit device samples approximately 1,000 litres of 
air per minute. 
The rate of inhaling RD9 Mycobacterium tuberculosis DNA copies per sampling episode (i.e. “r”) was 
estimated by:            (3) 
8 𝑙/𝑚𝑖𝑛
1000 𝑙/𝑚𝑖𝑛
 𝑥 𝐷𝑁𝐴 𝑐𝑜𝑝𝑖𝑒𝑠 𝑓𝑟𝑜𝑚 𝑑𝑑𝑃𝐶𝑅 𝑎𝑖𝑟 𝑠𝑎𝑚𝑝𝑙𝑖𝑛𝑔 𝑒𝑝𝑖𝑠𝑜𝑑𝑒 
Where: 8 l/min is the average adult human respiratory minute volume.53  1,000 l/min is the volume of air 
sampled via the Dry Filtration Unit per minute. 
The risk of an individual occupant inhaling at least one RD9 Mycobacterium tuberculosis DNA copy was 
estimated by:           (4) 
1 − exp(−𝑟) 
Where: exp= exponent; r= rate of inhaling RD9 Mycobacterium tuberculosis DNA copies per sampling 
episode obtained from equation (3) above. 
The risk of an individual occupant inhaling at least one RD9 Mycobacterium tuberculosis DNA copy during a 
35–minute lesson was obtained by;        (5) 




Where: Duration=duration of ddPCR air sampling.  
The estimated average risk of inhaling RD9 Mycobacterium tuberculosis DNA copies for classrooms or clinics 
was obtained by summing all classroom or clinic risk of inhaling one DNA copy, divided by the number 
of classrooms or clinics.  
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f) Symptom–screening for undiagnosed tuberculosis disease  
All students in classrooms selected for ddPCR air sampling were given a health education talk that covered 
tuberculosis disease symptoms and tuberculosis transmission, and information about the study that 
included the rationale and objectives, eligibility for participation, how the study would be conducted, 
potential benefits and risks, confidentiality and autonomy (optional participation). Any queries were 
addressed. Students who expressed interest to participate in the study were individually requested to 
provide their written informed assent or consent (signature or thumbprint), and to complete a self–
administered, tuberculosis disease symptom–based screening questionnaire written in their home 
language. Study staff were available to respond to any enquiries. Questionnaires included participant socio–
demographic data and presence/absence of the following symptoms: cough for ≥2 weeks; haemoptysis; 
weight loss of ≥2 months; fever of unknown cause for ≥2 weeks; or night sweats for ≥2 weeks. Symptom 
screening was performed on the same day as classroom ambient carbon dioxide concentration 
measurement and ddPCR air sampling. Participants with cough or any other of the five tuberculosis–
related screening symptoms who were willing to spontaneously expectorate sputum were given a sputum 
bottle and requested to provide one early morning sputum for Xpert MTB/RIF  Ultra testing at the study 
laboratory, in order to evaluate the rate of laboratory testing using the screening algorithm and the yield 
of tuberculosis disease diagnosis among those screened and tested. It was acknowledged that participants 
without cough were unlikely to be able to produce a sputum sample; and that some participants with cough 
might be sputum unproductive. Students with any symptom/s were also given a referral letter asking them 
to report to the nearest public health facility where additional tuberculosis diagnostic and treatment, and 
HIV testing, is offered free of charge. Further testing for clinical purposes, including for tuberculosis and 
HIV, was managed by routine clinic staff.  
5.5.6. Statistical analysis  
Descriptive statistical analysis was done to describe socio–demographic variables and distribution of 
tuberculosis disease symptoms. Box and whisker plots were used to compare ambient carbon dioxide 
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concentration in clinics and classrooms. Categorical data were summarized using frequency counts and 
percentages. Carbon dioxide values by type of space were described using medians and inter–quartile 
ranges and the Wilcoxon rank–sum test was used to compare median carbon dioxide values by type of 
space. The Chi–squared test was used to assess statistically significant differences between groups for 
categorical ddPCR assay results. The Spearman rank correlation (correlation coefficient=rs) was used to 
determine correlation between ambient carbon dioxide concentration and mean temperature by month. 
The two–sample test of equality of proportions was used to compare proportions of high/low ventilation 
risk spaces for Mycobacterium tuberculosis transmission and spaces with positive ddPCR assay for clinics and 
classrooms. The Agresti–Coull method was used to obtain confidence intervals for tuberculosis disease 
prevalence. Analysis was conducted in STATA statistical software version 15.59 For all hypothesis tests the 
alpha threshold was set at 0.05. 
 Results 
5.6.1. Characteristics of clinic and classrooms 
a) Duration of sampling and number of individual occupants 
For classrooms, the median duration of ambient carbon dioxide concentration measurement and ddPCR 
air sampling was 40 minutes (IQR: 35,54; Appendix 5.6). The number of students in classrooms was 
usually unchanged at the end compared to the start of ddPCR air sampling (median 34 (IQR: 29, 39)). 
For clinics, the median duration of ambient carbon dioxide concentration measurement and ddPCR air 
sampling was 82 minutes (IQR: 40,120; see Appendix 5.6). The number of individuals in clinics at the start 
of ambient carbon dioxide concentration measurement and ddPCR air sampling varied by type of space 
(see Appendix 5.7) and was highest in general patient waiting areas (42 (median) (IQR: 27, 45)) and lowest 
in tuberculosis clinic consultation rooms (3 (IQR: 3, 5)). The number of individuals in clinic spaces was 
usually unchanged at the end compared to the start of ddPCR air sampling, except for the general patient 
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waiting areas where the former was almost half the latter, 20 (IQR: 5, 24) vs. 42 (IQR: 27, 45) respectively. 
For clinics, the number of patients or clients got fewer as the day progressed from 10:00 am onwards. 
b) Windows and doors 
For classrooms, the proportion of all windows that were open was 27%, this varied by month (75% in 
March, 13% in May). The proportion of open classroom doors was approximately 50%. 
All clinic spaces had existing carbon dioxide monitors with alarm functions that had previously been 
installed by hospital authorities to monitor ambient carbon dioxide concentration. The overall proportion 
of all clinic windows that were open was 70% (range 46% to 89% (Appendix 5.8 and Appendix 5.9)). The 
proportion of open clinic windows was similar for the two months that ambient carbon dioxide 
concentration measurement and ddPCR air sampling was conducted (71% vs 69% for February and 
November, respectively). The proportion of open clinic doors was 20% (Appendix 5.10).  
c) Ambient carbon dioxide concentration and season 
Classroom median ambient carbon dioxide concentration was highest in July (1297 ppm ((IQR: 1235, 
2100); the coldest month of the year) and lowest in March (835 ppm ((IQR: 751, 893); the third warmest 
month of the year). There was a statistically significant negative correlation between ambient carbon 
dioxide concentration and average daytime temperature of the month of sampling for classrooms 
(p<0.001); and a statistically significant negative correlation between the proportion of open classroom 
windows and ambient carbon dioxide concentration (P<0.001).  
Clinic median ambient carbon dioxide concentration was similar for the two months of clinic space 
sampling (see Appendix 5.10 and Appendix 5.11). There was no statistically significant correlation between 
ambient carbon dioxide concentration and average daytime temperature of the month of sampling for 
clinic spaces (p=0.547), but there was a statistically significant negative correlation between the proportion 
of open clinic windows and ambient carbon dioxide concentration (p<0.001).  
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d) Ambient carbon dioxide concentration and time of sampling 
For classrooms, there was a statistically significant direct relationship between time of sampling and 
ambient carbon dioxide concentration (rs=0.211; p<0.001).  
For clinics, there was a statistically significant inverse relationship between time of sampling and ambient 
carbon dioxide concentration (rs= –0.273; p<0.001).  
e) Ambient carbon dioxide concentration  
The distribution of classroom ambient carbon dioxide concentration measurements was variable; and was 
impacted by the number of people in the space, and the number and proportion of open windows and 
doors. Representative examples for clinics and classrooms are shown in Figure 5.3(a) and Figure 5.3(b), 
respectively.  
All clinics had median ambient carbon dioxide concentration below 1,000 ppm (see Appendix 5.12 and 
Appendix 5.13); and the majority (>70%) of clinic ambient carbon dioxide concentration readings did not 
achieve steady state by the end of the sampling period. 
Figure 5.3(a): Representative examples of clinic ambient carbon dioxide concentration over time 
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Legend: CO2 =Carbon dioxide. Carbon dioxide concentration was measured in parts per million and showed 
variable distribution over the duration of measurement. Panel A=general patient waiting area, Panel B=tuberculosis 
clinic consultation room, Panel C = general patient waiting area; Panel D=general patient waiting area, Panel 
E=tuberculosis patient waiting area, Panel F = tuberculosis patient waiting area. Green dotted line= The median 
carbon dioxide level of open–air environmental space (387 ppm). The dotted red line is the upper threshold for 
recommended median carbon dioxide   concentration of 1,000 ppm. Portable carbon dioxide monitors recorded 
carbon dioxide   concentration every 60 seconds for clinic spaces. 
Steady state ambient carbon dioxide concentration was observed rarely in classrooms (e.g. Figure 5.3(b) 
panel E), despite peak concentration of >1,000 in several cases (Figure 5.3(b) Panel D). 
Figure 5.3(b): Representative examples of classroom ambient carbon dioxide concentration over time 
 
Legend: CO2 =Carbon dioxide. carbon dioxide   concentration was measured in parts per million and showed 
variable distribution over the duration of IAQ sampling. Panel A–F = classrooms. Green dotted line= The median 
carbon dioxide level of open–air environmental space (387 (384–403 ppm). The dotted red line is the threshold for 
recommended median carbon dioxide   concentration of 1,000 ppm.  
In Figure 5.3, we show that Clinic A, B and C had ambient carbon dioxide concentration of 405 (median) 
(IQR: 387–440), 595 (555–651), and 571(544–605), respectively. School B and D had carbon dioxide 
concentration of 904 (median) (719–1114) and 877 (761–1297), respectively. The carbon dioxide 
concentration of the open–air space was 387 (384–403) (Figure 5.4). 
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Figure 5.4: Comparison of ambient carbon dioxide concentration in clinics and classrooms  
 
Legend: CO2=Carbon dioxide. Carbon dioxide concentration was measured in parts per million (ppm). Green 
dotted line= The median ambient carbon dioxide concentration of open–air space (387 ppm). The dotted maroon 
line is the threshold for recommended median carbon dioxide concentration of 1,000 ppm. 
Overall, clinic spaces were better ventilated than classroom spaces; respectively for all clinics vs all 
classrooms, the median ambient carbon dioxide concentration was 490 ppm (IQR: 405–587) vs 886 ppm 
(IQR: 747–1223) (p–value <0.001). No clinic spaces and 40% of classrooms met the definition of high–
risk spaces for Mycobacterium tuberculosis transmission if defined by median ambient carbon dioxide 
concentration of ≥1,000 ppm (Table 5.1). Median classroom ventilation rate as estimated by air changes 
per hour was 6.10 (4.38, 8.21) in school B and 6.46 (3.69, 8.37) in school D.  
Classroom proportion of rebreathed air from fellow students was median 1.40% in school B and 1.26% 
in school D. Volume of rebreathed air per classroom learning session (35 minutes) was median 3.53 litres 
(2.70, 4.85) in school B and 3.21 litres (1.75, 5.50) in school D.  
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Table 5.1: Classification of ventilation risk status in clinics and classrooms 




Proportion of sampling 
duration with carbon 
dioxide   readings 
≥1000ppm  
(n/N (%)) 
Proportion of spaces 
with median carbon 
dioxide   ≥1,000 ppm 
(n/N (%)) 
Proportion of spaces 
with peak carbon 






Clinic A  22.0  0 (0%) 0/9 (0%) 0/9 (0%) 0.03% (0.02, 
0.10) 
Clinic B  14.3 0.15 (1.0%) 0/7 (0%) 3/7 (42.9%) 0.58% (0.47, 
0.63) 
Clinic C  8.7 0 (0%) 0/5 (0%) 0/5 (0%) 0.43% (0.33, 
0.52) 
School B 17.4 6.2 (35.6%) 11/32 (34.4%) 20/32 (62.5%) 1.40% (1.02, 
1.81) 




1.1 0 (0%) 0/3 (0%) 0/3 (0%) NA 
Legend: CO2=Carbon dioxide. Indoor ambient carbon dioxide concentration is in parts per million. 
IQR=Interquartile range. NA=Not applicable.  
5.6.2. ddPCR assay results 
Using the selected fluorescence amplitude intensity positivity threshold (5,000), ddPCR air sampling 
yielded a positive Mycobacterium tuberculosis ddPCR assay result from four clinics (10.3%) and 13 classrooms 
(18.1%) (p=0.276).  
For classrooms, there was no statistically significant association between a positive ddPCR assay result and 
high–risk ventilation status (χ2 p–value=0.170). Overall, the estimated average concentration of RD9 
Mycobacterium tuberculosis DNA for all classrooms was 3.61 copies per 180,000 litres but 20 copies (range 8–
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82 copies) per 180,000 litres when analysis was limited to classrooms with ddPCR assay positive filters 
only. The average risk of a classroom occupant inhaling one RD9 Mycobacterium tuberculosis DNA copy over 
one lesson (35 minutes) was 0.71%; and the estimated risk over one academic day was 2.7%, over one 
academic week was 12.6%, over one academic month was 41.7% and over one academic year was 100%. 
Students in South African high schools spend approximately 1,155 hours congregated in classrooms 
during approximately 199 school days (academic year) each calendar year.22 We estimate each student will 
have inhaled on average 11 RD9 Mycobacterium tuberculosis DNA copies per year. For only those classrooms 
with a positive ddPCR assay, the estimated average proportion of occupants who inhaled at least one copy 
of RD9 Mycobacterium tuberculosis DNA was 3.8% (range: 2.4%–20%). It is important to note that one RD9 
Mycobacterium tuberculosis DNA copy does not necessarily translate to one infectious Mycobacterium tuberculosis 
quantum.  
For clinic spaces, the overall estimated average concentration of RD9 Mycobacterium tuberculosis DNA was 
1.74 copies per 180,000 litres of air but 17 copies (range 2–27) per 180,000 litres of air for clinics with 
ddPCR assay positive filters only, and was similar for the tuberculosis clinic consultation room (19 copies) 
and patient waiting area (15 copies). The average risk of a clinic occupant inhaling one RD9 Mycobacterium 
tuberculosis DNA copy over a 35–minute period was 0.29% for all clinics. 
5.6.3. Sociodemographic characteristics of students screened for 
tuberculosis disease 
We enrolled 1,836 out of 2,262 students (81.2%) in the classrooms selected for ddPCR air sampling (Table 
5.2). The median age of study participants was 16.2 years. 779 (45.8%) of all study participants were male. 
School B predominantly had students of Mixed race (96.1%) whereas school D predominantly had 
students of Black African race (62.2%) (Table 5.2 and Appendix 5.14).  
Page | 124 
 
Table 5.2: Sociodemographic characteristics of enrolled students  
Variable School B  School D Total  
Enrolled participants (n (%)) 643 (73.0%) 1,193 (86.4%) 1,836 (81.2%) 
Age (median (IQR) 15.7 (14.8; 16.8) 16.6 (15.2; 17.9) 16.2 (15.1; 17.5) 
Sex (male) 272 (46.3%) 507 (45.6%) 779 (45.8%) 
Race    
Black African 10 (1.6%) 1073 (96.7%) 1083 (62.2%) 
Cape Mixed Ancestry 608 (96.1%) 36 (3.2%) 644 (36.9%) 
White 14 (2.2%) 0 (0.1%) 14 (0.8%) 
Indian/Asian 1 (0.2%) 1 (0.1%) 2 (0.1%) 
Legend: n (%) = number (percentage). IQR= Interquartile range. 
5.6.4. Symptom screening for tuberculosis disease  
90 students reported cough ≥2 weeks (4.9%), 14 reported haemoptysis (0.8%), 79 reported weight loss >2 
months (4.3%), 68 reported fever of unknown cause >2 weeks (3.7%), and 48 reported nights sweats >2 
weeks (2.6%). These proportions did not differ substantially by school (Table 5.3).  
215 (11.7%) students reported one or more tuberculosis–related symptoms, of whom 90 (41.9%) reported 
a cough ≥2 weeks and 125 (58.1%) reported no cough ≥2 weeks. 58 (64.4%) of those reporting cough ≥2 
weeks indicated they could produce sputum, but only 21 (36.2%) submitted sputum for Xpert MTB/RIF 
Ultra testing, one (4.8%) of which was positive, giving an estimated tuberculosis disease prevalence of 55 
(CI: 0–341) per 100,000). 
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Table 5.3: Screening for self–reported symptoms  
Symptom or attribute School B  
n or n/N (%) 
School D 
n or n/N (%) 
All  
n or n/N (%) 
Cough ≥ 2 weeks 36/640 (5.6%) 54/1180 (4.6%) 90/1820 (4.9%) 
Haemoptysis 5/640 (0.8%) 9/1174 (0.8%) 14/1814 (0.8%) 
Weight loss >2 months 30/636 (4.7%) 49/1185 (4.1%) 79/1821 (4.3%) 
Fever of unknown cause >2 weeks 32/637 (5.0%) 36/1180 (3.1%) 68/1817 (3.7%) 
Nights sweats >2 weeks 16/642 (2.5%) 32/1189 (2.7%) 48/1831 (2.6%) 
Household tuberculosis disease contact 28/640 (4.4%) 62/1186 (5.2%) 90/1826 (4.9%) 
≥1 tuberculosis disease screening symptom* 86/642 (13.4%) 129/1190 (10.8%) 215/1832 (11.7%) 
Sputum positive Xpert MTB/RIF Ultra (N= tested individuals) 0/3 (0.0%) 1/18 (5.6%) 1/21 (4.8%) 
Number screened to detect 1 case of tuberculosis disease NA 1190 1832 
Legend: Differences in denominator due to the fact that not all students responded to all questions on tuberculosis–
related symptoms. 
5.6.5. Relationship between classroom ambient carbon dioxide 
concentration, ddPCR air sampling, and tuberculosis disease 
symptoms  
Relationship between classroom ambient carbon dioxide concentration and ddPCR air sampling 
There was no statistically significant association between a positive ddPCR assay and high–risk ventilation 
status (χ2 p–value=0.170) for classrooms. χ2 p–value not applicable for clinics since all were low ventilation 
risk. Three (12%) of high-risk ventilation classrooms and 10 (26%) of low ventilation risk classrooms had 
a positive Mycobacterium tuberculosis ddPCR assay. However, the median ambient carbon dioxide 
concentration for ddPCR assay positive classrooms was significantly lower than ddPCR–negative 
classrooms (829 ppm (IQR: 700–1114) vs 914 ppm (IQR: 761–1243); p–value < 0.001), respectively. The 
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median ambient carbon dioxide concentration for ddPCR assay positive clinic spaces was higher than 
ddPCR–negative clinic spaces (581.5 ppm (IQR: 475.0–645.0) vs 468.5 ppm (IQR: 402–577); p–value 
<0.001). The median ambient carbon dioxide concentration for ddPCR assay positive classrooms was 
much higher than that for ddPCR assay positive clinics. 
Relationship between tuberculosis–related symptoms and Mycobacterium tuberculosis ddPCR 
air sampling 
There was a statistically significant direct association between self–reported weight loss of >2 months and 
classroom ddPCR assay positive result; but statistically significant inverse associations between fever >2 
weeks, nights sweats >2 weeks and classroom ddPCR assay positive result (Table 5.4). 
Table 5.4: Screening for self–reported tuberculosis disease symptoms among students by ddPCR assay 
result 
Symptom ddPCR assay positive 
n or n/N (%) 
ddPCR negative assay  
n or n/N (%) 
P–value 
Cough > 2 weeks 14/272 (5.2%) 76/1548 (4.9%) 0.868 
Haemoptysis  0/273 (0%) 14/1541 (0.9%) 0.114 
Weight loss >2 months 20/272 (7.3%) 59/1548 (3.8%) 0.009 
Fever >2 weeks 2/273 (0.7%) 66/1544 (4.3%) 0.004 
Nights sweats >2 weeks 2/274 (0.7%) 46/1557 (3.0%) 0.034 
≥1 tuberculosis disease screening symptom* 33/274 (12.0%) 182/1558 (11.7%) 0.864 
Legend: tuberculosis=tuberculosis. Numbers are n (%) or n (IQR). 
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Relationship between tuberculosis–related symptoms and classroom ambient carbon dioxide 
concentration 
There was no statistically significant association between the presence of self–reported tuberculosis–
related symptoms and low/high classroom ventilation risk status based on median ambient carbon dioxide 
concentration threshold (1,000 ppm) (Table 5.5).  
Table 5.5: Self–reported tuberculosis disease symptoms among students by ventilation risk status of 
classrooms 
Symptom or attribute Low ventilation risk 
classrooms 
n or n/N (%) 
High risk ventilation 
classrooms 
n or n/N (%) 
P–value 
Cough > 2 weeks* 34/936 (3.6%) 31/708 (4.4%) 0.442 
Haemoptysis  9/942 (1.0%) 5/711 (0.7%) 0.580 
Weight loss >2 months 41/940 (4.4%) 29/709 (4.1%) 0.139 
Fever>2 weeks 34/940 (3.6%) 20/708 (2.8%) 0.371 
Nights sweats >2 weeks 22/944 (2.3%) 14/711 (2.0%) 0.618 
≥1 tuberculosis disease screening symptom* 102/944 (10.8%) 67/711 (9.4%) 0.358 
Legend: tuberculosis=tuberculosis; *=Any symptom refers to any one or more of cough, haemoptysis, weight loss, 
self–reported fever and/or night sweats. Numbers are n (%) or n (IQR). * Not all classrooms had ambient carbon 
dioxide concentration readings hence the different denominators.  
5.6.6. Profile of classroom occupied by a student with undiagnosed 
tuberculosis disease 
The classroom with a microbiologically confirmed case of tuberculosis disease was a grade 12 classroom 
in school D that was occupied by 41 students in total, 29 (71%) of whom agreed to take part in this study. 
The median age of all students in this classroom was 18.4 years (IQR: 17.8, 19.6). Students spent 40 
minutes of the 58–minute sampling period (83%) with indoor ambient carbon dioxide concentration levels 
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above the recommended median ambient carbon dioxide concentration threshold. The median ambient 
carbon dioxide concentration was 1,242 ppm (IQR: 1,046–1,283 ppm; Figure 5.5). ddPCR air sampling of 
this classroom yielded a positive ddPCR assay.  
Figure 5.5: Indoor ambient carbon dioxide concentration monitoring of classroom with undiagnosed 
tuberculosis disease case 
 
Legend: CO2=Carbon dioxide. This Figure shows that students spent 40 minutes exposed to indoor ambient 
carbon dioxide concentration levels above the recommended median carbon dioxide   concentration of 1,000 ppm 
(dotted red line). 
Three male students reported at least one tuberculosis–related symptom. The student with confirmed 
tuberculosis disease was aged 20 years old and reported a cough of ≥2 weeks, but was unsure of any 
household contact with tuberculosis disease. The second student with self–reported symptoms had a 
cough of ≥2 weeks with no known household tuberculosis disease contact, and the third student had 
weight loss and self–reported fever, but was unsure whether he had a household contact with tuberculosis 
disease. It is not known whether other students in this classroom who did not consent to take part in 
symptom–screening (29%) were symptomatic or had a household tuberculosis disease contact. Only one 
of these three students was able to provide sputum for Xpert MTB/RIF Ultra assay; the other two students 
with self–reported symptoms were sputum unproductive. 
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 Discussion 
We built on the seminal work of Riley,23 Wells,24 Rudnick29 and Wood32 to study classroom ambient carbon 
dioxide concentration and tuberculosis symptom screening, in conjunction with air sampling for 
Mycobacterium tuberculosis using a highly sensitive molecular test,55 ddPCR, that to the best of our knowledge 
has not been previously used in school classrooms in a high tuberculosis burden setting. We showed that 
more than one–third of 72 classrooms in two schools in the study area were inadequately ventilated. One–
fifth of classrooms had evidence of airborne Mycobacterium tuberculosis DNA detected by ddPCR air 
sampling. However, yield from school–based TB symptom screening was low, consistent with the 
presence of undiagnosed subclinical TB cases and risk of ongoing transmission in the school setting. 
We also studied clinics as comparator spaces with high a priori risk of occupation by known tuberculosis 
patients. We showed that all clinics were adequately ventilated, based on a median ambient carbon dioxide 
concentration ≥1,000 ppm, although 14% of clinics had a high peak carbon dioxide ≥1,000 ppm indicating 
intermittent periods of poor ventilation during which Mycobacterium tuberculosis transmission risk might be 
elevated. All clinic readings were conducted during summer when ventilation due to open windows could 
be assumed maximal.  However, we obtained positive ddPCR assay results on filters from 10% of clinic 
spaces, all of which were defined as low ventilation risk by median ambient carbon dioxide concentration, 
which emphasises the need for strict adherence to other infection control measures, given the high 
probability of individuals with tuberculosis disease in this setting.  
In contrast to the findings in clinics, 40% of classrooms were inadequately ventilated with median carbon 
dioxide concentration ≥1,000 ppm. This finding is similar to the 60% observed in another South African 
study, which tracked spaces that 64 students visited over 91 school days using individual monitors for a 
total of 509 hours of school time.28 Inadequate classroom ventilation is also not limited to schools in 
developing countries. A study of 62 classrooms in 27 naturally–ventilated schools in Greece found 52% 
to be high risk ventilation spaces with mean indoor ambient carbon dioxide concentration of more than 
1,000 ppm.60 A systematic review on classroom ambient carbon dioxide concentration in European 
Page | 130 
 
schools (287 classrooms from 182 naturally–ventilated schools and 900 classrooms from 220 
mechanically–ventilated schools) also found 52% of classrooms to be high risk ventilation spaces.60 
However, the potential risk of Mycobacterium tuberculosis transmission would likely be higher in classrooms 
in high tuberculosis burden compared to low tuberculosis burden settings, given the same degree of sub–
optimal ventilation to which students are exposed. The poor ventilation of classrooms in this study is likely 
a result of the low percentage (27%) of open windows, which in turn was likely influenced by prevailing 
weather conditions in winter months. However, in this study, the mean rebreathed air volume for one 
classroom session (35 minutes) of 5.0 litres is lower than the 6.7 litres reported for an equivalent period in 
another adolescent study in a South African school.32  
A limitation of the study is time of year and season in which ddPCR air sampling was conducted, which 
limits our ability to compare adequacy of ventilation directly between clinics and classrooms. A study of 
both clinics and classrooms in winter only might not replicate our findings of an inverse association 
between average monthly temperature and median ambient carbon dioxide concentration in classrooms, 
but not clinics.  
The study of classrooms during the winter months with sub–optimal ventilation can be assumed as the 
worst–case scenario for tuberculosis transmission risk. Indoor environment and ventilation, as 
demonstrated by Wells and Riley are key determinants of transmission for airborne infections.23, 24 The 
following factors impacted ventilation in this study: month/season, proportion of open windows or doors, 
time of day and number of occupants in rooms. Other factors that impact indoor ventilation status and 
air quality include light intensity, wind direction, wind speed,61 desiccation rate,62 size of windows, relative 
humidity, temperature, use of mechanical ventilation and adaptive behaviours by room occupants to keep 
windows or doors closed or open, parameters which were not systematically measured in this study.60 
Mycobacterium tuberculosis ddPCR assay positive results were obtained from 10 (26%) adequately ventilated 
and three (12%) inadequately ventilated classrooms, including 12 (17%) classrooms in which tuberculosis 
disease symptom–screening did not detect additional undiagnosed tuberculosis disease cases, suggesting 
Page | 131 
 
additional undiagnosed tuberculosis disease cases in these classrooms were missed. We demonstrated the 
relationship between high risk ventilation and increased risk of ddPCR assay positive signal in clinics. 
Although we did not demonstrate the same relationship in classrooms, this may be due to the fact that 
even in ddPCR negative classrooms ventilation was not optimal. Median ambient carbon dioxide 
concentration in ddPCR negative classrooms was higher than that in ddPCR positive clinics. 
We report an average risk of a classroom occupant inhaling 1 DNA copy per classroom learning session 
of 35 minutes of 0.71%. Considering students in South African high schools spend approximately 1,155 
hours congregated in classrooms during approximately 199 school days (academic year) each calendar 
year,22 we estimate each student will have inhaled on average 11 RD9 Mycobacterium tuberculosis DNA copies 
per academic year. A South African study reported a concentration of approximately 40 colony forming 
units of Mycobacterium tuberculosis per 40 minutes of sampling, similar to that in our study.55 However, the 
only way to measure whether presence of RD9 Mycobacterium tuberculosis DNA from ddPCR air sampling 
was resulting in Mycobacterium tuberculosis transmission would be to measure prospective serial interferon 
gamma release assays (IGRA) in a fixed population of susceptible individuals. This study was designed 
pragmatically, to reflect the likely design of a future school–based tuberculosis disease screening strategy, 
which would not use TST/IGRA, chest X–ray or sputum induction due to feasibility and cost 
considerations. We set out to identify undiagnosed tuberculosis disease cases in classrooms with a positive 
ddPCR signal, but did not plan to use IGRA to identify students who might have been infected by these 
tuberculosis disease cases, because after each lesson there is a change of classes with mixing of students. 
Thus, it would not be possible to link individual infections with individual tuberculosis disease cases.  
The confidence interval of our adolescent tuberculosis disease prevalence estimate overlaps that of a 2005–
2007 estimate (prevalence 300 per 100,000 CI: 100–400 per 100,000 population) in this study community9 
and two other South African studies (476 cases per 100,000; CI: 0–1,30563 (2002) and 274 cases per 
100,000; CI: 263–28416 (2013)). Possible reasons for the relatively low prevalence estimate include 
underdiagnosis, since some students did not consent to participate in tuberculosis disease symptom 
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screening; some students who consented might have had asymptomatic, subclinical tuberculosis disease 
and were not detected by symptom screening; and some symptomatic students with tuberculosis disease 
might not have been able and/or willing to provide an expectorated sputum sample. All of these reasons 
for lower yield of our pragmatic tuberculosis disease surveillance approach would be equally applicable to 
the likely approach of a school–based tuberculosis disease surveillance system. 
Studies have postulated that quantitative airborne sampling may serve as a clinically relevant measure of 
infectivity to target high–risk spaces for more intensive tuberculosis disease surveillance efforts.55 A 
periodic classroom ddPCR air sampling strategy that identified ddPCR assay positive classrooms, followed 
by intensive symptom–screening accompanied by Xpert MTB/RIF Ultra testing and chest radiography of 
all students might be logistically feasible and cost–effective in resource–limited, high tuberculosis burden 
settings like South Africa. 
Further research is required to understand whether the Mycobacterium tuberculosis ddPCR assay arises from 
DNA incorporated in viable or non–viable Mycobacterium tuberculosis cells or, possibly, cell–free DNA; and 
how that ddPCR assay correlates with Mycobacterium tuberculosis transmission risk.55 The recommended 
dynamic range of the QX200 ddPCR system is 1–100,000 copies per 20 µl reaction.64 Estimation error is 
negligible compared with other error sources such as pipetting, sample processing, and biological 
variation.65  
Although ddPCR air sampling offers promise in Mycobacterium tuberculosis transmission research, further 
studies using a longitudinal study design that involves ddPCR air sampling, Mycobacterium tuberculosis culture 
and more intensive tuberculosis disease case detection, supported by sputum induction, may help 
determine the potential role of ddPCR air sampling for targeted classroom tuberculosis disease screening. 
Further research is also required to investigate the potential clinical role of ddPCR air sampling as a 
measure of infectivity in other high tuberculosis burden congregate settings.55 It is crucial to note that one 
RD9 Mycobacterium tuberculosis DNA copy does not translate to one infectious Mycobacterium tuberculosis 
quantum. Therefore, more research is required to estimate the number of inhaled RD9 Mycobacterium 
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tuberculosis DNA copies leading to established latent Mycobacterium tuberculosis infection in one person. This 
research is crucial to inform the accuracy and impact of school–based tuberculosis disease symptom–
screening program, which, based on our ddPCR air sampling data, might miss infectious undiagnosed 
tuberculosis disease cases in South African schools.  
Conclusion 
In conclusion, students in South African high school classrooms are exposed to inadequate ventilation 
during the winter months. Given the high tuberculosis disease prevalence rates in this population, 
inadequate ventilation exposes susceptible students to risk of Mycobacterium tuberculosis transmission. We 
have shown that ddPCR air sampling detects RD9 Mycobacterium tuberculosis DNA copies in South African 
classrooms, which suggest that the risks of inadequate ventilation are real. This highlights the importance 
of ventilation management (e.g. sensitization for window opening), tuberculosis infection control and 
surveillance for early TB disease case detection in the congregate school settings. However, yield from 
school–based tuberculosis symptom screening was low and thus school–based tuberculosis symptom 
screening alone as a surveillance strategy may be economically unfeasible due to the high likelihood of 
missing tuberculosis disease cases. Further, we have quantified the risk of the average student inhaling one 
RD9 Mycobacterium tuberculosis DNA copy per 35–minute lesson at 0.71% and more than 100% after two 
months. While acknowledging the limitations of seasonal sampling on generalizability of our results, we 
infer that the risk of tuberculosis transmission in South African classrooms in the winter months is at least 
as high, or greater than the risk of tuberculosis transmission in clinic settings where infection control 
measures have been deployed during the summer months.  
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In this chapter we discuss overarching themes, conclusions, outstanding research questions and public 
health implications of the findings presented in the preceding chapters. Briefly, the main findings of this 
project are:  
1) There is a paucity of literature reporting adolescent LTBI and TB disease prevalence in high TB 
burden African countries (1990–2018). Based on this limited available data, both LTBI and TB 
disease prevalence rates are high, but corresponding infection–to–disease ratios are inconsistently 
low compared to that expected from Styblo’s Rule.1  
2) In the study area, adolescent LTBI prevalence remained high and relatively unchanged over a 
decade.2 
3) Adolescent TB disease notification rates in the study area fell 45% over the same period.3  
4) More than one–third of 72 classrooms in two schools in the study area were inadequately 
ventilated. One–fifth of classrooms had evidence of airborne Mycobacterium tuberculosis DNA 
detected by ddPCR air sampling. However, yield from school–based TB symptom screening was 
low, consistent with the presence of undiagnosed subclinical TB cases and risk of ongoing 
transmission in the school setting. 
To the best of our knowledge, we present the first estimates of adolescent TB infection–to–disease ratios 
from high TB burden African countries. We note the change in estimated ratio from six–fold to two–fold 
higher for Nduba et al.4 (Kenya) vs. Mahomed et al.5 (South Africa) study, respectively, if culture is used in 
place of sputum smear microscopy. We infer that comparison of the infection–to–disease ratio across 
different studies and settings may require benchmarking against microbiologically–confirmed TB disease. 
However, it should be noted that Leth et al.6 argues the decrease in the infection–to–disease ratio compared 
to the pre–chemotherapy era (per Styblo’s Rule) may be due to improvements in treatment of TB disease.6 
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We compared regional adolescent LTBI prevalence data for the period 2014–2015, obtained from a clinical 
trial,7 with baseline LTBI prevalence data from an adolescent cohort study published in part by Mahomed 
et al.5, which was included in the systematic review (Chapter 1). The systematic review did not obtain a 
published manuscript that evaluated temporal trends in prevalence of adolescent LTBI or TB disease from 
a high TB burden African country (1990–2018), the sub–population with the highest force of Mycobacterium 
tuberculosis infection in this setting.8 These regional datasets permitted a comparison of changes in LTBI 
prevalence over the decade 2005–2015. Analysis of temporal trends in prevalence of both LTBI (Chapter 
2) and TB disease (Chapter 3) provided novel data on the adolescent TB epidemic in the study region to 
inform monitoring and outcomes of adolescent TB control. 
The 45% fall in adolescent TB disease notification rate in the face of constant LTBI prevalence in the 
same study area implies that the infection–to–disease ratio among adolescents in this community increased 
over the period 2005–2015, since ARTI is derived using LTBI prevalence. Using microbiologically–
confirmed TB, the adolescent infection–to–disease ratio increased from 2.5 in 2005 to 6.9 in 2015 in the 
study area. However, the ratio remains lower than that expected from the Styblo Rule (8–12). Differences 
in estimates of infection–to–disease ratio within the same country or the same community over time were 
also observed by Trunz et al.9 and Leth et al.6  Leth et al.6 argues that given these observations, the Styblo 
Rule should not be used to estimate incidence of smear–positive TB, a view endorsed by the WHO.6 It 
follows that TB prevalence surveys in high TB burden countries are likely the best tools for monitoring 
progress in TB control in the absence of adequate routine TB surveillance systems.6 We also appreciate 
that the observed trends in adolescent TB disease notification rates in the study area may not be 
extrapolated directly to all communities in South Africa, or to all high TB burden countries, because TB 
disease burden varies across communities based on contextual socioeconomic factors. Therefore, the first 
South African national TB disease prevalence survey, for which results are anticipated in 2020, would 
provide generalizable estimates of national TB disease prevalence, including that among adolescents.10  
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Over time, we would expect a decrease in adolescent Mycobacterium tuberculosis infection prevalence to 
precede any decrease in TB disease case notification rate in the same population, provided that duration 
of observation is sufficient to observe the expected changes. Our finding that adolescent prevalence of 
LTBI remained high and relatively unchanged, while adolescent notification rates of TB disease fell 45% 
over the same period,3  may be explained by the fact that the adolescent ARTI and LTBI prevalence 
represent cumulative lifetime measures,11 such that the majority of latently infected individuals have 
survived without reversion of their positive IGRA result to negative.8 Compared to force of Mycobacterium 
tuberculosis infection, ARTI underestimates adolescent rates of Mycobacterium tuberculosis infection, due to 
IGRA (and TST) reversion after conversion.8 For example, the point estimate of adolescent force of 
Mycobacterium tuberculosis infection (14%) in the study area is three–fold the adolescent ARTI estimate (3.6%, 
Chapter 2), which would impact the estimated adolescent infection–to–disease ratio.2, 8 Instantaneous or 
short–term risk of Mycobacterium tuberculosis  infection is best measured by force of Mycobacterium tuberculosis  
infection estimated from serial IGRA testing in prospective cohort studies, because force of Mycobacterium 
tuberculosis infection  changes quickly in response to TB control interventions, whereas LTBI prevalence 
rates change more slowly, especially in older age groups.12 It is not known whether force of Mycobacterium 
tuberculosis infection has changed in parallel with changing adolescent TB disease case notification rates. 
It appears from our data that a pragmatic school–based TB disease screening program for adolescents that 
relied primarily on self–reported TB symptom screening, without additional TST/IGRA, chest 
radiography, or sputum induction for sputum unproductive and/or asymptomatic individuals, would likely 
not be effective. We showed relatively low rates of symptom–positive learners among those interviewed, 
low rates of sputum production and testing among symptomatic learners, and a low yield of 
microbiological confirmation among symptomatic learners who provided a sputum sample for testing. 
The low yield of confirmed TB diagnosis from school–based symptom screening appears not only 
operationally inefficient, but is likely associated with missed subclinical TB disease cases, which is 
supported by the relatively high rate of positive Mycobacterium Tuberculosis ddPCR assay results from 
classroom air sampling.   
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There is limited published data on the cost/benefit ratio of school–based infection control and TB disease 
surveillance measures in Africa.13–15 This lack of data supports the need for research into more efficient 
strategies to target active TB disease case–finding. Our preliminary data suggest that Mycobacterium 
tuberculosis ddPCR air sampling might allow more intensive TB case–finding efforts, potentially including 
TST/IGRA, chest radiography and sputum induction, to be targeted at high risk learners who occupy 
ddPCR positive classrooms. This approach might be more efficient, cost–effective and operationally 
feasible in low– and middle–income high TB burden countries than mass symptom–based screening. 
Additional research is needed to further evaluate and optimize ddPCR air sampling for TB case–finding 
in congregate settings such as schools, including re–designing primers to obtain a robust ddPCR assay, 
and varying the annealing temperature to optimise specificity of primer binding.16 Some available PCR 
enhancers such as dithiotreitol, Beatine monohydrate, formamide are incompatible with the Biorad ddPCR 
chemistry platform used in the present study, and further research is needed to identify PCR enhancers 
compatible with the Biorad ddPCR chemistry platform to improve diagnostic accuracy.16 We can’t 
discount possibility of false positive ddPCR results, however we note that selection of ddPCR amplitude 
threshold was compatible with 100% positive controls and 100% negative controls samples.  The ddPCR 
assay is sensitive and offers superior DNA copy quantitation capability compared to real time PCR and 
other available molecular diagnostic approaches, but limitations of ddPCR air sampling include the fact 
that the ddPCR assay is costly to set up and run, and requires specialised training and high safety laboratory 
support (Biosafety level II or better). Results for ddPCR assays performed in the research laboratory are 
not rapidly available, due to the need to process samples in batches for cost–saving and efficient use of 
reagents and laboratory personnel.  
New studies are also needed to facilitate translation of ddPCR air sampling of congregate spaces from an 
early–stage research tool to an operational public health surveillance intervention. Intensive TB disease 
case–finding targeted at ddPCR positive classrooms would only be effective if all classroom occupants can 
be traced from classroom schedules and daily attendance rosters, in the event of a positive ddPCR assay 
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signal. It would also be crucial that the all learners occupying ddPCR positive classrooms participate in TB 
investigations and therefore sensitization to the importance of TB control measures and issues of potential 
TB stigma would have to be addressed.  
Our finding, based on ddPCR air sampling of high school classrooms, that cumulative risk of exposure to 
Mycobacterium tuberculosis DNA approached 100% after 2.5 months of classroom attendance, is consistent 
with our published finding that adolescent LTBI prevalence in this study area remained high through the 
decade 2005–2015, which suggests ongoing Mycobacterium tuberculosis transmission in the medium–term. It 
appears that inadequate classroom ventilation would increase the risk for Mycobacterium tuberculosis 
transmission in the event of a learner or teacher with TB disease occupying the same space as susceptible 
IGRA negative students. We acknowledge that seasonal differences in air sampling between clinics and 
classrooms limits direct comparison of transmission risk. However, based on the proportion of ddPCR 
positive spaces, classroom risk of Mycobacterium tuberculosis transmission in the winter months appeared at 
least as high, or even greater than in clinics during the summer months, which highlights the impact of 
seasonal environmental measures on air quality and risk for TB transmission. Although clinics would have 
been deemed ‘high risk’ for transmission due to the likelihood of occupancy by infectious TB patients, 
based on our ddPCR air sampling findings, the actual risk of exposure in clinics appears significantly 
mitigated by optimal ventilation practices, which was not the case in classrooms. There is a need to ensure 
schools are safe places for learning as envisaged in the South African Integrated School Health Policy.17, 18 
We therefore recommend strategies be put in place to ensure adequate ventilation in all school classrooms 
by for example, health education and sensitization of staff and learners to the need for adequate ventilation 
e.g. open windows whenever seasonal weather conditions permit; and install carbon dioxide monitors in 
classrooms with an alarm function that is triggered when carbon dioxide levels exceed the recommended 
maximum safe threshold of 1,000 ppm, similar to measures that are already in place in ‘high risk’ clinics. 
Development of effective TB intervention strategies requires identification of key locations for 
Mycobacterium tuberculosis transmission. Regional molecular epidemiological data indicate recent 
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Mycobacterium tuberculosis  transmission is responsible for at least 55% of the regional TB disease burden,19 
and statistical modeling estimates that 25% and 50% of new Mycobacterium tuberculosis  infections among 
South African individuals aged 0–14 and 15–19 years, respectively, occurs in the school setting.20 We 
therefore recommend, as a matter of urgency, new studies  of classroom ddPCR air sampling that 
incorporate Mycobacterium tuberculosis culture of parallel air filtrate samples and intensive TB case detection, 
supported by serial IGRA, chest radiography, and sputum induction for Xpert MTB/RIF Ultra and 
Mycobacterium tuberculosis molecular epidemiology testing (e.g. IS6110 Restriction Fragment Length 
Polymorphism (RFLP) or Mycobacterial Interspersed Repetitive Unit–Variable Number Tandem Repeat 
(MIRU–VNTR) to genotype Mycobacterium tuberculosis) to define relatedness of strains in incident TB 
disease cases.  
In conclusion, despite the decline in regional TB disease notification rates observed between 2005–2015, 
the adolescent burden of Mycobacterium tuberculosis infection in the study area remains high compared to 
other high TB burden countries in Africa. This finding, coupled with our observation of inadequate 
classroom ventilation during the winter months, very high cumulative risk of exposure to Mycobacterium 
tuberculosis DNA within months of classroom attendance, and the likelihood of classrooms being occupied 
by learners and/or staff with undiagnosed, subclinical TB disease, suggests that schools are high risk 
settings for exposure of susceptible students to Mycobacterium tuberculosis transmission. Our data suggest 
that pragmatic school–based TB symptom screening is low yield and inefficient. New and more efficient 
targeted TB case–finding strategies are needed for congregate settings, including schools, in high TB 
burden countries. Based on our preliminary data, classroom ddPCR air sampling for Mycobacterium 
tuberculosis DNA appears feasible for this purpose, but requires further research to optimise diagnostic 
accuracy and demonstrate the cost–effectiveness and public health value of this approach in high TB 
burden countries. 
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7. Appendices 
 Appendix 2.1 
Checklist of items in design of a systematic review protocol 
Domain Line item & PRISM–P code Page  
Section 1: Administrative information   
Title:   
 Identification (1a) √ 
 Update (1b) NA 
Registration Registration (2)  √ 
Authors:   
  Contact (3a) √ 
 Contributions (3b) √ 
Amendments Amendments (4) √ 
Support:   
 Sources (5a) √ 
 Sponsor (5b) √ 
 Role of sponsor or funder (5c) √ 
Section 2: Introduction 
Rationale Rationale (6) √ 
Objectives Objectives (7) √ 
Section 3: Methods   
Eligibility Eligibility criteria (8) √ 
Information Information sources (9) √ 
Search Search strategy (10) √ 
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Study records:   
 Data management (11a) √ 
 Selection process (11b) √ 
 Data collection process (11c) √ 
Data Data items (12) √ 
Outcomes Outcomes and prioritization (13) √ 
Bias  Risk of bias in individual studies (14) √ 
Data synthesis   
 Quantitative synthesis criteria (15a) √ 
 Appropriateness of data for synthesis (15b) √ 
 Sensitivity and subgroup analyses (15c) √ 
 Qualitative synthesis? (15d) √ 
Meta–bias(es) Meta–bias(es) (16) √ 
Confidence in cumulative evidence Assessment of strength of cumulative evidence (17) √ 
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 Appendix 2.2 
Search strategy 
Item  Search term Boolean 
operator 
Adolescents (“adolescent” (All Fields) OR “adolescence” (All Fields) OR “adolescent” (MeSH Terms) OR 
“adolescence” (MeSH Terms) OR “teen*” (All Fields) OR “child” (All Fields) OR “person” (All Fields) 
OR “persons” (MeSH Terms) OR “people” (All Fields)) 
AND 
Tuberculosis (“tuberculosis” (All Fields) OR “tuberculosis” (MeSH Terms) OR “TB” (All Fields) OR “TB” (MeSH 
Terms) OR “LTBI” (MeSH Terms) OR “LTBI” (All Fields) OR “latent” (MeSH Terms) OR “latent” (All 
Fields)) 
AND 
Countries (“Africa” (All Fields) OR “Africa” (MeSH Terms) OR “east*” (All Fields) OR “south*” (All Fields) OR 
“Congo” (All Fields) OR “Zaire” (All fields) OR “Ethiopia” (All Fields) OR “Kenya” (All Fields) OR 
“Uganda” (All Fields) OR “Tanzania” (All Fields) OR “Zimbabwe” (All Fields) OR “South Africa” (All 
Fields) OR “Mozambique” (All Fields) OR “Nigeria” (All Fields) OR “Angola” (All Fields) OR “ Sierra 
Leone ” (All Fields) OR (“Central” AND “African” AND “Republic”) (All Fields) OR “Lesotho ” (All 
Fields) OR “Liberia ” (All Fields) OR “Namibia ” (All Fields) OR “Zambia ” (All Fields) OR “Botswana ” 
(All Fields) OR “Cameroon ” (All Fields) OR “Chad” (All Fields) OR “ Ghana ” (All Fields) OR 
“Guinea–Bissau ” (All Fields) OR “Malawi ” (All Fields) OR “Swaziland ” (All Fields) OR “Somalia” (All 
Fields) ) 
AND 
Prevalence  (“epidemiology” (Subheading) OR “epidemiology” (MeSH Terms) OR “epidemiology” (All Fields) OR 
“prevalence” (All Fields) OR “prevalence” (MeSH Terms) 
AND 
Period Between 1st January 1990 and 13th August 2018  
*Covers both Democratic Republic of Congo and Congo 
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 Appendix 2.3 




































Additional records identified through 
other sources  
(n =…) 
Records after duplicates removed  
(n =…) 
Records screened  
(n = …) 
Records excluded  
(n = …) 
Full-text articles assessed 
for eligibility  
(n =…) 
Full-text articles excluded, 
with reasons  
(n =…) 
Studies included in 
qualitative synthesis  
(n = …) 
Studies included in 
quantitative synthesis 
(meta-analysis)  
(n = …) 
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 Appendix 2.4 
Data Extraction Form 
Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries 
in Africa 
Part A: Article identity 
Title of article ………………………………………………………………...................... 
First author ……………………………… Publication year …………………….………. 
Part B: Study characteristics 
Outcome:  □ TB disease prevalence only    □ LTBI prevalence only  □ Both LTBI & TB 
disease prevalence 
Country of study ……………………………  
Study design  
□ Cross–sectional study 
□ Cohort study 
□ Other. State if other ……………………………………………………………………….  
Population 
□ Non–students only 
□ Students only 
□ Both students and non–students 
□ Undefined  
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Period of study conduct 
□ State …………………………… 
Age range of study participants 
□ State ………………  
□ Mean age …………. 
Source population 
□ Nationally representative study 
□ Sub–national study 
Response rate 
□ State …………………………… 
Diagnostic modality for TB disease or latent TB infection 
Condition No. of events  Population size tested/evaluated 
TB disease   
Clinical   
Sputum smear    
Culture   
Xpert MTB/RIF    
X–ray   
LTBI   
IGRA    
TST    
Either IGRA or TST (Only if not disaggregated)   
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Study participants by gender, HIV and outcome  
Gender No. with 
LTBI 
Population size tested for 
LTBI 
No. with TB 
disease 
Population 







Male       
Female        
Total        
 
Include:  □ Yes    □ No 
If no, reason; 
o Age range ineligible 
o Country ineligible 
o Year ineligible 
o Study design ineligible 
o Language ineligible 
o Sampling non representative 
o Case definition or methodology unclear 
o Adolescent data unobtainable 
o Additional data unobtainable 
o Duplicate study 
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Part C: Quality assessment 
Item under review Score (Yes=1 or 
No=0) 
External Validity … 
Was the study’s target population a close representation of the national population in relation to relevant 
variables? 
… 
Was the sampling frame a true or close representation of the target population? … 
Was some form of random selection used to select the sample, OR was a census undertaken? … 
Was the likelihood of non–response bias minimal? … 
Internal validity … 
Were data collected directly from the participants (as opposed to a proxy)? … 
Was an acceptable case definition used in the study? … 
Was the study instrument that measured the parameter of interest shown to have validity and reliability? … 
Was the same mode of data collection used for all participants? (1 point) … 
Was the length of the shortest prevalence period for the parameter of interest appropriate? … 
Were the numerator(s) and denominator(s) for the parameter of interest appropriate? … 
Total … 
Summary item on the overall risk of study bias: low, moderate or high risk of bias  
Legend: Response options for individual items are either low (1) or high risk of bias (0). If there is insufficient 
information in the article to permit judgment of the specific item, then the article is deemed to be at high risk of 
bias with respect to that item. 
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 Appendix 2.5 
Amendments to systematic review protocol 
The published protocol was amended as follows: 
1) BMS left the organisation and was replaced by Simon C. Mendelsohn.  
2) The period of study conduct was changed from “studies reported between 1st January 1990 and 1st 
July 2016” to “studies conducted and reported between 1st January 1990 and 11th August 2018”: 
(1) In order to avoid inclusion of historical studies reported over this period that would not meet 
our core objective of studies conducted in mature HIV epidemics between ≥1990; (2) Due to delay 
occasioned by research fieldwork; and (3) To leverage on the delay to increase probability of 
obtaining eligible articles. 
3) To reduce chances of missing eligible articles we supplemented our search by searching reference 
lists of ‘all full–text articles screened’ and not just reference lists of ‘selected articles’ as published 
in the protocol.  
4) We used ‘Endnote’ software instead of ‘RefWorks’ bibliographic management software. Endnote 
was found to be superior to ‘RefWorks’ in systematic review bibliographic management.  
5) We used time–series modelling and linear regression to estimate time–adjusted adolescent TB 
disease prevalence rates for 2010 for the South African studies. Using these estimates, we 
compared with the published adolescent TB prevalence rates in the studies conducted in 2010 in 
Kenya and Uganda. This was done by assuming adolescent TB trends followed a pattern similar 
to the corresponding general population TB trends. We assumed the rate of change (i.e. gradient) 
for adolescent TB rates was the same as that of the line obtained by linear regression of WHO–
reported general population TB rates for 1999–2010, a finding we observed for South African 
regional data (chapter 3).24.  
6) Styblo et al.10 did seminal work on infection–to–disease ratios of tuberculosis by calculating the 
ratio between the number of tuberculous infections (based on ARTI estimates) and the number 
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of smear–positive TB disease cases per year and obtained a ratio of 8–12. We calculated the ratio 
between the number of Mycobacterium tuberculosis infections based on Annual Risk of TB Infection 
(ARTI) estimates and the number of smear– and culture–positive TB disease cases per year for 
the same study population; and compared the observed ratio to the expected ratio of 8–12 
published by Styblo et al.10 We used 8–12 as a benchmark for description purposes and not to 
indicate our agreement or disagreement with Styblo’s rule. As in literature, this sub–analysis was 
only done for studies with infection and disease data for the same population. ARTI was calculated 
from LTBI prevalence using the formula ARTI = 1 – (1 – Prevalence) 1/(mean age+0.5).25 The number 
of TB infections per annum was  obtained by multiplying the ARTI by the number of LTBI 
negative individuals in a given study. Reported sputum positive TB disease cases in the study were 
used as TB disease cases in our calculation, as in the literature. 
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 Appendix 2.6 
Results of quality assessment and evaluation of risk of bias of included studies 
Author, year (Ref) Outcome 
measure 
External validity Internal validity  Summary of risk of bias 
  1 2 3 4 5 6 7 8 9 10  
Mahomed, 20112 LTBI           Moderate 
Middelkoop, 20141 LTBI           Moderate 
Mumpe–Mwanja, 20155 LTBI           Moderate 
Marais, 20053 LTBI, TB           Low 
Nduba, 20154 LTBI, TB           Low 
Mahomed, 20137 TB           Moderate 
Snow, 20178 TB           High  
Waako, 20135 TB           Moderate 
Legend: TB=Tuberculosis; LTBI=Latent Tuberculosis Infection. Green box=score of 1 on Hoy et al. quality 
assessment tool for prevalence studies (i.e. low risk of bias); Red box=score of 0 on Hoy et al.26 quality assessment 
tool for prevalence studies (i.e. high risk of bias). Numbered items in 2nd row refer to items listed below obtained 
from Hoy et al.26 quality assessment tool;  
External Validity 
1. Was the study’s target population a close representation of the national population in relation 
to relevant variables? 
2. Was the sampling frame a true or close representation of the target population? 
3. Was some form of random selection used to select the sample, OR was a census undertaken? 
4. Was the likelihood of non–response bias minimal? 
Internal validity 
5. Were data collected directly from the participants (as opposed to a proxy)? 
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6. Was an acceptable case definition used in the study? 
7. Was the study instrument that measured the parameter of interest shown to have validity and 
reliability? 
8. Was the same mode of data collection used for all subjects?  
9. Was the length of the shortest prevalence period for the parameter of interest appropriate? 
10. Were the numerator(s) and denominator(s) for the parameter of interest appropriate? 
Summary item interpretation: Summary item on the overall risk of study bias was scored as low, moderate 
or high for risk of bias. Low=Low risk of bias i.e. Further research is very unlikely to change our 
confidence in the estimate; Moderate=Moderate risk of bias i.e. Further research is likely to have an 
important impact on our confidence in the estimate and may change the estimate; High=High risk of bias 
i.e. Further research is very likely to have an important impact on our confidence in the estimate and is 
likely to change the estimate. 
Narrative summary of quality assessment  
Both LTBI and TB prevalence studies scored poorly on external validity items numbered (1) and (2) 
because the Hoy et al. tool for assessment of external validity gives weight to national surveys with sampling 
frames that include all households in the country of study conduct or that perform a census. Such studies 
are often costly and resource intense and are rarely commissioned by national TB control programs. This 
quality assessment highlights limitation of community surveys in determining country–level adolescent TB 
burden and the need for more research on adolescent LTBI and TB prevalence or revised reporting by 
surveillance systems or surveys to profile adolescent TB burden for monitoring.  
Marais, 20053 and Nduba, 20154 et al. aspects of the criteria save the fact that they were not national in 
scope, otherwise the studies were rigorously designed meeting all other key assessment items. 
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Snow, 20178 study was rated as high risk of bias because by nature passive surveillance likely grossly 
underestimates TB incidence and the fact that all items on the Hoy et al.’s external validity scoring had an 
unfavorable score. 
Waako, 20135 and Mumpe–Mwanja, 20155: these two are research outputs from the same study with 
two publications, for LTBI and for TB prevalence. The main reason for classification as ‘moderate’ on 
overall risk of bias is that sample selection was by a convenience sample, no random sample selection. 
Mahomed, 20112 and Mahomed, 20137: these two are research outputs from the same study with two 
publications, for LTBI and for TB prevalence. The main reason for classification as ‘moderate’ on overall 
risk of bias is that sample selection was by a convenience sample and only conducted in schools, thus no 
random sample selection and non–school–going adolescents are not represented. Middelkoop, 20141, 
similar to Mahomed et al., used a convenience sample of nearly schools, thus no random sample selection 
and non–school–going adolescents are not represented. 
References  
See reference list for chapter 2 
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 Appendix 3.1 
Distribution of study participants by age 
 
Legend: There were only 5 and 0 study participants aged 12 years in 2005–2007 and 2014–2015 respectively. There 
were 134 and 0 study participants aged 19 years in 2005–2007 and 2014–2015 respectively. Study participants were 
aged between 12.3 and 19.1 years. 
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 Appendix 3.2 
Prevalence of latent TB infection by school and quintile category among high school students in 
Worcester 
Variable Prevalence for 
2005 – 2007 
{n/N (%; CI)} 
Prevalence for 
2014 – 2015 






Prevalence for both 
periods 
{n/N (%; CI)} 
School      
A 740/1413 
(52.4%; 49.8 – 55.0) 
251/452 




(53.9%; 51.6 – 56.3) 
B 763/1181 
(64.6%; 61.9 – 67.3) 
220/399 




(59.9%; 52.8 – 67.0) 
C 444/867 
(51.2%; 47.9 – 54.5) 
218/427 




(51.1%; 51.0 – 51.2) 
D 338/678 
(49.9%; 46.1 – 53.6) 
262/512 




(50.5%; 49.5 – 51.5) 
E 50/261 
(19.2%; 14.4 – 23.9) 
38/94 




(29.8%; 13.9 – 45.7) 
F 46/215 
(21.4%; 15.9 – 26.9) 
8/20 




(30.7%; 16.8 – 44.6) 
G 23/192 
(12.0%; 7.4 – 16.6) 
6/21 




(20.3%; 7.9 – 32.7) 
H 30/73 
(41.1%; 29.8; 52.4) 
22/43 




(46.0%; 38.5 – 53.5) 
Quintile of 
school 
     


















3 … … … … … 
4 1184/2280 
(51.8%; 50.8, 52.8) 
469/879 




(52.6%; 50.0, 55.1) 
5 149/741 
(20.4%; 11.8, 32.8) 
74/178 




(29.2%; 20.4, 39.8) 
Legend: *=statistically significant; **=insufficient data for comparison of proportions; …***=insufficient data; 
NA=not applicable e.g. because the study was not conducted over this period; HS=high school; 
SES=Socioeconomic status. ****=Classification into low and high SES of the school was obtained from the National 
Department of Basic Education.  
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 Appendix 3.3 
Changes in prevalence of LTBI by socioeconomic quintile category of the school 
 
Legend: LTBI=Latent Tuberculosis Infection. There was no quintile 3 school in our study population. We 
observed a significant direct relationship between age and prevalence of LTBI for quintile 1 (rs= 0.100; p–value 
<0.001), quintile 4 (rs= 0.099; p–value <0.001) and quintile 5 (rs= 0.077; p–value <0.019) schools but not for quintile 
2 schools (rs= 0.044; p–value=0.078). 
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 Appendix 3.4 
Percentage change in Annual risk of Tuberculosis Infection across the two periods by school 
 
Legend: ARTI= Annual risk of Tuberculosis Infection. This figure shows the change in ARTI in 2014–2015 as 
compared to 2005–2007 and demonstrates that ARTI substantially increased in schools F, G and H and substantially 
reduced in school B. 
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 Appendix 3.5 
Annual Risk of Tuberculosis Infection by sociodemographic characteristics 
Variable  ARTI for 2005 – 2007 (%) ARTI for 2014 – 2015 (%) Overall ARTI (%) 
All participants 3.60% 4.23% 3.89% 
Sex    
Male 4.10% 4.10% 4.08% 
Female 4.24% 4.34% 4.26% 
Race/Ethnic group    
Black 4.81% 4.50% 4.68% 
Mixed Race  4.97% 4.24% 4.58% 
White 0.67% 1.86% 0.79% 
Asians/Indians 1.45% 1.74% 1.54% 
Grade    
8 4.21% 6.80% 5.21% 
9  4.44% 4.06% 4.26% 
10 4.50% 4.23% 4.35% 
11 3.98% 2.96% 3.45% 
12 2.60% 0.13% 1.60% 
Age    
12 5.05% 3.00% 3.75% 
13 3.32% 3.69% 3.53% 
14 3.55% 4.14% 3.86% 
15 3.71% 4.11% 3.91% 
16 3.75% 5.09% 4.39% 
17 3.43% 4.37% 3.85% 
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18 3.73% … … 
19 … … … 
School     
A 4.66% 5.21% 4.90% 
B 6.29% 5.07% 5.60% 
C 4.51% 4.56% 4.52% 
D 4.28% 4.55% 4.44% 
E 1.34% 3.38% 2.25% 
F 1.53% 3.27% 2.32% 
G 0.81% 2.17% 1.44% 
H 3.31% 4.42% 3.83% 
Legend: ARTI= Annual risk of Tuberculosis Infection.  
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 Appendix 4.1 
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Legend: % is number of notified TB disease cases/total number of notified TB disease cases in specified year. 
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 Appendix 4.2 
Temporal trends in TB disease case notification rate by age 
Age  2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 P–value  
0–4 3979 3406 2842 1864 1682 2416 2601 2585 2557 4521 4055 0.876 
5–9 1353 773 428 436 222 528 569 495 429 541 373 0.276 
10–14 379 297 223 172 129 188 265 190 226 166 151 0.087 
15–19 938 822 777 740 552 663 525 570 613 549 566 0.008 
20–24 1309 1173 1089 1102 900 989 1055 990 913 807 859 0.003 
25–29 1574 1384 1505 1349 1291 1228 1041 1138 1007 905 1007 <0.001 
30–34 1984 2009 1695 1498 1545 1820 1515 1504 1476 1279 1331 0.003 
35–39 1851 1729 1742 1978 1673 1501 1648 1390 1332 1211 1046 <0.001 
40–44 1867 1697 1469 1610 1415 1346 1593 1194 1295 1344 1221 0.003 
45–49 1403 1793 1557 1471 1736 1499 1694 1209 1370 1117 1284 0.062 
50–54 1312 1220 1082 1056 1043 852 1192 842 1128 1068 1023 0.062 
55–59 743 928 1045 873 846 774 826 860 909 691 755 0.275 
60–64 708 699 690 557 428 624 815 628 620 631 755 1.000 
≥65 433 293 494 464 364 383 435 283 324 298 326 0.213 
All 1535 1376 1237 1113 1002 1105 1155 1042 1050 1180 1131 0.161 
Legend: TB=Tuberculosis; TB disease case notification rate is per 100,000 for all notified cases of TB in the 
respective age group. The Mann–Kendall test was used to test for trend. “All” refer to all TB disease cases in the 
general population. 
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 Appendix 4.3 
Temporal trends in adolescent microbiologically confirmed TB disease case notification rate 
 
Legend: ART coverage= The proportion of persons living with HIV receiving antiretroviral therapy; 
TB=Tuberculosis disease. The figure shows that between 2005–2015, there was a significant negative temporal 
trend in microbiologically–confirmed TB among adolescents (TB rates fell 38% (from 492 to 305 per 100,000)) and 
adults (TB rates fell 34% (from 1267 to 832 per 100,000)), but a marked increase in childhood microbiologically–
confirmed TB rates (TB rates rose 250% (from 24 to 84 per 100,000)). The proportion of all persons living with 
HIV in the general population on ART was <1% in 2005, 12% in 2007, 40% in 2013 and 55% in 2015.9 P–value is 
for temporal trend between 2005–2015. 
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 Appendix 4.4 
TB disease case notifications in the general population by age, HIV status and laboratory test result status in 2015 
Age–
group 





lab confirmed3 HIV–4 HIV+5 All cases New 
cases 
lab confirmed All cases New 
cases 
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≥65 30  21  24 17  7  17  14  15  7 6  4 6 1  5 
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(1%) (70%) (80%) (71%) (29%) (2%) (82%) (88%) (1%) (86%) (57%) (3%) (17%) (83%) 




























Legend: Denominator; for 1=all notified TB disease cases in 2015; 2=new + relapse cases; 3=lab + non–lab confirmed; 4=HIV– + HIV+ 
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 Appendix 4.5 
Overall TB disease case notification rate in the general population in Breede Valley subdistrict by year 









confirmed TB (CI) 
Proportion with known HIV status 
of notified TB disease cases n/N 
(%) 
Proportion HIV+ of notified TB 
disease cases with known HIV status 
n/N (%) 
2005 2372 154565 1535  
(1473–1598) 






2006 2155 156611 1376  
(1319–1435) 






2007 1963 158654 1237  
(1183–1293) 






2008 1788 160701 1113  
(1062–1165) 






2009 1631 162747 1002  
(954–1052) 






2010 1821 164794 1105  10.3% 657  938/1821  366/938  
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(1055–1157) (619–698) (51.5%) (39.0%) 
2011 1927 166826 1155  
(1104–1208) 






2012 1761 169010 1042  
(994–1092) 






2013 1798 171226 1050  
(1002–1100) 






2014 2047 173468 1180  
(1129–1232) 






2015 1987 175740 1131  
(1081–1181) 








NA NA 1246  
(1018–1474) 
NA 720  
(504–936) 
NA NA 
Legend: CI=95% confidence interval for rate per 100000; CNR=Case Notification Rate per 100000; Incidence rate is per 100000; NA=Not applicable; TB=Tuberculosis; 
n/N=. Note, patients ‘transferred in’ and ‘moved in’ are excluded in this calculation, but transfer out, moved out or relapses are included. TB disease notification rate in the 
general population fell by 26% from 1,535 (2005) to 1,131 (2015) per 100,000 per annum. 
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 Appendix 4.6 
Adolescent TB disease case notification rate by sex 
Year  All TB disease cases in males  All TB disease cases in females  TB rate in males TB rate in females 
2005 88 99 627 696 
2006 69 92 485 639 
2007 66 80 458 548 
2008 55 80 377 541 
2009 45 57 304 381 
2010 70 59 467 389 
2011 65 56 429 365 
2012 46 72 300 463 
2013 73 59 469 375 
2014 57 57 362 357 
2015 59 57 369 353 
Average  63 73 425 496 
p–value  NA NA 0.087 <0.001 
Legend: TB rates refer to adolescent TB disease case notification rate per 100,000 adolescents. All TB disease cases 
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 Appendix 5.1 
Carbon dioxide logger 
 
Legend: Brief description of device and how it works 
This device is a carbon dioxide logger (Ethernet Multilogger – thermo–hygro–carbon dioxide   meter with 
2 MiniDIN and 2 Terminals).51 It measures 17.8 cm by 9.5 cm by 3.7 cm. It has an internal carbon dioxide   
sensor that uses non‐dispersive infrared technology to sense carbon dioxide   and measure carbon dioxide   
concentration in the air as a function of transmitted light. The device is designed for measuring and 
recording temperature, humidity, carbon dioxide   concentration with adjustable recording intervals from 
1 second to 24 hours. The internal carbon dioxide   concentration sensor measures carbon dioxide   
concentration in the air with a range of 0 to 2,100 ppm with an accuracy of 50 ppm + 2% of the measured 
value. 
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 Appendix 5.2 
The Dry Filtration Unit 
 
Brief description of The Dry Filtration Unit and how it works42 
This device is a Dry Filtration Unit, a novel, portable, electricity–powered, ddPCR air sampling device that 
measures approximately 0.5 metres by 0.5 metres by 0.5 metres. The device works by filtering air through 
removable filters. Air is suctioned through an air inlet vent of approximately 10–centimetre diameter on 
the very top part of the chimney (the chimney is the black device on the top part of the Dry Filtration 
Unit with two white protruding “horns” (that serve as removable filter holders) on opposite ends/sides 
of the black protruding chimney). Air is suctioned via removable filters then out through an air outlet vent 
of approximately 5–centimetre diameter on the bottom–right side of the Dry Filtration Unit device. The 
Dry Filtration Unit device samples approximately 1,000 litres of air per minute. The removable filters 
within the “white horns” collect/trap particles from room air that may include any dust, bacteria or viruses 
onto the two filters in each of the two filter holders. After a period of ddPCR air sampling, the filters are 
extracted and transported to a laboratory for processing using sensitive analytical technologies such as 
Polymerase Chain Reaction for detection of bacteria and viruses and electrochemical luminescence for 
detection of toxins for routine samples.42 
Page | 181 
 
 Appendix 5.3 
Key socioeconomic and health indicators for Breede Valley local municipality(66) 
Indicator  Estimate (2015, unless otherwise stated) 
Demographic indicators  
General population size  174,198 
Households 46,963 
Annual growth rate 1.31% 
Economic indicators  
Unemployment (2014) 25% 
Per Capita Income (2013), US$ 2,502 
Households earning less than 38.6 p.m. (2011) 13.7% 
Housing indicator  
Informal dwellings (2014) 21% 
Education indicators  
Basic education enrolment (2014) 32,076 
Average school dropout rate (2012) 40.9 
Literacy Rate (2011) 82.1% 
Health indicators  
HIV prevalence (2010)67 4.6% 
ART patient load 4,584 
Mother–to–child HIV transmission rate 1.2% 
Number of ART clinics/treatment sites 8 
Maternal Mortality Ratio (per 100 000 live births) 27.0 
Full immunisation coverage for infants 86% 
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Legend: Pm=per month. ART=Antiretroviral therapy. Literacy rate is calculated as the proportion of individuals 
aged ≥14 years who have successfully completed ≥7 years of formal education. Basic education refers to enrolment 
in first 12 years of formal education.  
 
 Appendix 5.4 
Number of times spaces were sampled (either ddPCR air sampling or ambient carbon dioxide 
concentration measurement) 
Type of space Clinic A Clinic B Clinic C School B School D Open air 
space 
Total  
General patient waiting area 5 5 NA NA NA NA 10 
Open air space NA NA NA NA NA 5 5 
TB clinic consultation room 5 NA 9 NA NA NA 14 
TB clinic patient waiting area 5 5 5 NA NA NA 15 
Classroom  NA NA NA 32 40 NA 72 
Legend: NA=Not applicable 
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 Appendix 5.5 
ddPCR assay analytical methodology 
The ddPCR assay was performed by the Desmond Tutu HIV Centre54 of the University of Cape Town in 
collaboration with the laboratory of Professor Digby Warner (University of Cape Town). 
Sample preparation for ddPCR assay  
Polycarbonate track etch filters were processed as follows prior to ddPCR assay. 
1. Double–bagged sterile 50 ml falcon tubes containing polyester felt filter of 47mm diameter and 1.0μm 
pore size (American Felt and Filter Company, New Windsor, New York; Lockheed Martin, 
Alexandria, VA, USA) filters samples were retrieved from storage (2–4° Celsius).   
2. The bags were then surface–sterilized, opened inside a level III Biosafety cabinet (BSC), and the 
falcon tubes placed in a rack. 
3. 10 ml of cold 1 X phosphate buffered saline with 0.5% Tween80 PBS.T was pipetted into each tube. 
Each tube was securely closed and placed in a rack. These were placed in a secondary container, or 
bagged and left to soak overnight, at room temperature.  
4. The lid was securely fastened, and vortexed twice for 1 minute (with a pause in between). 
5. The filter was squeezed against the side of the tube with a sterile serological pipette tip, before being 
discarded into the non–liquid waste bag. 
6. Falcon tubes were loaded into centrifuge buckets inside the BSC, closed, decontaminated then placed 
into the centrifuge and centrifuged at 4500 rpm for 15 minutes.  
7. Transport centrifuge buckets containing tubes back to the BSC. Transfer the tubes onto an 
appropriate rack. Decontaminate the buckets and put back in the centrifuge. 
8. Discard the supernatant by pipetting it out into a liquid waste bottle. Leaving behind the last drop of 
liquid; the volume of which usually amounts to ±100 ul.  Resuspend the pellets in the remaining 
liquid.  
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9. Transfer the resuspended pellets into 2 ml tubes and heat–kill at 80 ̊ C for 1 hour in a water bath. 
10. Remove the tubes containing the heat–inactivated bacterial pellets from the water bath. Secured in 
an appropriate rack; allow the tubes to cool down to room temperature for 10 minutes.  
11. Spray the rack with 70% Ethanol and place it in a bag. Spray the bag and place it at the door for 
removal from the BSL 3. In the anteroom, place the bag containing the rack with the tubes within a 
decontaminated transport box. Transport the heat inactivated pellets to the BSL 2 for DNA 
extraction and ddPCR.  
12. Decontaminate the transport box again and return to the anteroom, in the BSL3. 
ddPCR assay 
1) Preparation of 22 µL PCR reactions. 
Stored field samples at 4°C containing gDNA (where applicable), controls and reagents were thawed on 
ice or preheated to 37–42°C. A master mix was prepared in the PCR–clean room using the following 
mastermix reagents (components) from BioRad Laboratories, Inc (Denver, Colorado, USA)56 for each 
reaction: 11 µl of 2X Super Mix, 0.75 µl of Forward Primer 10 (µM), 0.75 µl of Reverse Primer 10 (µM), 
0.5 µl of Probe 10 (µM), 1 µl of AmpErase 0.055U/µL, 1 µl of HINDIII 5U/µl. All reactions were pipetted 
in duplicates. The controls were positive Mycobacterium tuberculosis (H37RV) and No Template Controls 
(NTC) comprised of the master mix, with no added template. Enough mastermix was prepared for at least 
3 extra reactions, to compensate for possible pipetting errors and the extra mastermix required to make 
22 µl of NTC. Mastermix reagents were mixed in clean 1.5–2 ml PCR tubes, vortexed and span down. 30 
µL of mastermix was added to each well in every second column on a 96–well plate to ensure accurate 
duplication after DNA–addition. The 96–well plate was put into sterile sealable bag, UV light turned on, 
heating block turned on and samples taken from DNA extraction room and moved to DNA–addition 
hood. 14 µL of DNA was added to each well containing mastermix. The sample was then mixed well, and 
duplicates created by pipetting 22 µL of PCR–mixture to adjacent, empty wells (using multichannel 
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pipette). The 96–well plate was sealed using the PX1 PCR Plate sealer and the pierceable foil (at 180 ̊C for 
4 seconds). The 96–well plate was placed on ice, vortexed and briefly centrifuged using a plate spinner. 
2) Generation of droplets  
Bleach (using lint–free cloths) and ethanol (using alcohol wet wipes) were used to clean the interior of the 
Auto Droplet Generator (AutoDG) at least once a month. The following items were loaded; consumables, 
cartridges, tips, waste bin, and a new 96–well–plate on ice block (freeze for at least 2 hours at –20 ̊ C prior 
to droplet generation) and samples. Correct loading was marked by color change from amber to green. 
The Auto DG was then run for droplet generation. The PCR plate containing droplets was sealed using 
the PX1 PCR plate sealer 
3) Running ddPCR  
The dd_UNG (at 40 µl) program on the Thermal Cycler was chosen. The following PCR program was 
followed sequentially: 50 °C for 2 min (incubation for Amperase); 95 °C for 10 minutes; 94 °C for 30 
seconds; 60 °C for 1 minute; repeat 94 °C for 30 sec 40 times; 98 °C for 10 minutes; hold at  4 °C for 
between 5 hours to 24 hours before reading the plate after thermal cycling.  
4) Reading fluorescence amplitude from ddPCR 
The QX100 BioRad Droplet Reader was turned on for 30 minutes prior to PCR reading. The setting on 
the Auto DG was set to: Experiment – ABS (absolute quantification); Super Mix – (ddPCR Supermix for 
Probes); Target 1: Name – RD 9; Type – Ch1 Unknown; Target 2: Type:  Unused; Save and run the 
experiment; Choose Fam/Vic (dyes) in the pop–up window. The QX100 BioRad Droplet Reader was run 
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Quantification of Mycobacterium Tuberculosis DNA 
The starting concentration of each target DNA molecule was calculated by modeling as a Poisson 
distribution; the formula used for Poisson modeling is; Copies per droplet=–ln(1–p) where p=fraction of 
positive droplets (units/ul). 
 
 Appendix 5.6 
Duration of sampling by type of space 
Type of space n Duration of sampling 
median (IQR) 
Duration of sampling 
min, max 
General patient waiting area 10 (8.8%) 86 (40, 120) 20, 300 
Open air space 5 (4.4%) 81 (40, 120) 20, 300 
TB clinic consultation room 13 (11.5%) 82 (39, 117) 15, 301 
TB clinic patient waiting area 15 (13.3%) 82 (40, 122) 20, 306 
Classroom  70 (61.9%) 40 (35, 54) 15, 149 
Overall 113 (100%) 45 (35, 82) 15, 306 
Legend: Duration of sampling is in minutes; n=number of times the space was sampled for classroom ambient 
carbon dioxide concentration measurement. 2 classrooms did not have classroom ambient carbon dioxide 
concentration measurements; min=minimum; max=maximum 
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 Appendix 5.7 
Number of people in room by type of space 
Type of space Number of people in room at start of 
sampling 
Median (IQR)  
Number of people in room at end of 
sampling  
Median (IQR)  
General patient waiting area 42 (27, 45) 20 (5, 24) 
Open air space 0 (0, 0) 0 (0, 0) 
TB clinic consultation room 3 (3,5) 3 (2,5) 
TB clinic patient waiting area 5 (2,7) 5 (1,11) 
Classroom  34 (29, 39) 34 (29, 38) 
Legend: IQR=Interquartile range. 
 
 Appendix 5.8 
Distribution of windows by type of space 
Type of space Number of windows 
Median (IQR)  
Number of windows open 
at start of sampling  
Median (IQR)  
Number of windows open 
at end of sampling  
Median (IQR) 
General patient waiting area 12.5 (10, 17) 7.5 (6, 13) 7 (6, 13) 
Open air space NA NA NA 
TB clinic consultation room 2 (2,2) 0 (0,2) 0 (0,2) 
TB clinic patient waiting area 2 (0,8) 2 (0,6) 2 (0,6) 
Classroom  7 (5, 7) 2 (0.5, 3) 2 (0, 3) 
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 Appendix 5.9 
Proportion of windows open by type of space 
Type of space Total number of 
windows* N 
 
Proportion of windows 
open at start of sampling n 
(%) 
 
Proportion of windows 
open at end of sampling n 
(%) 
General patient waiting area 125 86 (69%) 82 (66%) 
Open air space NA NA NA 
TB clinic consultation room 24 11 (46%) 9 (38%) 
TB clinic patient waiting area 36 32 (89%) 31 (86%) 
Classroom  501 137 (27%) 132 (26%) 
Total 706 275 (39%) 258 (37%) 
Legend:  *=For clinic spaces, windows were counted for every instance of repeat sampling in the same space. 
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 Appendix 5.10 
Distribution of doors and proportion of doors open by type of space 
Season  
(weather) 
Month  Average daytime 
temperature 
(Degrees Celsius) 
Proportion of all available 
windows open in 
classrooms  
n/N (%) 
Proportion of all available 
windows open in clinic 
spaces  
n/N (%) 
carbon dioxide   
concentration 
Median (IQR) 
Summer February 29 NA 25/35 (71%) 543 (392, 583) 
Fall March 27 18/24 (75%) NA 835 (751, 893) 
April 25 18/79 (23%) NA 933 (774, 1321) 
May 22 17/135 (13%) NA 872 (761, 1448) 
Winter July 20 5/27 (19%) NA 1297 (1235, 2100) 
August 20 40/110 (36%) NA 860 (679, 1114) 
Spring  September 21 39/126 (31%) NA 935 (813, 1161) 
November 25 NA 104/150 (69%) 467 (408, 589) 
Legend: NA=No sampling took place. No sampling occurred in January, June, October and December. Weather 
seasons in South Africa are approximately Summer (1 December – 28/29 February), Winter (1 June – 31 August), 
Spring (1 September – 30 November), Autumn/Fall (1 March – 31 May).  
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 Appendix 5.11 
Distribution of doors and proportion of doors open by type of space 
Type of space Number of doors per 
space* N 
 
Total number of 
doors for all instances 
of sampling * N 
Proportion of 
doors open at 
start of sampling 
n (%) 
Proportion of 
doors open at end 
of sampling n (%) 
General patient waiting area 4.5 (2,5) 51 13 (24%) 10 (20%) 
Open air space NA NA NA NA 
TB clinic consultation room 1 (1, 2) 27 5 (19%) 5 (19%) 
TB clinic patient waiting 
area 
4 (3, 9) 56 12 (21%) 12 (21%) 
Classroom  1 (1, 1) 121 39 (54%) 34 (47%) 
Total 1 (1, 2) 263 72 (27%) 63 (24%) 
Legend:  *=For clinic spaces, doors were counted for every instance of repeat sampling in the same space.  Data 
on the volume of each space is not available. 
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 Appendix 5.12 
Summary of shape of distribution (skewness) of carbon dioxide   values 
Distribution of carbon dioxide   values Clinic Classroom 
High negative skew 4 (19%) 8 (12%) 
High positive skew 10 (47%) 13 (21%) 
Moderate negative skew 1 (5%) 13 (21%) 
Moderate positive skew 4 (19%) 5 (8%) 
Symmetrical 2 (10%) 24 (38%) 
Total 21 (100%) 63 (100%) 
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 Appendix 5.13 
Distribution of carbon dioxide concentration by episode of sampling 
Space ID Type of space Median 
carbon 
dioxide   
Nadir 
carbon 
dioxide   
Peak 
carbon 
dioxide   
Kurtosis Skewness Distribution/
skew 
WORC–093 classroom 2100 1929 2100 21.03 –4.35 High Neg  
WORC–079 classroom 2100 1375 2100 6.34 –2.11 High Neg  
WORC–056 clinic space 555 447 591 7.66 –1.86 High Neg  
WORC–122 classroom 984 753 1020 5.46 –1.8 High Neg  
WORC–052 clinic space 619 392 702 6.53 –1.73 High Neg  
WORC–071 classroom 2034 1488 2100 4.42 –1.65 High Neg  
WORC–118 classroom 906 813 938 5.05 –1.4 High Neg  
WORC–066 classroom 1162 664 1250 3.69 –1.37 High Neg  
WORC–050 clinic space 616 491 671 4.01 –1.17 High Neg  
WORC–057 clinic space 584 390 676 3.4 –1.11 High Neg  
WORC–091 classroom 1242 816 1320 2.7 –1.1 High Neg  
WORC–102 classroom 2100 572 2100 2.39 –1.01 High Neg  
WORC–008 clinic space 408 384 526 3.6 1.04 High Pos  
WORC–074 classroom 761 690 904 6.82 1.2 High Pos  
WORC–010 clinic space 411 381 524 3.64 1.22 High Pos  
WORC–076 classroom 595 524 821 3.98 1.26 High Pos  
WORC–009 clinic space 595 437 1128 5.25 1.26 High Pos  
WORC–126 classroom 788 679 1210 4.26 1.32 High Pos  
WORC–108 classroom 638 585 969 3.79 1.32 High Pos  
WORC–124 classroom 816 792 1167 4.01 1.46 High Pos  
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WORC–073 classroom 1452 1243 2100 5.24 1.68 High Pos  
WORC–095 classroom 753 650 1131 6.19 1.83 High Pos  
WORC–020 clinic space 459 408 640 12 1.85 High Pos  
WORC–007 clinic space 591 391 1085 16.68 1.97 High Pos  
WORC–098 classroom 1018 915 1320 8.54 2.02 High Pos  
WORC–083 classroom 838 775 1282 7.06 2.11 High Pos  
WORC–018 clinic space 379 368 515 10.19 2.24 High Pos  
WORC–053 clinic space 385 372 616 7.61 2.35 High Pos  
WORC–120 classroom 554 532 626 9.12 2.35 High Pos  
WORC–101 classroom 761 651 1350 9.04 2.39 High Pos  
WORC–014 clinic space 400 389 434 10.38 2.44 High Pos  
WORC–077 classroom 617 566 919 10.48 2.58 High Pos  
WORC–086 classroom 759 605 1303 11.7 2.95 High Pos  
WORC–012 clinic space 384 377 562 16.6 3.82 High Pos  
WORC–017 clinic space 379 372 484 25.72 4.48 High Pos  
WORC–096 classroom 994 659 1127 2.54 –0.92 Mod Neg  
WORC–080 classroom 2080 1191 2100 2.23 –0.9 Mod Neg  
WORC–117 classroom 2100 983 2100 2.19 –0.89 Mod Neg  
WORC–107 classroom 1097 895 1179 2.73 –0.83 Mod Neg  
WORC–111 classroom 945 731 992 2.18 –0.8 Mod Neg  
WORC–062 classroom 815 501 1013 2.84 –0.67 Mod Neg  
WORC–110 classroom 1447 973 1615 2.18 –0.66 Mod Neg  
WORC–059 clinic space 556 439 623 3.57 –0.64 Mod Neg  
WORC–106 classroom 699 647 714 2.07 –0.61 Mod Neg  
WORC–099 classroom 1814.5 654 2100 1.79 –0.6 Mod Neg  
WORC–119 classroom 1254 705 1458 2.01 –0.6 Mod Neg  
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WORC–075 classroom 1003 701 1114 1.77 –0.55 Mod Neg  
WORC–092 classroom 1189.5 577 1449 1.91 –0.55 Mod Neg  
WORC–085 classroom 856 566 947 2.54 –0.54 Mod Neg  
WORC–081 classroom 1383 887 2100 3.5 0.52 Mod Pos  
WORC–013 clinic space 682 519 1026 2.54 0.62 Mod Pos  
WORC–025 clinic space 615 548 777 2.48 0.62 Mod Pos  
WORC–065 classroom 1327 1288 1384 2.15 0.63 Mod Pos  
WORC–072 classroom 835 641 1435 1.96 0.67 Mod Pos  
WORC–115 classroom 925 855 1269 1.8 0.71 Mod Pos  
WORC–089 classroom 861 818 978 3.14 0.8 Mod Pos  
WORC–027 clinic space 557 422 810 3.15 0.83 Mod Pos  
WORC–023 clinic space 444 408 528 4.97 0.87 Mod Pos  
WORC–112 classroom 829 603 867 1.58 –0.5 Symmetrical 
WORC–088 classroom 1313 425 1944 2.71 –0.49 Symmetrical 
WORC–103 classroom 1699 731 2100 1.79 –0.46 Symmetrical 
WORC–067 classroom 1290 970 1472 3.31 –0.46 Symmetrical 
WORC–113 classroom 1064 648 1202 1.71 –0.45 Symmetrical 
WORC–078 classroom 1688 991 2100 1.83 –0.44 Symmetrical 
WORC–116 classroom 807 651 906 2.01 –0.41 Symmetrical 
WORC–097 classroom 597.5 553 629 2.27 –0.33 Symmetrical 
WORC–121 classroom 993 627 1206 1.86 –0.31 Symmetrical 
WORC–082 classroom 822 750 882 2.98 –0.28 Symmetrical 
WORC–104 classroom 694 609 764 3.15 –0.28 Symmetrical 
WORC–125 classroom 871 821 902 2.15 –0.16 Symmetrical 
WORC–109 classroom 637 594 669 1.58 –0.12 Symmetrical 
WORC–069 classroom 585 529 638 1.84 –0.12 Symmetrical 
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WORC–064 classroom 847 532 1128 2.04 0.01 Symmetrical 
WORC–100 classroom 867 758 964 1.97 0.03 Symmetrical 
WORC–114 classroom 1257 564 2100 1.7 0.09 Symmetrical 
WORC–068 classroom 842 745 967 2.8 0.17 Symmetrical 
WORC–084 classroom 768 713 850 2.89 0.17 Symmetrical 
WORC–070 classroom 816 672 978 2.72 0.2 Symmetrical 
WORC–094 classroom 619 575 668 2.25 0.21 Symmetrical 
WORC–030 clinic space 582 445 787 2.09 0.24 Symmetrical 
WORC–063 classroom 874 820 946 2.11 0.26 Symmetrical 
WORC–105 classroom 874 572 1282 3.19 0.32 Symmetrical 
WORC–011 clinic space 657 522 861 2.52 0.38 Symmetrical 
WORC–123 classroom 1018 865 1218 2.03 0.42 Symmetrical 
Legend: Mod=Moderate. Pos=positive. Neg=Negative. Carbon dioxide concentration is in parts per million 
(ppm). Notes on interpretation of skewness and kurtosis;69, 70  
1) If skewness is less than −1 or greater than +1, the distribution is highly skewed.  
2) If skewness is between −1 and −½ or between +½ and +1, the distribution is moderately skewed.  
3) If skewness is between −½ and +½, the distribution is approximately symmetrical. 
4) For kurtosis, the reference standard is a normal distribution, which has a kurtosis of 3. 
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 Appendix 5.14 
Sociodemographic characteristics of students screened for TB disease by ventilation risk status  
Variable Low ventilation risk classrooms High risk ventilation classrooms 
Number of participants (n(%)) 980 (57.8%) 716 (42.2%) 
Age (median (IQR) 16.3 (15.0; 17.4) 15.9 (15.1; 17.4) 
Sex (male) 393 (45.4%) 297 (44.3%) 
Race   
African 486 (54.2%) 449 (65.1%) 
Mixed race 401 (44.6%) 235 (34.1%) 
White 10 (1.1%) 4 (0.6%) 
Indian/Asian 1 (0.1%) 1 (0.2%) 
Legend: Numbers are n (%) or n (IQR).  
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 Appendix 5.15 
Description of measurement of proportion of rebreathed fraction, absolute rebreathed air volume, 
classroom ventilation rate and volume of air through the classroom 
To calculate the proportion of rebreathed fraction from other people, we adjusted the rebreathed fraction 
for the number of people in the defined space, as follows.32 
fo=f
*((n–1)/n)            (2) 
Where n is the total number of people in the defined space and f is the rebreathed fraction.  
To obtain the absolute rebreathed air volume, we obtained the product of proportion of rebreathed air 
from other people (fo) and respiratory minute volume ((p) and summed over all observations (termed 
‘summation’ in statistics). i.e.32  
Rebreathed Air Volume =∑p fo (t)          (3) 
Where p is the respiratory minute volume, estimated from literature as 8.0 litres/minute.53 
Ambient carbon dioxide concentration values can thus be used to estimate rebreathed (shared) air in an 
enclosed space.32 
Calculation of classroom ventilation rate 
The conversion between indoor carbon dioxide concentration and ventilation rate (in litres per person per 
second) was obtained using the following equation;71 
Q=G/(Cin–Cout)            (4) 
Where: Q=Ventilation rate per person (l/p/s); Cin= indoor carbon dioxide concentration in ppm; Cout= 
outdoor carbon dioxide concentration in ppm; G=carbon dioxide  generation rate in classroom (in litres  
per person per second) which was obtained using the formulae:28 
G=?̅?Cex            (5) 
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Where Cex= carbon dioxide concentration in exhaled breath (38,000 from literature);
53  V̅=average volume 
of gas exhaled by adolescents per second (0.13 litres/second/person from literature).53 Therefore, 
G=5067.  
The ventilation rate per person obtained above was used as one of the parameters in the equation for 
obtained the air flow or ventilation rate to a room. 
Classroom ventilation in air changes per hour (ACH) was obtained by the following equation from 




            (6) 
Where; ACH= Air Changes per Hour; Q= per person ventilation rate (l/p/s); n=Number of students in 
classroom and Volume=Estimated volume of classroom in litres. 
Volume of air through the classroom 
The total volume of air that was in the classroom for the duration of ddPCR air sampling, for calculation 
of RD9 Mycobacterium tuberculosis DNA  concentration per volume of air was obtained by the following 
equation; 
Total volume=ACH * Estimated volume of classroom * Duration of sampling in hours      (7) 
Where; ACH= Air Changes per Hour. 
See reference list of Chapter 4 for bibliographies of references in appendix 15. 
 
